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I. INTRODUCTION
Genetic engineering is changing the semantics, the meaning of
life itself We're trying to usurp the plant's choice. To force alien
words into the plant's poem, but we [have] a problem. We barely
know the root language. Genetic grammar's a mystery ....
We've learned a lot about the letters-maybe our ability to read
and spell words now sits halfway between accident and design-
* Debra Strauss is an Assistant Professor of Business Law at Fairfield Univer-
sity, Charles F. Dolan School of Business. She received her B.A. from Cornell Uni-
versity and her J.D. from Yale Law School. Professor Strauss, a former Food and
Drug Law Institute Scholar, currently teaches the legal environment of business,
international law, and law and ethics.
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but our syntax is still haphazard. Scrambled. It's a semiotic
nightmare.
Man alone of all Nature's children thinks of himself as the center
about which his world, little or large, revolves, but if he persists in
this hallucination he is certain to receive a shock that will waken
him or else he will come to grief in the end.!
One of the essential functions of life is the ability to reproduce
for the survival of future generations. The biotechnology industry is
taking this ability away in order to turn a profit for no other reason
than because they can-man has figured out the essence of life.
Genetically Modified Organisms (GMOs) are created when the
genes of one organism are inserted into the DNA of another organ-
ism, causing the target trait to be expressed in that non-related spe-
cies.' The genetically modified (GM) plants then produce GM foods
and ingredients, which now occupy a vast majority of food products
on U.S. grocery store shelves.4 Glyphosate-tolerant soybeans (e.g.,
Roundup Ready® by Monsanto) contain a gene that protects them
from the herbicide glyphosate, allowing the fields to be sprayed with
the herbicide to kill the weeds while leaving the soybeans standing.'
Herbicide-resistant varieties of canola, cotton, corn, radicchio, rice,
and sugar beet are also on the market.6 Genes derived from a bacte-
rium in the soil used as an insecticide, Bacillus thuringiensis (Bt), have
been inserted into crops to induce the plant to produce a toxin
against certain insects, producing Bt-corn, Bt-cotton, Bt-potatoes, Bt-
rice, and Bt-tomatoes.7 The United States has approved virus-
1. RUTH OZEKI, ALL OVER CREATION 124-25 (Penguin Books 2003).
2. Id. at 243 (quoting LUTHER BURBANK & WILBUR HALL, THE HARVEST OF THE
YEARs (1927); Luther Burbank was a pioneer of agricultural science who, among
other things, developed the Burbank potato).
3. See Associated Press, Americans Clueless About Gene-Altered Foods (Mar. 24,
2005), available at http://pewagbiotech.org/newsroom/summaries/dis-
play.php3?NewsID=857.
4. The Grocery Manufacturers of America estimates that seventy-five percent of
all processed foods in the United States contain a GM ingredient, including almost
every product with a corn or soy ingredient and some containing canola or cotton-
seed oil. See id. (statement of Stephanie Childs, Grocery Manufacturers of Amer-
ica).
5. See Food & Drug Administration (FDA), Center for Food Safety & Applied
Nutrition (CFSAN), List of Completed Consultations on Bioengineered Foods (Nov.
2005), available at http://www.cfsan.fda.gov//-Ird/biocon.html.
6. See id.
7. See id. "Bacillus thuringiensis (Bt) is a naturally occurring soil bacterium that
produces proteins active against certain insects." Mike Mendelsohn et al., Are Bt
Crops Safe?, 21 NATURE BIOTECHNOLOGY 1003 (Sept. 2003).
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resistant varieties of papaya, potato, and squash, along with tomato
and cantaloupe varieties containing a gene that slows the ripening
process to allow fruit to ripen longer on the vine.' There is even an
invention called "Terminator" technology, also known as Genetic
Use Restriction Technologies (GURTs), which refers to plants that
have been genetically modified to render sterile seeds at harvest,
eliminating the possibility of future generations from a plant's
seeds.9 Terminator technology was developed by the multinational
seed/agrochemical industry and the United States Department of
Agriculture (USDA) to prevent farmers from saving and replanting
harvested seed.'" Terminator technology has not yet been commer-
cialized or field-tested, but tests are currently being conducted in
greenhouses in the United States."
Unlike the strict regulatory approach of European and interna-
tional law, the United States does not treat genetically modified
foods differently than other foods.'" Since the development of GM
foods, no federal legislation has been enacted, nor have regulatory
agencies required any labeling or special approval of these sub-
stances." The legal system in the United States appears to be ill-
equipped or unwilling to recognize the risks (i.e., the Food and
Drug Administration (FDA) does not consider genetically engi-
8. See id.
9. Ban Terminator, Genetic Use Restriction Technologies (GURTs),
http://www.banterminator.org/glossary/genetic use-restriction-technologies
_gurts (last visited Aug. 18, 2007).
10. CANADIAN INST. FOR ENVTL. L. & POL'Y, FACT SHEET SERIES ON INNOVATIVE
TECHNOLOGIES-2006: GENETIC USE RESTRICTION TECHNOLOGIES (GURTs) OR
TERMINATOR TECHNOLOGY, at 3 (2006), available at http://www.cielap.org/
pdf/TerminatorTechnologyFactsheet.pdf.
11. "Genetic Use Restriction Technologies (GURTs) is the 'official' name for
Terminator technology that is used at the United Nations and by scientists. It re-
fers to ... technologies that, in their design, provide a mechanism to switch intro-
duced genes on or off, using external inducers like chemicals or physical stimuli
(e.g., heat shock). This mechanism allows for restricted use or performance of
transgenes." See Ban Terminator, supra note 9. Two types of GURTs rely on the
same mechanism: variety-related (V-GURTs) and trait-related (T-GURTs). V-
GURTs control reproductive processes to result in seed sterility, thus affecting the
viability of the whole variety. T-GURTs control the use of traits such as insect resis-
tance, stress tolerance or production of nutrients. See id.
12. See Debra M. Strauss, The International Regulation of Genetically Modified Or-
ganisms: Importing Caution into the U.S. Food Supply, 61 FOOD & DRUG L.J. 167, 168
(2006) [hereinafter International Regulation of Genetically Modified Organisms] (dis-
cussing the legal issues associated with the regulation of GMOs, including a com-
parison of European and international law to the U.S. approach and a proposal for
labeling and monitoring).
13. Id. at 182.
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neered foods to be a "substantially different" product or a "mate-
rial" change from other hybrid methods)'4 and regulate this area.'5
Perhaps this is another area where an examination of the ethical
issues can lead to developments in the law-the arguments have to
be raised for the community to address the concerns and resolve
these issues.
Meanwhile, the proliferation of GM crops continues. "Global
biotech crop acreage grew to 252 million acres in 2006, according to
the International Service for the Acquisition of Agri-biotech Appli-
cations (ISAAA)."" Since biotech crops were first commercialized in
1996, the global biotech crop area has increased more than fifty-
fold; most astonishingly, the one-billionth cumulative acre of biotech
crops was planted in 2005.'" These GM crops were planted in
twenty-two countries by 10.3 million farmers.'8 Of the 10.3 million
farmers, ninety percent are resource-poor farmers in developing
countries, and developing countries comprise more than one-third
of the global biotech crop acreage." However, the United States
leads in total crop acreage-49.8 million hectares (fifty-five percent
of the global biotech area)-with the biotech crops of soybean,
maize, cotton, canola, squash, and papaya."° Biotech soybean was
the principal biotech crop in 2005, occupying 54.4 million hectares
(sixty percent of global biotech area), followed by maize (21.2 mil-
lion hectares at twenty-four percent), cotton (9.8 million hectares at
eleven percent) and canola (4.6 million hectares at five percent).'
Between 1996 and 2005, the first decade of commercialization of
GM crops, the dominant trait introduced into crops was herbicide
14. Id. at 183.
15. Id. at 168.
16. Biotechnology Industry Organization (BIO), 2006 Global Biotech Crop Acreage
Increases by 13 Percent Over 2005, http://www.bio.org/news/features/
20060210.asp?p=yes (last visited Aug. 18, 2007).
17. See Truth About Trade & Technology, One Billionth Acre of Biotech Crops Has
Been Planted, http://www.truthabouttrade.org/article.asp?id=3833 (last visited Aug.
18, 2007).
18. See BIO, supra note 16.
19. See id. See also Truth About Trade & Technology, supra note 17.
20. CLIVEJAMES, INT'L SERV. FOR THE ACQUISITION OF AGRI-BIOTECH APPLICATIONS
(ISAAA), ISAAA BRIEFS No. 34-2005: EXECUTIVE SUMMARY: GLOBAL STATUS OF
COMMERCIALIZED BIOTECH/GM CROPS: 2005, at iii, available at http://
www.isaaa.org/Resources/publications/briefs/34/download/isaaa-brief-34-
2005.pdf.
21. Id. at iv.
[VOL. 3:1
2007] ETHICAL IMPLICATIONS OF GENETICALLY MODIFIED PLANTS 5
tolerance, followed by insect resistance and stacked genes for the
two traits.'
This growth has led the industry to proclaim that "agricultural
biotechnology has been adopted faster than any other farming im-
provement since introduction of the tractor in the 1800's."' A small
number of powerful companies own large percentages of the world
seed market, consolidating their seeds and agricultural chemical
operations through buy-outs and licensing of technology.24 "Mon-
santo's role as probably the most incessant promoter of genetic en-
gineering in agriculture has been bolstered by its acquisitions of
many of the largest, most established seed companies in the U.S."'
Monsanto is publicly touting bringing to the market their "second
generation traits" and their "commercial head start is helping [Mon-
santo] move new products through pipeline development to market
faster."" In fact, some say that transgenic crops have been devel-
oped, introduced, and adopted quickly in the United States, perhaps
in part because approval is cheaper and faster than the approval
process for a new chemical pesticide.' With its focus on marketing,
speed, and market share, this biotechnology company clearly sounds
like the big business that it is, rather than a scientific organization
that gives greater consideration to public policy and safety concerns.
22. Id.
23. Monsanto, Learn About Agricultural Biotechnology, http://www.monsanto.
com/monsanto/layout/feature02.asp (last visited Aug. 18, 2007).
24. See, e.g., Delta and Pine Land Company (DPL), D&PL Investor News,
http://www.deltaandpine.com/press-investors.asp (last visited Aug. 18, 2007).
This U.S.-based transnational "seed giant that vows to commercialize Terminator
seed technology is expanding its global reach with the recent acquisition of Syn-
genta's global cotton seed business. The new acquisition gives Delta & Pine Land's
cotton seed business a bigger stake in India, Brazil, and Europe. The company is
the world's leading cotton seed company. In 2005, DPL had revenues of $366 mil-
lion." See Ban Terminator, Delta & Pine Land, developer of Terminator seeds, extends
global reach, May 22, 2006, http://www.banterminator.org/news-up-
dates/newsupdates/delta-pinejland-developer of terminator seeds extends-glo
balreach (last visited Aug. 18, 2007).
25. Brian Tokar, Resisting Biotechnology and the Commodification of Life, 18
SYNTHESIS/REGENERATION, Winter 1999, available at http://www.greens.org/s-
r/18/18-01.html.
26. Monsanto, Products and Solutions, Setting the Standard in the Field,
http://www.monsanto.com/monsanto/layout/products/default.asp (last visited
Aug. 18, 2007).
27. DAVID E. ERVIN ET AL., HENRY A. WALLACE CTR. FOR AGRIC. & ENV'T POLICY AT
WINROK INT'L, TRANSGENIC CROPS: AN ENVIRONMENTAL ASSESSMENT 14 (Nov. 2000),
available at http://www.winrock.org/wallace/wallacecenter/documents/trans-
genic.pdf.
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These facts raise key queries: Do we trust companies like Monsanto
to make these significant decisions about the future of our food
supply? Given their inherent focus on profit, are they the appropri-
ate parties to make ethical determinations about where our re-
sources and technology should be directed? 8
A recent survey on GM foods revealed that a significant major-
ity of consumers believe that the government should include ethical
and moral considerations when making regulatory decisions about
genetic engineering.' Moreover, consumers "seek an active role
from regulators to ensure that new products are safe. "'° In making
these decisions about the public health, participation of all stake-
holders is essential.
In view of the mandate from consumers and the critical role of
food safety in human health and the environment, more reflective
thought must be given to the direction of biotechnology in the fu-
ture. Part II of this article will analyze the promise of this technol-
ogy to see whether it has fulfilled its purported goals of reducing
world hunger, decreasing pesticide use, improving nutritional con-
tent, and increasing farmers' income. It will then contrast these re-
sults with the potential risks of GM plants and GMOs in the food
supply. In Part III, this article will examine some of the key ethical
issues arising from genetic engineering: respect for nature and the
value of life; consideration of the environment; rights and responsi-
bilities; equity, power, and the economically disadvantaged; and
conflicts of interest in public research. Part IV will present a pro-
posal that takes into account these ethical concerns and, accord-
ingly, advocates involving all stakeholders, including farmers, con-
sumers, the environment, and underprivileged populations, as well
as the biotechnology industry; educating the public on the science
and risks; requiring comprehensive labeling to enable informed
consumer choice; and promoting a more active and independent
role for government agencies in regulating biotechnology compa-
nies. Part V will conclude with an exploration of some questions
that would aid policymakers in implementing a new regulatory
scheme in the United States, including comparisons to the approach
28. See generally HELENA PAUL & RICARDA STEINBRECHER, HUNGRY CORPORATIONS:
TRANSNATIONAL BIOTECH COMPANIES COLONISE THE FOOD CHAIN (2003).
29. See The Melman Group, Memorandum to the Pew Initiative on Food & Bio-
technology, at 7, available at http://pewagbiotech.org/research/2005update/
2005summary.pdf.
30. See generally Pew Initiative on Food & Biotechnology, Public Sentiment About
Genetically Modified Food (Nov. 2005), available at http://pewagbiotech.org/re-
search/2005update/.
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taken by the international community. An incorporation of ethical
issues into U.S. law would call for the government to fulfill its re-
sponsibility to protect its citizens, respond to their concerns, and
not betray their trust by compelling them to bear the risks of GMOs
without informed consent. This article will also consider global in-
terests such as the disparities in natural resources and technical ex-
pertise between the United States and economically developing
countries, and urge that biotechnology not be used to divert impor-
tant resources from the research and application of more sustain-
able solutions for world food security.
II. THE FAILED PROMISE
The promoters of biotechnology in agriculture promised great
benefits of genetically engineered crops. A study commissioned by
the World Health Organization (WHO) cited several expected bene-
fits of this food technology, including the potential for increased
agricultural productivity and improved nutritional values, along with
"reduced agricultural chemical usage and enhanced farm income,
and improved crop sustainability and food security, particularly in
developing countries."3 Supporters tout the goals of reducing hun-
ger by increasing food productivity, conserving the environment by
reducing pesticide and herbicide use, enhancing nutritional content,
and improving food quality."
However, the same study found that many of these goals have
not been met." "Some [farmers] report lower yields, continuing
dependency on chemical sprays, loss of exports, and critically re-
duced profits for farmers as a consequence of using biotechnol-
ogy.' A closer look at each of the claimed benefits reveals that the
promise of this technology has not been realized. In fact, the poten-
tial risks may far outweigh any expected benefits.
31. World Health Organization (WHO), Modern Food Biotechnology, Human
Health and Development: an Evidence-Based Study, at iii (June 24, 2005) [hereinafter
WHO Study], available at http://www.who.int/foodsafety/publications/biotech/
biotech en.pdf.
32. See, e.g., Tzu-Ming Pan, Current Status and Detection of Genetically Modified
Organism, 10J. FOOD & DRUG ANALYSIS 229, 230 (2002).
33. WHO Study, supra note 31, at 53-55.
34. Id. at 53; see also Press Release, Soil Association, GM crops increase chemical
use by 70 million pounds (Jan. 13, 2004), available at http://
www.soilassociationscodland.org/web/sa/saweb.nsf/848d689047cb466780256a6b0
0298980/4111f557521ae02680256e1a005eba55!OpenDocument.
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A. The Reduction of World Hunger
Despite its noble goals to increase the food supply on the
planet, the technology has not been applied in that direction. So
far, the large yield increases, which had been anticipated from crops
such as engineered Bt-corn and cotton, have not been documented.5
Experimental trials now indicate that genetically engineered seeds
do not increase crop yields.' Moreover, genetically modified (GM)
products currently on the market appear to benefit seed companies
and some large farmers, rather than offering higher quality or lower
prices to consumers."
Fundamentally, the notion that GM crops hold the solution to
world hunger misconceives and oversimplifies the problem, which is
not due to a lack of food. Experts affirm that enough food exists to
feed the world population and that the hunger problem is due to a
lack of access, distribution, and sustainability of practices.' In de-
nouncing the view that hunger is due to a gap between food produc-
tion and human population growth, others point to poverty, ine-
quality, and lack of access to food and land as the real causes." The
use of this technology cannot be effective as a quick fix for a larger
social problem.
There are suggestions that the use of biotechnology in agricul-
ture may even worsen the situation by diverting attention and re-
sources from the real issues and solutions. Studies show that much
of the needed food can be produced by small farmers located
throughout the world using agroecological technologies." Farmers
35. Margaret Rosso Grossman, Biotechnology, Property Rights and the Environment,
50 AM.J. COMP. L. 215, 218 (Supp. 2002) (outlining the risks and benefits associated
with GM foods); ERVIN, supra note 27, at 20-21, 30.
36. Miguel A. Altieri & Peter Rosset, Ten Reasons Why Biotechnology Will Not
Ensure Food Security, Protect the Environment and Reduce Poverty in the Developing
World, 2 AGBIoFORUM 155, 156 (1999), available at
http://www.agbioforum.org/v2n34/v2n34a03-altieri.pdf.
37. See Grossman, supra note 35; see also John Hodges, The Genetically Modified
Food Muddle, 62 LIVEsTOCK PROD. Sci. 51, 52 (Dec. 1999).
38. Sophia Kolehmainen, Precaution before Profits: An Overview of Issues in Geneti-
cally Engineered Food and Crops, 20 VA. EVNTL. L.J. 267, 286 (2001) (Director of Pro-
grams at the Council for Responsible Genetics discussing risks of GMOs to human
health and environment).
39. Altieri & Rosset, supra note 36.
40. Norman Uphoff & Miguel Altieri, Alternatives to Conventional Modern Agricul-
ture for Meeting World Food Needs in the Next Century (Report of a Bellagio Confer-
ence, Cornell International Institute for Food, Agriculture and Development)
(1999), available at http://rodaleinstitute.org/international/conference/bella-
gio.pdf.
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and non-governmental organizations initiating new rural develop-
ment approaches and low-input technologies are making progress in
securing food sustainability at the household, national, and regional
levels in Africa, Asia, and Latin America." Supporting GM technol-
ogy may actually hamper these efforts, in that "[flailure to promote
such people-centered agricultural research and development due to
the diversion of funds and expertise towards biotechnology will
forego an historical opportunity to raise agricultural productivity in
economically viable, environmentally benign, and socially uplifting
ways. "4 Most significantly, these alternate, arguably preferable
methods do not carry the same risks to human health and the envi-
ronment that are involved with the use of biotechnology. In con-
trast, any promise to end world hunger has been thwarted as the
companies have utilized this technology to produce Terminator
seeds, so that the farmers and poor nations are forced to buy the
seeds every year and change the traditional ways of farming.3 To
make matters worse, the Terminator gene can spread to the farm-
ers' other crops through cross-pollination, contaminating them and
effectively condemning all future generations of these plants to a
death sentence." The security of the world's food supply has never
been more precarious."
B. The Reduction of Pesticide Usage
As part of its pledge, Monsanto promises to "use sound and in-
novative science and thoughtful and effective stewardship to deliver
high-quality products that are beneficial to [its] customers and to the
environment."' Contrary to its marketing materials which promise
farmers that they will reduce pesticide use or chemical inputs, the
41. Altieri & Rosset, supra note 36, at 159 (citing JULES PRETTY, REGENERATING




44. See Martha L. Crouch, How the Terminator Terminates: An Explanation for the
Non-Scientist of a Remarkable Patent for Killing Second Generation Seeds of Crop Plants,
18 SYTHESIS/REGENERATION (1999) (explaining the patent for killing second genera-
tion seeds of crop plants and the environmental risks involved).
45. See Ricarda A. Steinbrecher & Pat Roy Mooney, Terminator Technology: The
Threat to World Food Security, 28 THE ECOLOGIST 276 (1998), available at
http://www.orpheusweb.co.uk/john.rose/ttech.html.
46. Monsanto, Our Pledge, http://www.monsanto.com/monsanto/layout/our_
pledge/monsantopledge.asp (last visited Aug. 18, 2007).
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herbicide resistant plants may in fact do the opposite." Instead of
applying pesticides sparingly, farmers can spray even more toxic
chemicals on the plants because they are not concerned about kill-
ing the GM crops as they would be with non-genetically engineered
varieties. " Moreover, this GM product may increase pesticide use
even further in the future with the inevitable development of herbi-
cide resistant weeds.49 One expert has predicted that "[a]lthough in
a few instances [herbicide-resistant crops] may result in a reduction
of toxic herbicide use, it is more likely that the use of herbicide-
resistant crops will increase herbicide use and environmental pollu-
tion."0 In addition, he notes that "farmers will suffer because of the
high costs of employing herbicide-resistant crops [particularly since
herbicide-resistant crops] may increase weed control costs two-
fold.""5
The profit motive of the biotechnology companies is obvious, as
they also own the companies supplying the chemicals. The names
of the products themselves clearly indicate this connection, for ex-
ample, Monsanto's Roundup® pesticide to be used with Monsanto's
Roundup Ready® (Roundup® resistant) plants." It is not surpris-
ing, then, that "more than forty percent of the research conducted
by biotechnology firms focuses on the development of herbicide-
resistant crops."' If the use of these crops increases sales of pesti-
cides, these companies raise their revenue exponentially. Juxta-
posed in Monsanto's promotional materials is a statement of its re-
cord sales of $5.95 billion in the first three quarters of 2006, which
Monsanto attributes primarily to its seed and traits business and
47. Institute of Science, Technology, and Public Policy, Genetic Engineering: A
Cautionary Approach (Feb. 13, 2001), http://www.istpp.org/genetic-engineer-
ing.html (last visited Aug. 22, 2007).
48. Id.
49. Id. "Some scientists estimate that not only will herbicide use triple as a result
of herbicide resistant crops, but will ultimately give rise to herbicide resistant weeds
as well." Id.
50. David Pimentel, Overview of the Use of Genetically Modified Organisms and Pesti-
cides in Agriculture, 9 IND.J. GLOBAL LEGAL STUD. 51, 63 (2001) (a study by a Profes-
sor of Ecology and Agricultural Science at Cornell University of the effect of GMOs
on pesticide use in agriculture).
51. Id.
52. Altieri & Rosset, supra note 36.
53. Id.
54. Pimentel, supra note 50.
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higher sales of Roundup herbicides in the United States and Argen-
tina."
In addition, even plants that are genetically engineered for pest
resistance, such as Bt crops, may need the application of pesticides.
When farmers plant Bt-engineered crops that kill their target preda-
tors, they still need to spray their fields to control other insects that
are resistant to Bt.' Moreover, these pest-resistant varieties may
trigger the creation of Bt-resistant "super bugs." 7 Bt crops violate
the widely accepted principle of integrated pest management
(IPM)-that reliance on any single pest management technology
tends to trigger shifts in pest species or the evolution of resistance
through one or more mechanisms. 8
It should also be noted that as the effectiveness of Bt as a pesti-
cide is ultimately reduced by this extreme overuse, the organic
farmer will be further impacted. Currently, Bt is one of the only
resources available to organic farmers, who use it in small quantities
in its original form as a natural pesticide. The insertion of the Bt
gene directly into the cells of these plants may render useless the
natural Bt pesticide that is relied upon by organic farmers and oth-
ers desiring to reduce chemical dependence.'
Theoretically at least, the use of engineered plants in sustain-
able and integrated agriculture should reduce pesticide use, but this
is not the current trend. "The current products--especially herbi-
cide-resistant crops and Bt-resistant crops-have serious environ-
mental impacts."6' These facts, combined with the risks associated
with GMOs and the greater threat that GM crops pose to the or-
ganic farming industry, reveal that the use of genetics to control
weeds and pests in this situation may not be as beneficial as
55. Monsanto, Seed and Traits Business Drives Record Third-Quarter Sales: U.S. corn
seed and traits business sees continued market share gains, broader adoption of stacked corn
traits, http://monsanto.mediaroom.com/index.php?s=43&item=17 (last visited
Aug. 18, 2007).
56. See Andy Coghlan & Barry Fox, Keep that Spray: Crops Made Resistant to Pests
Still do Better With Chemicals, NEW SCIENTIST, Dec. 18, 1999, at 5 (explaining that
Novartis patent applications indicate that farmers may need to use more pesticides
to get the most out of GM plants).
57. Id.
58. See NATIONAL RESEARCH COUNCIL, NATIONAL ACADEMY OF SCIENCES,
ECOLOGICALLY BASED PEST MANAGEMENT (1996).
59. Altieri & Rosset, supra note 36, at 157 (citing James Mallet & Patrick Porter,
Preventing insect adaptations to insect resistant crops: are seed mixtures or refugia the best
strategy? 250 PRO. ROYAL Soc'Y LONDON B 165 (1992)).
60. Id.
61. Pimentel, supra note 50, at 64.
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claimed." Moreover, a fundamental ethical question resounds: is it
a noble end of man to use biotechnology to cause plants to be resis-
tant to insecticides, so that whenever stronger pesticides are sprayed
on the fields, only these resistant plants are left standing?
C. The Improvement of Nutritional Content
In answer to the question of whether GMOs are the best way to
ensure nutritionally adequate food, one expert responds "no," ex-
plaining that "food insecurity is a problem of inadequate access, and
GMOs promise to do little to remedy that problem.""2 The com-
mercial interests that dominate the developments in Genetically
Modified Organisms (GMOs) perceive "too little financial return to
develop products targeted towards poor, malnourished populations"
who would be the most likely beneficiaries of vitamin or mineral-
rich grains. ' Moreover, the focus on GMOs and public investments
in biotechnologies for developing countries diverts research and
development from the "agroecological, people-centered approaches
that are more likely to benefit small-scale producers in the short and
long term."' Citing this "clash between monocrop, high-tech seed,
cash chemical-intensive agriculture on the one hand, and diversified,
farmer-controlled, management-intensive agriculture on the other,"
the author concludes that "the best way to make new technologies
serve the people is by having more control over these technologies
in the public sector." '
In an apparent response to these criticisms, the biotech indus-
try has recently focused its marketing campaign on the production
of rice that is genetically fortified with vitamin A, called "Golden
Rice."67 This genetically engineered rice produces beta-carotene in
its endosperm, giving it a distinct yellow color. The industry claims
that Golden Rice will aid people in developing countries who lack
vitamin A in their diets.' Critics of the biotechnology industry,
62. See, e.g., Kolehmainen, supra note 38, at 285-86.
63. Ellen Messer, Food Systems and Dietary Perspective: Are Genetically Modified
Organisms the Best Way to Ensure Nutritionally Adequate Food?, 9 IND.J. GLOBAL LEGAL
STUD. 65, 89 (2001).
64. Id. at 67.
65. Id. at 88.
66. Id. at 87.
67. Kolehmainen, supra note 38, at 286.
68. See id. See also Trisha Gura, New Genes Boost Rice Nutrients, 285 ScI. 98
(1999); Press Release, GE Food Alert, Monsanto Joins First Lady's Vitamin A Out-
reach Efforts: Beta Carotene Technology Offered to Developing World Farmers
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however, cite the use of genetic engineering technology as another
example of a "quick techno-fix to a larger, more complex prob-
lem."69 They say that such GM products will not end vitamin A defi-
ciencies because a paucity of a single micronutrient like vitamin A
"seldom occurs in isolation, but is one aspect of a larger context of
deprivation and multiple nutrient deficiencies."7" In other words,
people suffer from vitamin A deficiency, not because their rice con-
tains too little vitamin A or beta-carotene, but because of a lack of
variety in their diet, and they suffer many other dietary illnesses that
cannot be addressed by beta-carotene.' "A magic-bullet solution
that places beta-carotene into rice-with potential health and eco-
logical hazards-while leaving poverty, poor diets, and extensive
monoculture intact is unlikely to make any durable contribution to
well-being."'
Furthermore, this situation presents as much a social problem
in that "the obstacles of access and distribution," as with non-GE
rice, "must still be overcome to get the rice to those who need it."7'
There may also be cultural barriers; in the past, non-white grains
have not been accepted by some societies. The Rural Advance-
ment Foundation International (RAFI)75 has suggested other "low-
tech and more cost-effective initiatives, [including the planting of]
many vitamin-rich food plants that were once cheap and available."76
This organization argues that, "[r]ather than nurture a strategy that
encourages biodiversity, golden rice could promote monocultures
(March 16, 1999), http://www.gefoodalert.org/News/news.cfm?NewsID=165 (last
visited Aug. 20, 2007).
69. Kolehmainen, supra note 38, at 286.
70. Genetic Res. Action Int'l, Engineering Solutions to Malnutrition (March 2000),
http://www.grain.org/publications/reports/malnutrition.htm (last visited Aug. 18,
2007).
71. Peter M. Rosset, Transgenic Crops to Address Third World Hunger? A Critical
Analysis, 25 BULL. OF ScI. TECH. & Soc'Y 306, 310 (2005), available at
http://www.landaction.org/gallery/RossetGMhunger.pdf.
72. Id.
73. Kolehmainen, supra note 38, at 287.
74. Id. at 286-87.
75. RAFI, now called the Action Group on Erosion, Technology and Concentra-
tion (ETC group), is an organization "dedicated to the conservation and sustainable
advancement of cultural and ecological diversity and human rights." See ETC, About
ETC Group, http://www.etcgroup.org/en/about/ (last visited Aug, 17, 2007).
76. RAFI, ON GOLDEN PAwNS: THE GOLDEN RICE DEAL-Do THE POOR GET
UNPROVEN GM RICE WHILE ASTRAZENECA GETS THE GOLD? (June 20, 2000), available
at http://www.etcgroup.org/upload/publication/319/01/geno-ongolden.pdf.
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and genetic uniformity. This is the wrong strategy."77  Thus, al-
though the use of this technology in this manner provides good pub-
licity for the industry, it may not be able to fulfill its promises.
D. The Increase in Farmers' Income
Results on farmer profitability have been mixed, at best. A
United States Department of Agriculture (USDA) report on the
economic consequences of GM crops summarized a positive impact
of the adoption of Bt-cotton on net farm returns, but a negative im-
pact in the case of Bt-maize.7" "An improvement of returns has also
been seen with herbicide-tolerant maize, whereas no significant im-
pacts were observed with herbicide-resistant soybean." 9 A study by
the European Commission on the economic impact of GM crops on
agriculture found that "a quick adoption by farmers in the United
States was the result of strong profitability expectations" but "there
was no conclusive evidence on farm-level profitability of GM
crops."8" In addition, a report by the Soil Association found that
farmers are not achieving the higher profits promised by the bio-
technology companies due to the collapse of markets for GM foods
and widespread GM contamination.'
The WHO study determined that the cost-efficiency of GM
crops appears to vary with the specific situations, such as growth
conditions that are dependent on regional agro-ecological factors,
particularly the baseline of pest pressure and pesticide uses.7 As a
consequence, the study concluded that in certain situations "other
77. Justin Gillis, Monsanto offers patent waiver on 'Golden Rice,' WASH. POST, Al,
Sept. 30, 2000, available at http://www.grain.org/bio-ipr/?id=175.
78. WHO Study, supra note 31, at 53.
79. Id. (citing JORGE FERNANDEZ-CORNEJO & WILLIAM MCBRIDE, U.S. DEPT. OF
AGRIC., GENETICALLY ENGINEERED CROPS FOR PEST MANAGEMENT IN US
AGRICULTURE, AGRIC. ECON. REP. No. AER786 (May 2000), available at
http://www.ers.usda.gov/publications/AER786/).
80. Id. at 53-54 (citing EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR
AGRICULTURE, ECONOMIC IMPACTS OF GENETICALLY MODIFIED CROPS ON THE AGRI-
FOOD SECTOR (Working Document), available at http://europa.eu.intV
comm/agriculture/publi/gmo/ch3.htm).
81. "The Soil Association estimates that GM soya, maize, and oilseed rape could
have cost the U.S. economy $12 billion since 1999 in farm subsidies, lower crop
prices, loss of major export orders and product recalls." Press Release, Soil Asso-
ciation, GM crops are economic disaster shows new report (June 5, 2003), available
at http://www.soilassociation.org/web/sa/saweb.nsf/848d689047cb466780256a6b
00298980/80256ad80055454980256c320058c60e!OpenDocument.
82. WHO Study, supra note 31, at 54.
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practices for planting may be more valuable because of various re-
gional or market-related reasons."83 In fact, in some countries pro-
hibiting the planting of GM crops would give the region a marketing
edge by guaranteeing that none of its food exports contain GM
crops?' In other countries, potentially expensive efforts to segregate
GM crops from crops of conventional or organic farming include
specific isolation distances, buffer zones, pollen barriers, control of
volunteer plants, crop rotation, and planting arrangements for dif-
ferent flowering periods, as well as monitoring during cultivation,
harvest, storage, transport, and processing. Moreover, the WHO
study identified additional costs from the issues of liability and
compensation for economic loss due to contamination.'
As a means of decreasing poverty in developing countries, GM
crops do not appear promising. A study of global hunger data ana-
lyzed the constraints affecting the productivity of small farmers in
the third world and found that in impoverished nations, people are
too poor to buy the food that is available (but often poorly distrib-
uted) or lack the land and resources to grow it themselves; in fact,
overproduction-and consequent low crop prices-is one of the most
persistent problems generating poverty (and thus hunger) in rural
areas.' Rather than helping the situation, GM crops could have the
opposite effect because "[a]n examination of the special risks these
varieties pose for poor farmers in the complex, diverse, and risk-
prone environments that characterize peasant agriculture on a
global scale suggests that transgenic crop varieties are likely to be
more of hindrance than a help to the advancement of poor farm-
ers."87 In particular, the environmental risks would be heightened
for the vulnerable peasant farmers; cross-contamination could cause
the loss of the locally adapted varieties that they depend on and the
biodiversity critical for world food security.
83. Id.
84. Id. (citing NUFFIELD COUNCIL ON BIOETHICS, THE USE OF GM CROPS IN
DEVELOPING COUNTRIES (1999), available at http://www.nuffieldbioethics.org/
go/browseablepublications/gmcropsdevcountries/report_153.html; Hans van Meijl
& Frank van Tongeren, Agric. Econ. Res. Inst., International diffusion of gains from
biotechnology and the European Union's Common Agricultural Policy (2002), available at
http://www.cepr.org.uk/meets/wkcn/6/ 6608/papers/tongeren.pdf; and Novis,
Economy to benefit from GMfree zones? (Dec. 22, 2003), http://
www.foodnavigator.com/news/ng.asp?id=48708 (last visited Aug. 21, 2007)).
85. Id. at 53.
86. See generally Rosset, supra note 71.
87. Id. at 306.
88. Id. at 312.
JOURNAL OF FOOD LAW & POLICY
In addition, most products and new technologies are designed
for western agriculture systems, not for developing countries. "For
example, if Terminator genes enter the seed market, it will not be
possible for traditional or small farmers to use their plants to pro-
duce seeds."89 For this reason, peasant farmers and developing
countries have been protesting the development of Terminator
technology and pressing for the ban of these seeds." Rafael Alegria
of Via Campesina, an organization representing over 10 million
peasant farmers worldwide, declares, "Terminator is a direct assault
on farmers and indigenous cultures and on food sovereignty. It
threatens the well-being of all rural people, primarily the very poor-
est."91
For the organic farmer, too, the effects of GM crops could
prove detrimental. In addition to the negative implications of the
overuse of Bt by the biotechnology industry discussed above, or-
ganic farming could be impacted by direct contamination of organic
fields due to cross-pollination." Organic farmers are now struggling
to isolate their fields with only limited success and greater economic
costs because they need to leave fields uncultivated as a buffer. For
example, "a farmer may harvest 100 rows from the sides of non-
GMO fields to avoid cross-pollination and have additional costs for
travel to an elevator that handles non-GMO crops." '  Once con-
tamination has been detected, their crops are useless.95 In one inci-
dent, Bt corn cultivated in Texas contaminated the fields of a certi-
fied organic farmer.96 When Terra Prima, a Wisconsin food process-
ing company that had used the organic farmer's corn to make or-
ganic tortilla chips, detected traces of genetically engineered corn
through DNA testing, it had to destroy 87,000 bags of chips, worth
89. See Pimentel, supra note 50, at 63-64.
90. See, e.g., Press Release, Ban Terminator, UN Upholds Moratorium on Termi-
nator Seed Technology, Worldwide Movement of Farmers, Indigenous Peoples and
Civil Society Organizations Calls for Ban, March 31, 2006,
http://www.banterminator.org/news-updates/news-updates/un-upholds_morato
rium on terminator_seed-technology (last visited Aug. 15, 2007).
91. Ban Terminator, Introduction to Terminator Technology, http://www.banter-
minator.org/thejissues/introduction (last visited Aug. 17, 2007).
92. See Kolehmainen, supra note 38, at 280.
93. Id.
94. Grossman, supra note 35, at 222.
95. Kolehmainen, supra note 38, at 280.
96. See Anthony Shadid, Blown Profits Genetic Drift Affects More Than Biology-U.S.
Farmers Stand to Lose Millions from 'Genetic Drift' Phenomenon, BOSTON GLOBE, GI,
Apr. 8, 2001.
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over $ 150,000.17 Organic farmers may even lose their organic certi-
fication and face income loss during the years needed to be recerti-
fied as organic producers.98 Worse yet, if this contamination goes
undetected, these foods can cause potential harm to the consumers
who purchased the organic food precisely to avoid ingesting
GMOs-and without their knowledge and consent.
Despite the expectation that farmers and the hungry should be
the main beneficiaries of agricultural research, this technology is
controlled by the private sector with its development centered on
profitability." "By controlling germplasm from seed to sale, and by
forcing farmers to pay inflated prices for seed-chemical packages,
companies are determined to extract the most profit from their in-
vestment.""' ° Thus, the only real beneficiaries are the companies
with the capacity to use this genetic engineering in agriculture. '
As a result, many would conclude that the opportunity to direct
biotechnology to meet these lofty goals has been squandered (e.g.,
on the development of herbicide resistant plants engineered to sur-
vive the spraying of the company's own pesticides or Terminator
seeds that cannot reproduce, forcing these impoverished developing
countries to buy additional seeds from the manufacturer). More-
over, these largely unrealized benefits in fact may be outweighed by
the potential of new dangers to human health and the environment.
E. The Potential Risks
Unlike traditional pesticide use, which involves the application
of highly toxic chemicals to the outside of the plant in carefully
measured amounts so as not to kill the plant and can be washed off
the food by consumers, genetically engineered plants contain the
herbicide tolerance or pesticide resistance in every cell of the plant.
Thus, these toxins are unavoidably ingested by people, animals, and
beneficial insects. Although the effects on humans are as of yet un-
97. See id.
98. Grossman, supra note 35, at 222.
99. Altieri & Rosset, supra note 36 (citing SHELDON KRIMSKY & ROGER P. WRUBEL,
AGRICULTURAL BIOTECHNOLOGY AND THE ENVIRONMENT: SCIENCE, POLICY AND
SOCIAL IssuEs (1996)).
100. Id.
101. ChristianJ. Peters, Genetic Engineering in Agriculture: Who Stands to Benefit? 13
J. AGRIC. & ENVrL. ETHICS 313, 322-23 (2000).
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known, the deleterious effects on the monarch butterflies"°n and the
lacewings"°3 do not bode well for the future.
It should be noted that the process of creating GM plants dif-
fers from ordinary hybrids because it forces recombinations that do
not occur in nature, directly injecting genetic material to induce
traits that are not natural for the plant, for example, insect resis-
tance, herbicide resistance, or nut protein in a soybean to increase
protein content. In contrast, hybridization "works harmoniously
with superficial aspects of nature without fully disturbing the essen-
tial life force at the center of each cell."1°
Scientists have warned of the uncertainties and dangers inher-
ent in genetic engineering of food products and crops. In the in-
ternational community, the WHO study identified several risks pre-
sented by GMOs and GM foods to human health as part of its safety
assessment, including: "(a) direct health effects (toxicity); (b) ten-
dencies to provoke allergic reactions (allergenicity); (c) specific
components thought to have nutritional or toxic properties; (d) sta-
bility of the inserted gene; (e) nutritional effects associated with the
specific genetic modification; and (f) any unintended effects which
could result from the gene insertion.""°' In addition, GMOs gener-
ate risks to the environment such as unintended effects on non-
target organisms, ecosystems, and biodiversity, including heightened
development of resistant insects; outcrossing of transgenes; and
cross-contamination that may lead to genetically modified crops as
the dominant species."° Many of these risks have already become a
reality both in initial studies and alarming incidents. 7
102. John E. Losey, Linda S. Rayor, & Maureen E. Carter, Transgenic Pollen Harms
Monarch Larvae, 399 NATURE 214 (1999), available at http://www.biotech-
info.net/butterfliesbtcorn.html.
103. See A. Hilbeck et al., Effects of Transgenic BT Corn-Fed Prey on Mortality and
Development Time of Immature Chrysoperla carnea, 27 ENVrL. ENTOMOLOGY 480
(1998). See also Kolehmainen, supra note 38, at 285.
104. See Nathan Batalion, 50 Harmful Effects of Genetically Modified Food (2000),
http://www.cqs.com/50harm.htm (last visited Aug. 15, 2007). See also Ronnie
Cummins, Problems with Genetic Engineering 18 SYNTHESis/REGENERATION (1999),
available at http://www.greens.org/s-r/18/18-02.html (chronicling the dangers
associated with the insertion of "[a]nimal genes and even human genes into plants
or animals to create unimagined transgenic life forms").
105. WHO Study, supra note 31, at 12.
106. Id. at 20.
107. See Debra M. Strauss, Genetically Modfied Organisms in Food: A Model of Label-
ing and Monitoring With Positive Implications for International Trade, 40 LNT'L LAW. 95
(2006) [hereinafter Genetically Modified Organisms in Food] (providing a detailed
discussion of the risks and the mounting evidence).
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The amount that is unknown about genes significantly out-
weighs the amount that is known, prompting serious questions
about how much risk is too much and who should bear the burden
of this risk."°8 Since foods with GM ingredients are not identified,
American consumers are forced to accept the potential conse-
quences of these foods." In effect, U.S. citizens are the guinea pigs
in a grand experiment without their knowledge and consent because
these genetically altered foods are not labeled, segregated, or moni-
tored in the United States.110 Query, has the risk reached the level
where it has outweighed any potential benefit? Do individuals have
the right to determine their own fate?
The dangers to the ecosystem and biodiversity may return to
haunt the inventors; once the creation is let loose, it may spread
through the planet and become the dominant species. Since GMOs
are not currently segregated or labeled in the United States, and
their genetic mutations can mingle with natural species, if health
hazards are uncovered will it be too late to recall GM products from
the food chain? As a consequence, the outcome of man as the ulti-
mate conqueror of nature may be deeply disturbing. The WHO
study concludes that "[t]he risks of biotechnology, the problems of
interfering with nature, evolution and creation, and ethical consid-
erations are of increasing importance in the civil-society debate on
the development and introduction of GMOs.". The scientific
community has devised methods to handle disagreements over sci-
entific facts, but disagreements over the value and ethical compo-
nents of food-safety assessments are often much more difficult to
resolve.1 Yet discussions of the ethical implications are essential to
society's decision on how to proceed in this area.
III. THE ETHICAL ISSUES
To address from an ethical perspective the claims being made
in the ongoing debate about Genetically Modified Organisms
(GMOs), the Food and Agriculture Organization of the United Na-
tions (FAO) has formed an expert panel on ethics in food and agri-
108. See Kolehmainen, supra note 38, at 277.
109. Id.
110. See Strauss, Genetically Modified Organisms in Food, supra note 107 (comparing
U.S. law to the international law regulating GM foods).
111. WHO Study, supra note 31, at 56; see generally JANE MONTGOMERY &
SIVRAMIAH SHANTHARAM, BIOTECHNOLOGY, BIOSAFETY, AND BIODIVERSITY: SCIENTIFIC
AND ETHICAL ISSUES FOR SUSTAINABLE DEVELOPMENT (1999).
112. Id. at 57.
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culture."' The first report of the FAO panel, Ethical issues in food
and agriculture, introduces ethical questions related to its mandate,1
4
such as: What is the value of food? What is the value of human
health? What is the value of nature and natural resources? The
FAO panel identifies as values the right to adequate food, trust, op-
timization, informed consent and equity, in asserting that these
questions and ethical concerns are central to the debate about the
future."'
The FAO's second report, Genetically modified organisms, consum-
ers, food safety and the environment, highlights the role of ethical con-
siderations in food and agriculture, both in view of discussions on
GMOs and in relation to food safety and the environment."'6 Issues
discussed include ownership of the necessary tools to produce
GMOs, potential consequences of their use, and undesirable effects
that could result from their application, both now and in the fu-
ture."7 Above all, the report advocates the participation of all stake-
holders in making decisions regarding GMOs, emphasizing that
"[w]idely communicated, accurate and objective assessments of the
benefits and risks associated with the use of genetic technologies
should involve all stakeholders .... Experts have the ethical obliga-
tion to be proactive and to communicate in terms that can be un-
derstood by the lay person."
118
These economic and moral concerns have prompted the Euro-
pean Union (EU) and other countries to restrict the import of bio-
engineered foods or to require labeling of foods with genetically
modified (GM) ingredients."'9 The continued development of ge-
netically modified plants raises broad ethical issues, several of which
will be explored below: respect for nature and the value of life; con-
sideration of the environment; rights and responsibilities; equity,
113. For more information about the Food and Agriculture Organization (FAO),
see http://www.fao.org/ (last visited Aug. 15, 2007).
114. FAO, ETHICAL ISSUES IN FOOD AND AGRICULTURE (2001) [hereinafter FAO
REPORT 1], available at http://www.fao.org/DOCREP/003/X9601E/
X9601E00.HTM.
115. See id. See also WHO Study, supra note 31, at 56-57.
116. See FAO, FAO ETHICS SERIES 2: GENETICALLY MODIFIED ORGANISMS,
CONSUMERS, FOOD SAFETY AND THE ENVIRONMENT (2001) [hereinafter FAO REPORT
2], available at ftp://ftp.fao.org/docrep/fao/003/x9602e/x9602eOO.pdf.
117. Id.
118. Id. at25.
119. Farid E. Ahmed, Detection of Genetically Modified Organisms in Food, 20 TRENDS
BIOTECHNOLOGY 215 (2002). See also Strauss, Genetically Modified Organisms in Food,
supra note 107 (discussing international laws regarding GMOs).
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power, and the economically disadvantaged; and conflicts of interest
in public research.
A. Respect for Nature and the Value of Life
In the international community, the United Nations' Conven-
tion on Biological Diversity (CBD) recognizes the implicit value of
nature itself.2 ° The CBD by its terms embraces life, including "the
conservation of biological diversity" and "the sustainable use of its
components." l"' Thus, the CBD recognizes that "biological diversity
is about more than plants, animals and micro organisms and their
ecosystems-it is about people and our need for food security, medi-
cines, fresh air and water, shelter, and a clean and healthy environ-
ment in which to live.'"" In describing the CBD, the World Health
Organization (WHO) report observes, "[t]he summary of these ob-
jectives shows that all the main arguments usually discussed in a risk-
benefit evaluation of food biotechnology interfere with each other,
thus requiring a high level of ethical consideration." 3
In contrast to the principles of the CBD, the biotechnology in-
dustry, with its production of genetically engineered crops, reflects a
view of nature as objects to be manipulated and controlled with life
forms as commodities. One author recognizes that, despite this
consumerism, the United States "also share[s] an ethical commit-
ment to democracy, freedom and love for the land, however ma-
nipulated these ideas have been in the past."'24 He thus urges U.S.
citizens to question their blind allegiance to science fiction and
deepen their understanding of the integrity of the natural world. 5
The use of biotechnology on the cellular level to target agricul-
tural issues does not involve only science and the law, but raises
ethical and policy issues that strike at the very essence of life. Doing
120. See FAO REPORT 1, supra note 114; see also WHO Study, supra note 31, at 56.
The UN Convention on Biological Diversity (CBD) was adopted in Rio deJaneiro in
1992. See IISD Linkages, A Brief Introduction to the Convention on Biological Diversity,
http://www.iisd.ca/biodiv/cbdintro.html (last visited Aug. 15, 2007). The United
States signed the CBD but did not ratify it.
121. CBD, art. 1, available at http://www.biodiv.org/convention/arti-
cles.asp?lg=0&a=cbd-01.
122. CBD, About the CBD, http://www.biodiv.org/convention/default.shtml (last
visited Aug. 16, 2007).
123. WHO Study, supra note 31, at 56.
124. See Tokar, supra note 25.
125. See id.
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so should not be taken lightly without consideration of all of the
ramifications, recognizing that
[w]hen we start to alter the genetic composition of organisms, we take
into our own hands the instructions for life-instructions that have been
slowly and carefully evolving since the first appearance of life on this
planet, instructions that support the delicate balance of our ecosystem.
In assuming the immense responsibility to change those basic instruc-
tions, we must honestly and thoroughly analyze every possible motiva-
tion and ramification of this novel technology-not only environmental,
but social, political, ethical, and economic as well.1
2
6
The biotechnology industry acts on a drive to convert into a market-
able product all that is alive, altering the patterns of nature so as to
suit the whims of the commercial market. Genetic engineering con-
tradicts the unpredictability and freedom that is an inherent com-
ponent of life, to control that which cannot be the controlled. As a
result,
[n]othing in nature, from the bacteria that live deep within boiling hot
geysers to the molecules that form the human immune and reproductive
systems, would be immune from such exploitation and, where possible,
redesign. Biotechnology offers a way to continue ignoring underlying
problems, and perpetuates the myth that the inherent ecological limita-
tions of a nature-denying way of life can simply be engineered out of ex-
istence. 
2 7
In imposing a non-living model on nature, this use of technology
ignores critical values and reflects a lack of respect for life itself.
From an ethical perspective, Terminator seeds represent the
height of this folly--the biotechnology companies have taken away
the essential function of life to reproduce. In addition, this tech-
nology involves issues of ownership and the appropriateness of pat-
enting life forms.' Patenting genetic material is inherently prob-
126. MARTIN TEITEL & KIMBERLY WILSON, GENETICALLY ENGINEERED FOOD:
CHANGING THE NATURE OF NATURE: WHAT You NEED TO KNOW TO PROTECT
YOURSELF, YOUR FAMILY, AND YOUR PLANET 18 (1999).
127. Tokar, supra note 25. See also VANDANA SHIVA, BIOPIRACY: THE PLUNDER OF
NATURE AND KNOWLEDGE 24 (1997) (arguing that genetic engineering, far from
being socially useful, is "the ultimate expression of the commercialization of science
and the commodification of nature").
128. As a legal matter, the patenting of life has been permitted, commencing with
the U.S. Supreme Court decision in Diamond v. Chakrabarty, 447 U.S. 303 (1980),
which allowed a live organism (bacterium) to be patented. The availability of utility
patent protection for plants and seeds was confirmed in JE.M. Ag. Supply, Inc. v.
Pioneer Hi-Bred Int'l, Inc., 534 U.S. 124 (2001). As a result of this treatment by the
courts and U.S. Patent Office, biotechnology patents have proliferated.
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lematic as it also raises issues of social ethics."' Others have con-
cluded that allowing such monopolies through patents on genes
hampers scientific progress and is therefore not in the public inter-
est." For years, these companies have tried to control seeds and
their "new" creations as their property. Monsanto attracted atten-
tion in 1998 "with its aggressive prosecutions of farmers accused of
'pirating' its seed varieties" by following the traditional farming
practice of saving and replanting the company's (now patented)
seeds."' Rather than to continue to pursue these actions, the com-
panies have now developed a direct enforcement mechanism."' The
plants effectively self-destruct at the end of their cycle, by preventing
farmers-or nature-from continuing its innate course of germina-
tion to future generations.'
For these reasons, in 2000 the United Nations (UN) through the
CBD adopted a de facto moratorium on sterile seed technologies,
which it calls Genetic Use Restriction Technologies (GURTs).7 Ear-
lier this year, despite pressure from Canada, Australia, and New Zea-
land-"supported by the U.S. government and the biotechnology
industry"-the CBD upheld the international de facto moratorium
on Terminator technology."5  However, this UN ban has not
stopped the development of this technology or the support by other
129. See Keith Douglass Warner, Are Life Patents Ethical? Conflict Between Catholic
Social Teaching and Agricultural Biotechnology's Patent Regime, 14 J. AGRIC. & ENVTL.
ETHICS 301, 316 (2001), available at http://www2.ucsc.edu/cgirs/research/environ-
ment/afsrg/publications/Warner_- 2001.pdf (stating that "[t]he privatization of
germplasm formerly considered the common heritage of humankind is incompati-
ble with notions of the common good and economic justice"). See generally DONALD
BRUCE & ANN BRUCE, ENGINEERING GENESIS: THE ETHICS OF GENETIC ENGINEERING IN
NON-HUMAN SPECIES (1998); MARTIN TEITEL & HOPE SHAND, THE OWNERSHIP OF
LIFE: WHEN PATENTS AND VALUES CLASH (1997).
130. See WHO Study, supra note 31, at 55.
131. Tokar, supra note 25. See also Altieri & Rosset, supra note 36, at 156 (arguing
that "[b]y controlling germplasm from seed to sale, and by forcing farmers to pay
inflated prices for seed-chemical packages, companies are determined to extract the
most profit from their investment").
132. See generally Tokar, supra note 25.
133. Id.
134. Ban Terminator, The Campaign, http://www.banterminator.org/the-cam-
paign (last visited Aug. 17, 2007). See CBD, Agricultural Biodiversity Genetic Use Re-
striction Technologies (GURTs), http://www.biodiv.org/programmes/areas/agro/
gurts.aspx (last visited Aug. 17, 2007).
135. Ban Terminator, UN Upholds Moratorium, supra note 90.
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countries that continue to issue patents.'" Life continues to be
treated as an inert commodity.
B. Consideration of the Environment
Tampering with the genetic blueprints for life carries the possi-
bilities for enormous potential impact on the environment. As one
consumer advocate warns,
[n]o one has a crystal ball to see future consequences. Nevertheless,
alarm signals go off when a technology goes directly to the center of
every living cell-and under the guidance of a mechanical or non-living
way of restructuring or recreating nature. The potential harm can far
outweigh chemical pollution because chemistry only deals with things al-
tered by fire-or things that are not alive. 17
A farmer can use toxic chemicals and eventually convert the land
back to its natural state, perhaps for organic farming, after the
chemicals break down into natural chemicals in a matter of years. '
In contrast, with genetic pollution the alteration of the life in the
soil lasts forever."9 Farms may someday be blacklisted for having
once planted GM crops. As the acreage of GM plantings exponen-
tially expands, "the spreading potential impact on all ecosystems is
profound.""
The use of bioengineering in foods involves numerous threats
to the environment, particularly cross-pollination and lack of biodi-
versity, as discussed above. "[G]enetically engineered plants may be
more likely to exchange pollen with other plants than their non-
genetically engineered cousins" and "[g]enetic contamination of
neighboring crops has now been documented in the case of both
corn and rapeseed (canola).". The damaging effects of these trans-
genic plants on beneficial insects such as ladybugs and lacewings, as
well as the potential impact on other wildlife, should be taken into
136. Ban Terminator, Delta & Pine Land, developer of Terminator seeds, extends global
reach, supra note 24.
137. See Batalion, supra note 104. See also Ricarda Steinbrecher, What is Wrong
with Nature?, 18 SYNTHESIS/REGENERATION (1999), available at
http://www.greens.org/s-r/18/18-12.html (quoting a genetic scientist who argues,
"[a]t a time when our environment is already suffering extreme stress we should
avoid risking the fragile balance or compounding our problems with genetic engi-
neering").
138. See Batalion, supra note 104.
139. Id.
140. Id.
141. See Tokar, supra note 25.
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account when deciding whether genetic engineering is worth the
risk. Under the present analysis, the potential harm to human
health and the environment does not appear to be outweighed by
sufficient benefit.
42
Despite these initial misgivings, one commentator calls atten-
tion to that fact that the number of scientists studying the ecological
consequences of genetic engineering is far less than the multitudes
of researchers and technicians "who are employed to develop the
next generation of genetically engineered crop varieties."
4
In making determinations on how to proceed, policymakers
must consider the rights and responsibilities of all stakeholders-
farmers, consumers, the environment, and underprivileged popula-
tions-as well as the biotechnology industry. The environment is a
particularly vulnerable stakeholder, to whom we owe a special duty,
because it does not have the voice to defend itself from the med-
dling of mankind. One is reminded of the late Justice Douglas'
haunting dissent in Sierra Club v. Morton, when he lamented that
natural resources that "feel the destructive pressures of modern
technology and modern life" should have standing to sue for their
own protection "before these priceless bits of Americana (such as a
valley, an alpine meadow, a river, or a lake) are forever lost or are so
transformed as to be reduced to the eventual rubble of our urban
environment, the voice of the existing beneficiaries of these envi-
ronmental wonders should be heard.' "14
C. Rights and Responsibilities
Genetic modification of plants and the failure of the U.S. gov-
ernment to treat these crops and food products as different from
other foods raise critical ethical issues for consumers. " ' The nondis-
closure of the fact that their food was developed using bioengineer-
ing techniques removes the right of informed choice. This fails the
assessment from any ethical perspective, particularly a Kantian
model. U.S. citizens have been deprived of their autonomy and
freedom of choice, just as the farmers have been deprived of their
142. See, e.g., Kolehmainen, supra note 38, at 281. See generally GERHOLD K.
BECKER & JAMES P. BUCHANAN, CHANGING NATURE'S COURSE: THE ETHICAL
CHALLENGE OF BIOTECHNOLOGY (1996) (listing some environmental and ethical
considerations of genetically engineered plants and foods).
143. See Tokar, supra note 25.
144. Sierra Club v. Morton, 405 U.S. 727, 743, 750 (1972).
145. See generally Warner, supra note 129.
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independent livelihoods and the plants have been deprived of their
essence."'' Individuals have the fundamental right to know what
they are buying and eating, as well as the responsibility towards oth-
ers and the natural world.
An economic model also favors the disclosure of information.
47
According to this reasoning, "the market for GMOs at both the con-
sumer and producer level is unable to achieve a rational, efficient
and socially optimal result due to asymmetrical information. " '
Without adequate information, consumers cannot make rational
decisions about whether to purchase and consume GMOs, farmers
do not have the tools to negotiate with biotech seed producers, and
organic farmers cannot effectively allocate resources to protect their
crops from contamination by genetic drift.' 9 This market can only
function efficiently "if a mechanism is established for ensuring that
rational, scientifically-based information on the effects of GMOs on
human health, agricultural production, and the environment is
available to the public. Because transaction costs would be prohibi-
tively high for individual consumers or farmers to obtain such in-
formation, a system of mandatory disclosures tied to discretionary
participation in the market for GMOs should be established by the
government."'
The government has a responsibility to protect its citizens, par-
ticularly in such a critical area as the safety of the food supply.'1 As
a matter of ethics, the risks must not be placed on the unsuspecting
public rather than on the companies who have created these genetic
modifications.' To do so would also betray consumers' trust in
their government to ensure their health and well-being as fiduciaries
acting on their behalf.'3 The Food and Drug Administration (FDA)
has recognized this mandate in its regulatory approach to other ar-
eas of the food supply.'"
146. Tokar, supra note 25.
147. See Luke Brussel, Engineering a Solution to Market Failure: A Disclosure Regime
for Genetically Modified Organisms, 34 CUMB. L. REV. 427, 435 (2003-2004).
148. Id. at 430.
149. Id.
150. Id. at 432.
151. See, e.g., Debra M. Strauss, Reaffirming the Delaney Anticancer Clause: The Legal
and Policy Implications of an Administratively Created De Minimis Exception, 42 FOOD
DRUG COSM. L.J. 393, 426 (1987).
152. See id.
153. See id.
154. See id. at 423 (applying a zero risk policy to prohibit the introduction into the
food supply of food and color additives determined to cause cancer in laboratory
animals).
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Consumers have the right to choose what they eat, and in-
formed choice can only be realized through labeling.' According
to Consumers International, consumers' desires and opinions
should be respected due to a fundamental right to know and make
informed decisions." For example, a lack of labeling as to the pres-
ence of an introduced gene removes the individuals' right to avoid
known allergens and control their own fate. Eight percent of chil-
dren in the United States possess food allergies, some of which can
be fatal.' 7 When Pioneer Hi-Bred spliced Brazil nut genes into a
soybean to improve its protein content, the altered soybean pro-
voked severe allergic attacks in eight individuals sensitive to Bra~ll
nuts but not soybeans.' 8 Without a label alerting consumers that a
soybean could contain genes from a highly allergic nut, even indi-
viduals aware of their severe allergies would have no warning.'5
While the risks generate a need for labeling of the presence of
GMOs, such an approach is also necessitated above and beyond
safety issues, as a matter of taste and preference and for many
health-related reasons. It must be recognized that many consumers
make food choices based on religious, ethical, and environmental
considerations, for example, deciding not to eat veal, mass-produced
chickens, or non-organic produce. If biotechnology raises similar
ethical, health, and environmental concerns, it is not irrational for
people to act on these preferences and aversions to risk."n In order
to make these informed decisions, food products must be compre-
hensively labeled. As a matter of ethics and public policy, "[s]ince
labeling laws are created to meet consumer needs, consumer opin-
ion should be respected."'
155. Jean Halloran & Michael Hansen, Why We Need Labeling of Genetically Engi-
neered Food, 18 SYNTHESIS/REGENERATION (Winter 1999), available at
http://www.greens.org/s-r/ 18/18-07.html.
156. Id.
157. Kolehmainen, supra note 38, at 278.
158. Julie A. Nordlee et al., Identification of a Brazil Nut Allergen in Transgenic Soy-
beans, 334 NEw ENG.J. MED. 688 (1996).
159. "About twenty-five percent of Americans have adverse reactions to foods.
Eight percent of children and two percent of adults have food allergies as tested by
blood immunoglobins." Batalion, supra note 104. Some "individuals... are so aller-
gic to [the Brazil] nut, they go into apoplectic shock (similar to a severe bee sting
reaction), which can cause death." Id. See also Marion Nestle, Allergies to Transgenic
Foods: Questions of Policy, 334 NEw ENG.J. MED. 726 (1996).
160. TEITEL & WILSON, supra note 126, at 68. See also Halloran & Hansen, supra
note 155.
161. Halloran & Hansen, supra note 155.
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The decision to allow the public to consume unlabeled geneti-
cally engineered food strikes some people as "grossly undemocratic
and slanted too far in favor of corporate interests."'62 "Should our
society allow the purported commercial rights of a corporation to
supersede the citizen's right to make informed decisions in the mar-
ketplace?"'63 Every person has a right to make choices about what
they eat. Every person has a right to know. "
For consumers who are sensitive about the content of the food
they eat, eating organic foods may be a choice they can make, but it
is not a workable and equitable solution for the masses. Organic
foods tend to be more expensive than non-organic products and
they are not available for all foods, stores, and areas of the country.
Thus, most consumers do not have the true choice to purchase or-
ganic foods as an alternative to what has previously been known as
"traditional" foods. Moreover, issues of cross-contamination in-
creasingly threaten the integrity and economic viability of the or-
ganic food supply. 5
The government has the ethical obligation to protect the safety
of the mainstream food supply for all of its citizens. The FAO ex-
pert panel on ethics recognized that
[t]he right to adequate food, as understood today, carries with it obliga-
tions on the part of states to protect individuals' autonomy and capacity
to participate in public decision-making fora, especially when other par-
ticipants are more powerful, assertive or aggressive. These obligations
can include the provision of public resources to ensure that those fora
take place in a spirit of fairness and justice. ' 66
The FAO report concluded that this right has not been fulfilled in
connection with genetically engineered products.'67 The most im-
portant stakeholders have been excluded from the process because
[c]itizens have a direct interest in technological developments, yet there
are obstacles to their participation in decision-making that must be ac-
knowledged and overcome. The public has not been adequately in-
formed about the application of gene technology to food production or
162. TEnELL& WILSON, supra note 126, at 61.
163. Id.
164. Id. at 73. See also Gerad Middendorf, Mike Skladany, Elizabeth Ransom &
Lawrence Busch, New Agricultural Biotechnologies: The Struggle for Democratic Choice,
50 MONTHLY REV. 85 (1998).
165. WHO Study, supra note 31, at 53 (citing Codex Alimentarius Commission,
Guidelines for the Production, Processing Labeling and Marketing of Organically Produced
Foods, available at http://www.fao.org/organicag/doc/glorganicfinal.pdf).
166. FAO REPORT 2, supra note 116.
167. See id. at 25-26.
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the consequent potential impacts on consumers' health and the envi-
168
ronment.
As a result, with the confusing and conflicting jumble of claims in
the media, "the public is losing faith in scientists and government.""
Following similar reasoning, Geoffrey Podger, the Executive Di-
rector of the European Food Safety Authority (EFSA), favors a label-
ing approach as a means to regaining the support of the public.7'
He explains that the European opposition to GMOs was based on
ethical grounds as a reaction to being denied a choice when GMO
and non-GMO varieties could not be differentiated. 7' Thus, the
European regulatory approach arose in part as a solution to this
ethical and practical duty to inform. The advantage of labeling is
that it provides a choice "[a]nd while the people who insist on
choice may be quite a small part of the population, they are very
vociferous and they are often in positions of power and promi-
nence."'" Accordingly, the key to public perceptions is a transpar-
ent regulatory process that gives people all available information on
the science.73
In the United States, the public outrage at being denied a
choice has generated a grassroots political effort to raise conscious-
ness of consumers and alert them as to what they are not being told,
while advocating labeling. 4 New legislative efforts attempt to re-
spond to the public's right to know, as well as the safety concerns
for consumers and farmers. On May 2, 2006, Representative Dennis
Kucinich (Democrat-Ohio) introduced the "Genetically Engineered
Food Safety Act" and four other bills regarding GMOs. 7'
168. Id. at 25.
169. Id.
170. Geoffrey Podger, European Food Safety Authority Will Focus on Science, 5 EUR.
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Most important is the responsibility of government to protect
its citizens and respond to their concerns. This moral imperative
would suggest mandatory labeling and monitoring of, and possibly a
moratorium on, the use of GMOs in food. '76 Unlike the Europeans,
U.S. citizens trust their government and regulatory agencies. 7 This
fact offers an even greater reason why it is critical that the govern-
ment does not betray that trust.
D. Equity, Power, and the Economically Disadvantaged
Any exploration of ethical issues should include consideration
of equity, distributive justice, and the greater good. Of particular
interest are two of the questions adopted by the Rotary Club as part
of their statement of business ethics: "[i]s it fair to all concerned?"
and "[w]ill it be beneficial to all concerned?"78
Contrary to these ethical principles, the story of biotechnology
in food has become a matter of corporate control. "A small number
of powerful transnational companies have come to increasingly
dominate the fields of seed production, agricultural chemicals and
pharmaceuticals."' According to the Action Group on Erosion,
Technology and Concentration (ETC Group), the top ten multina-
tional seed firms control half of the world's commercial seed sales (a
total worldwide market of approximately $21 billion per year).' "
Corporate control and ownership of seeds-the first link in the food
chain-has far-reaching implications for global food security. Sophia
Kolehmainen, Director of Programs at the Council for Responsible
Genetics, explains that
[a] small number of corporations are taking legal and physical control
over the world's food supply, thereby decreasing biodiversity while
2007). See also Strauss, International Regulation of Genetically Modified Organisms,
supra note 12, at 186-87 (describing these bills the last time they were introduced by
Rep. Kucinich in May 2002).
176. For more on the proposals for a regulatory response, see Strauss, Interna-
tional Regulation of Genetically Modified Organisms, supra note 12.
177. George Gaskell et al., Worlds Apart? The Reception of Genetically Modified Foods
in Europe and the U.S., 285 Sci. 384 (1999) (describing an attitudinal study analyzing
public perceptions of biotechnology, together with press coverage and policy for-
mation).
178. Rotary International, About Rotary, http://www.rotary.org/aboutrotary/
4way.html (last visited August 21, 2007).
179. Tokar, supra note 25.
180. ETC Group Communiqu6, Global Seed Industry Concentration-2005,
Sept./Oct. 2005, Issue #90, available at http://www.etcgroup.org/upload/publca-
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working within systems of food ownership at the genetic level. The is-
sues of patents on living organisms, ag-biotech monopolies, and the
creation of monocultures all raise serious questions about the soundness
of genetically engineering the world's food supply.
181
The prevalence of large monopolies in the seed and chemical indus-
try threatens to exclude the voices of farmers and consumers from
the debate about genetically engineering food. This scenario is un-
wise for ethical and public policy reasons, as "[r]elying on a handful
of self-interested corporations to make important and far-reaching
decisions about agriculture and food cannot possibly result in equi-
table policies, because genetic engineering threatens even the small
organic farmer with risks of genetic drift and genetic pollution.""
For example, the creation of monocultures by biotechnology com-
panies precludes the natural diversity that plants need to survive."
Given that the control of seeds and agricultural research is held in
fewer hands-with the power and priority of protecting their finan-
cial interests in the technology-the world's food supply is "increas-
ingly vulnerable to the whims of market maneuvers.""
The use of Terminator technology raises issues of equity as well,
because it makes farmers dependent on biotech companies and
takes away their livelihoods, preventing them from regenerating
their plants from year to year." The latter is particularly ironic for
developing countries, adding a financial burden to an impoverished
country that biotechnology was supposed to help-one of the origi-
nal justifications for its development. The agrochemical industry
has been increasingly usurping the choices that farmers make each
year about that season's crops, from the systematic patenting of
plant varieties, to the restricting of crops and usage of pesticides
under contract." With the Terminator, the self-destruct mechanism
embedded in each plant has achieved the ultimate in corporate con-
trol of these natural resources.
As discussed earlier, unequal access and ability to pay for or-
ganic foods prevents this source from being a viable alternative for
the masses. Moreover, in view of the dangers of cross-
181. Kolehmainen, supra note 38, at 282.
182. Id. at 283.
183. A classic example of the dangers of monocultures was seen in the 1845 Irish
Potato Famine. Id.
184. Seed Industry Concentration, supra note 180. See also LAWRENCE BUSCH ET AL.,
PLANTS, POWER AND PROFIT: SOCIAL, ECONOMIC AND ETHICAL CONSEQUENCES OF THE
NEW BIOTECHNOLOGIES (1992).
185. See Tokar, supra note 25.
186. Id.
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contamination, organic fields cannot be relied upon as a solution to
the security of the food supply in the long run.
Similarly, specialized equity concerns come into consideration
with respect to economically disadvantaged countries, raising issues
such as distributive justice, fairness, utility, and competing values
systems. Developing countries who have access to natural resources
often find the benefits diverted to the companies who possess the
technology, distribution, and control. A group of experts at a
roundtable on the ethics of biotechnology posed the question,
"[h]ow can we foster collaborations with countries that have natural
resources that may benefit all countries through technological de-
velopment and provide a fair return to the country of origin?"187 In
the international realm, the principles of the CBD provide that, in
addition to the conservation of biological diversity and the sustain-
able use of its components, countries should promote "the fair and
equitable sharing of the benefits derived from utilization of genetic
resources."'" If in fact benefits come from biotechnology products
that are derived from a country's natural resources, "how much of
that value should fairly be shared?" "
E. Conflicts of Interest in Public Research
Many people have expressed concern that the academic com-
munity involved in research is predominantly tied to the industries
and the patents they seek to develop."' This direct financial stake,
via stock options or patent participation, creates an inherent conflict
of interest. One fear is that "the lure of profit could color scientific
integrity, promoting researchers to withhold information about po-
tentially dangerous side-effects." 9'
Well-funded programs in plant genetics and genetic engineer-
ing are supplanting research to enhance organic methods and other
low-input alternatives. A 1990 study discovered that "from [ten per-
cent] up to one third of biomedical researchers at prestigious uni-
187. Diane E. Hoffman & Lawrence Sung, Symposium Report: Future Public Policy
and Ethical Issues Facing the Agricultural and Microbial Genomics Sectors of the Biotech-
nology Industry, 24 BIOTECH. L. REP. 10, 25 (2005) (roundtable discussion by experts
of the most significant public policy and ethical issues that will emerge as a result of
biotechnology).
188. CBD, art. 1., Objecive, available at http://www.biodiv.org/convention/arti-
cles.asp?lg=0&a=cbd-01.
189. Hoffman & Sung, supra note 187, at 23.
190. Id. at 12-13.
191. Batalion, supra note 104.
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versities such as Stanford and MIT had direct corporate ties. '""
With the exponential growth of the biotechnology industry since
then, today's figures are no doubt even higher. Will this connection
continue to divert more public funds to support the research agenda
of the biotechnology industry?19" '
Some groups have also raised the issue of intellectual property
practices as restricting the development of new genetically engi-
neered crops. In July 2003, a coalition of public sector research in-
stitutions announced the formation of the Public-Sector Intellectual
Property Resource for Agriculture (PIPRA).'" PIPRA, which is
funded by the Rockefeller and McKnight Foundations, argues that
"the benefits of much publicly funded research come to private in-
dustry through university technology transfer programs, limiting
universities' flexibility to conduct research.""95 The concern is that
biotechnology patents will not be applied to developments with little
commercial value that would benefit the poor.'" Perhaps this is one
reason the original goal of food security has not materialized.
Because the research at public institutions is often heavily influ-
enced by the source of funding for these projects, this predomi-
nantly private funding has diverted research time and money away
from projects that would benefit "the public good, such as biological
control, organic production systems and general agroecological
techniques." '97 This problem has prompted calls that "[c]ivil society
must request more research on alternatives to biotechnology by uni-
versities and other public organizations." '98
IV. AN ETHICAL PROPOSAL
Upon an examination of the issues discussed above, it becomes
apparent that ethical principles should shape the solution of the
future of biotechnology food products. Such a resolution should
include a plan to: (1) involve all stakeholders-farmers, consumers,
192. Tokar, supra note 25.
193. Id.
194. Richard C. Atkinson et al., Public Sector Collaboration for Agricultural IP Man-
agement, 301 Sci. 174 (2003). See also Public Sector Intellectual Property Resource
for Agriculture (PIPRA), http://www.pipra.org/ (last visited Aug. 21, 2007).
195. Hoffman & Sung, supra note 187, at 15.
196. Id.
197. Altieri & Rosset, supra note 36 (citing SHELDON KRIMPSKY & ROGER P.
WRUBEL, AGRICULTURAL BIOTECHNOLOGY AND THE ENVIRONMENT: SCIENCE, POLICY
AND SOCIAL ISSUES (1996)).
198. Id
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the environment, and underprivileged populations, as well as the
biotechnology industry; (2) inform them on the science, including
all potential and discovered risks to human health and the environ-
ment; (3) require comprehensive labeling, which is necessary for
informed consumer choice; and (4) promote more active and inde-
pendent involvement of regulatory agencies vis4-vis the biotechnol-
ogy companies.
The biotechnology companies have usurped the function of
government and streamlined Genetically Modified Organisms
(GMOs) into production without including the full scientific com-
munity, the public, and underrepresented stakeholders such as de-
veloping countries, the small farmers, and the environment. The
government must reassert its duty to protect the public by adopting
a more cautious approach with greater weight on safety concerns.
At this point, labeling as to the use of GMOs or genetically modified
(GM) processes is essential. But "labeling must not take away the
responsibility of authorities for risk assessment and decision-
making.""n This should include, at the very least, segregation of GM
products, monitoring and pre- and post-market safety assessments. °"
If warranted after a full investigation into the scientific, legal, and
ethical ramifications, society may ultimately decide to severely re-
strict or ban GMOs in food. Most importantly, all participants
should be wary not to be blinded by a brilliant but unfulfilled prom-
ise.
The future of biotechnology depends in large measure on ap-
propriate public education on both the science and the ethics to
allow consumers to reach an informed opinion. In the past, the in-
dustry has learned that public perceptions, in Europe for example,
can have a detrimental effect on their acceptance and on interna-
tional trade." ' Accordingly, there must be public involvement in,
and a forum for, legal and ethical issues with the realization that
"[fWrom this collective knowledge, balanced public policies will be
possible.""'2
It is significant to note that the roundtable on ethics in biotech-
nology identified as a top priority the "need for common regula-
tions regarding labeling and risk reduction across international bor-
ders so that new GM products can be imported and exported with
199. WHO Study, supra note 31, at 54.
200. See Strauss, International Regulation of Genetically Modified Organisms, supra
note 12, at 191.
201. Hoffman & Sung, supra note 187, at 24.
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assurance that the products meet global standards of safety." °3 The
global nature of the technology prompted a consideration of the
harmonization of laws in the international community regarding
intellectual property, public health and safety regulations, and natu-
ral resource and expertise disparities. '  In addition, scientists
should be encouraged to carry out research relevant to helping de-
veloping countries with new technologies.
The World Health Organization (WHO) study also recognized
the need and responsibility for communicating risks to the public so
that "ethical components of food-safety decisions are clearly identi-
fied as early in the process as possible" and "value-laden choices
made by risk managers are made in an open, participatory process
that respects the fights and roles of all stakeholders."" The report
by the Food and Agriculture Organization (FAO) of the United Na-
tions concluded that "a strategy that is more sensitive to ethical is-
sues should make food-safety risk analysis more effective, by making
decisions sounder, more transparent, more democratic and better
understood. This, in turn, should make risk-analysis decisions more
acceptable to and useful for the governments and citizens of all na-
tions."" °'
V. CONCLUSION
From an ethical perspective, the problem is not that this tech-
nology exists, but how that technology is being used. This article
has raised for discussion some important issues to consider as to
ethical dimensions of the technology and how it is being utilized. Is
it being applied towards the greater good? Are genetically modified
(GM) plants being cultivated to produce food for the masses, or to
create profits for a company whose seeds have been genetically
modified to require purchase every year and not regenerate as
farmers have done for centuries in order to make their living? Are
GM plants being used to help the environment, or is there a greater
203. Id. at 27; see also Strauss, Genetically Modified Organisms in Food, supra note
107.
204. See id.
205. Id. The participants observed that the cost-benefit analysis for each type of
technology is very different. For example, a GM product like Golden Rice to ad-
dress vitamin A deficiency would be considered more cost effective than Roundup
Ready® soybeans, which are not positioned as the solution to world hunger.
Hoffman & Sung, supra note 187, at 23-24.
206. WHO Study, supra note 31, at 56 (citing FAO REORT 1, supra note 114).
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potential for harm to human health and the environment? And do
the current regulations or lack thereof violate our responsibilities to
others by not allowing them a choice as to whether they knowingly
and willingly assume the risks of ingesting these GM substances?
If anything, this new technology should be used to assist less-
developed nations, rather than to further the disparities in natural
resources and technical expertise between the United States and
economically developing countries. Accordingly, research should be
directed towards eliminating world hunger and lowering the barri-
ers to food distribution. While the development of Golden Rice is
certainly preferable as an ethical matter to Roundup Ready® crops,
note that this justification for bioengineered food has been revealed
to be flawed, as an oversimplification of the problems of world hun-
ger, vitamin deficiencies, and more complex social issues. Biotech-
nology should not be used to divert important resources from re-
searching and applying more sustainable solutions for world food
security.
Raising global concerns, the World Health Organization
(WHO) study concluded that there is a need to discover opportuni-
ties where biotechnology can contribute to the secure generation of
nutritious foods in keeping with regional needs, recognizing that
"[s]uch opportunities should be based on sustainable food produc-
tion preserving biodiversity and respecting the values of nature,
while taking into consideration ethical objectives and social equity in
respect to regional conditions, needs and wants.""0 8 Thus, a secure
future would encompass a respect for nature and the value of life,
consideration of the environment, rights and responsibilities of all
stakeholders, equity, and distributive justice. As proposed above,
fully informing the public and transparency in the regulatory proc-
ess are key.
The ethical implications are clear, followed by the expectation
that the legal system will fill in the ethical gap as it has done in so
many other areas and, at the very least, require labeling, pre-market
approval, and monitoring of Genetically Modified Organisms
(GMOs) in food products and ingredients. EU law takes into ac-
count ethical issues."° It is morally imperative for U.S. law to do so
208. Id. at 59.
209. See, e.g., Council Directive 2001/18/EC, 2001 O.J. (L106), available at
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as well. The government must fulfill its responsibility to protect its
citizens, respond to their concerns, and not betray their trust by
forcing them to bear the risk of GMOs without informed consent.
As one scholar has queried, "[w]ill we be able to make ethical
choices about what is humanly desirable, or will society become
progressively more enslaved to the 'free-market' dictum that what-
ever can be done will be done?" °10
Some opponents of genetically modified foods have labeled
them "Frankenfoods." "' The origins of this analogy, as a reaction to
the proliferation of untested technology with consequences that are
as yet unknown, cannot easily be dismissed. Perhaps policymakers
should heed the advice of that classic moral: "Learn from me, if not
by my precepts, at least by my example, how dangerous is the ac-
quirement of knowledge, and how much happier that man is who
believes his native town to be the world, than he who aspires to be-
come greater than his nature will allow." 12 Fundamentally, geneti-
cally modified plants substitute human wisdom for the wisdom of
nature."' Our society has yet to address the ultimate issue, particu-
larly with regard to Terminator seeds-should mankind be usurping
the basic functions of life?
porting on ethical issues and the involvement of the public in the authorisation
process").
210. Tokar, supra note 25.
211. John S. Applegate, The Prometheus Principle: Using the Precautionary Principle to
Harmonize the Regulation of Genetically Modified Organism, 9 IND. J. GLOBAL LEGAL
STuD. 207, 209-12 (2001).
212. Id. at 212 (citing MARY SHELLEY, FRANKENSTEIN, OR, THE MODERN
PROMETHEUS, at 56 (Airmont Publishing Co. 1963) (1817)).
213. Id. at 211-13.
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I. PREFACE: THE STARBUCKS PROBLEM
On March 7, 2007, the New York Times reported that Starbucks,
the retail coffee chain which sells millions of baked goods every day
from its over 8,700 U.S. stores, had asked its suppliers to eliminate
all trans fats from their products by the end of the year.' The big
story for New York readers, though, was not that Starbucks was re-
quiring the elimination of trans fats from its baked goods. In fact,
New York City had just passed an ordinance strictly limiting the use
of artificial trans fats, the type present in partially hydrogenated
vegetable oil (PHVO), by virtually all of the city's food service estab-
lishments.2 Rather, the "scoop" for New York readers was the
source of the trans fats being eliminated by Starbucks' bakeries-
butter!.
The article reported that U.S. wholesale bakeries were being
forced to take butter out of their recipes because it contains small
amounts of natural trans fats (the type present in products devel-
oped from the fat of ruminants), even though a large body of evi-
dence suggests that those fats may actually be beneficial to health."
* Ross Williams will receive his J.D. from the University of Texas School of
Law in May of 2008. He would like to thank Professor Thomas McGarity for all of
his help and encouragement in preparing this article.
1. Kim Severson, Trans Fat Fight Claims Butter as a Victim, N.Y. TIMES, Mar. 7,
2007, at Fl.
2. New York City Health Code § 81.08 (effective July 1, 2007); see also New
York, N.Y., Dep't of Health & Mental Hygiene, Board of Health-Notice of Adoption of an
Amendment (§ 81.08) to Article 81 of the New York City Health Code, available at
http://www.nyc.gov/html/doh/downloads/pdf/public/notice-adoption-hc-art8l-
08.pdf.
3. See Severson, supra note 1.
4. See Janet Raloff, Trans Fats are Bad, aren't they? (Dec. 16, 2006),
http://www.sciencenews.org/articles/20061216/food.asp (last visited Dec. 28,
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Apparently, Starbucks' request was causing great confusion in the
food industry. Matthew Reich, a supplier of baked goods to 500
Starbucks locations from Philadelphia to Hartford, complained that
the request was "causing problems for every big baker in the coun-
try," and that he personally "didn't even know where to find trans-
free margarine."5 Because of the short notice, many bakeries were
reacting by hastily replacing butter with palm oil,' margarine, and
other processed substances high in saturated fat-a type of fat gen-
erally known to have a significant negative effect on heart health.'
Starbucks company spokesman Brandon Borman was quoted as
saying that "for [Starbucks], it's easier for the customer to walk in
and see zero grams trans fat rather than zero grams artificially cre-
ated trans fat."' The New York Times article explained that while the
New York City ordinance only covers artificial trans fats, the Food
2007) (discussing the potential health benefits of the non-regulated trans fat, li-
noleic acid (CIA), which occurs and is de facto eliminated from recipes with the
regulated natural trans fat, vaccenic acid); Janet Raloff, The Good Trans Fat:Will One
Family of Animal Fats Become a Medicine?, 159 (9) Sc. NEWS 136 (2001); Food Label-
ing: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health
Claims, 68 Fed. Reg. 41433, 41461 (July 11, 2003) (codified at 21 C.F.R. pt. 101)
(acknowledging that vaccenic acid metabolizes onto CIA in the human body);
FOOD & NUTRITION BD., INST. OF MED. OF THE NAT'L ACADS. (IOM), DIETARY
REFERENCE INTAKES FOR TRANS FATTY ACIDS (2002), at 14,
http://www.iom.edu/Object.File/Master/13/083/TransFattyAcids.pdf (last visited
Dec. 28, 2007) [hereinafter DIETARY REFERENCE INTAKES] (suggesting that eliminat-
ing all trans fat, including that from ruminant sources, might introduce undesirable
effects, such as inadequate intake of protein and micronutrients); S. Banni et al.,
Vaccenic Acid Feeding Increases Tissue Levels of Linoleic Acid and Suppresses Develop-
ment of Premalignant Lesions in Rat Mammary Gland, 41(1-2) NUTR. CANCER 91, 91-97
(2001); E. Thom et al., Conjugated Linoleic Acid Reduces Body Fat in Healthy Exercising
Humans, 29(5) J. INT'L MED. RES. 392, 392-96 (2001); H. Blankson et al., Conjugated
Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans, 130(12)J. NUTRI-
TION 2,943, 2,943-48 (2000); Letter from Gregory D. Miller, Senior Vice Pres. of
Nutrition & Prod. Innovation, Nat'l Dairy Council, & PeterJ. Huth, Dir. of Reg. &
Res. Transfer, Nat'l Dairy Council, to Div. of Dkts. Mgt., Food & Drug Admin. (June
18, 2004) (on file with author); D. Mozzafarian et al., Trans Fatty Acids and Cardio-
vascular Disease, 354 (15) NEW ENG.J. MED. 1,601, 1,601-13 (2006) (stating that "the
sum of the current evidence suggests that the public health implications of consum-
ing trans fats from ruminant products are relatively limited" but warning that that
this may be the result of relatively low consumption of trans fats from animal
sources compared to artificial ones).
5. Severson, supra note 1.
6. See id.
7. See WORLD HEALTH ORG. (WHO), DIET, NUTRITION AND THE PREVENTION OF
CHRONIC DISEASES, WHO TECHNICAL REPORT SERIES 916, at 82 (Geneva 2003),
available at http://www.who.int/dietphysicalactivity/publications/trs9l6/en/.
8. Severson, supra note 1.
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and Drug Administration (FDA) labeling regulation recognizes no
difference between artificial and natural trans fats and covers them
both. Aside from illustrating a general lack of awareness as to the
FDA regulation's coverage,9 this reaction demonstrates the way in
which large producers like Starbucks treat the FDA regulation, and
illustrates the local efforts to regulate trans fats as a de facto ban on
trans fat generally, removing potentially beneficial natural trans fats
from food and hastily replacing them with substances known to be
more harmful to heart health simply because the natural trans fat
sources are covered by the federal, and potentially some local, regu-
lations.
The New York Times article also provides a quote that is symp-
tomatic of the wider public misunderstanding regarding trans fat
regulation: Marion Nestle, nutrition professor at New York Univer-
sity and author of Safe Food: Bacteria, Biotechnology, and Bioterrorism,
said that "this is an important issue because anything made with
animal fats will have trans fats and make it impossible to claim trans
fat-free. Milk has trans fats, after all, and you can see what a mess
this is going to cause."'" This statement is inaccurate for several rea-
,ns: there is no definition of "trans fat free" in the current FDA
regulations;" at the current serving size, whole milk and whipped
butter are both allowed to claim that they contain zero grams of
trans fat per serving;' and products made with animal fats can still
claim that they contain zero grams trans fat on their nutrition label
as long as the individual serving size of the products contains less
than 0.5 grams of the regulated type of natural trans fat per serv-
ing. 1
Ultimately, the article raises two key issues: the widespread
misunderstanding regarding trans fat regulation, and the way in
which the current federal regulation" interacts with a myriad of re-
cently passed local ordinances" to influence Starbucks and other
9. The FDA regulation actually covers only nonconugated trans fatty acids, one
type of trans fat present in animal fats. See 68 Fed. Reg. at 41461.
10. Severson, supra note 1.
11. Indeed, the sections referring to it were intentionally removed by the draft-
ers. See 68 Fed. Reg. at 41434.
12. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
13. Id.; see also 21 C.F.R. § 101.12 (2006).
14. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
15. See New York City Health Code (N.Y.) § 81.08 (2006). See also Nat'l Rest.
Ass'n, Trans Fat Legislation, http://www.restaurant.org/government/state/
nutrition/billstransfat.cfm (last visited Dec. 28, 2007) (listing current efforts by
states to regulate trans fats).
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national food producers and suppliers to remove both artificial and
natural trans fats in favor of processed oils high in saturated fats,
which may result in a negative net effect on public health. 6 The
latter issue may also be affected by businesses' overreaction to po-
tential tort suits regarding the continued use of trans fats.17 This
article explores these issues and others regarding the current state
of trans fat regulation and suggests possible avenues for change.
II. INTRODUCTION
Thanks to advances in technology, the American food system
has grown from an amalgamation of discrete, local supply chains
into a system organized on a regional, national, and global scale.'"
While our food system has become increasingly complex, the
sources that supply it have decreased significantly in number: more
and more Americans are being fed by fewer and fewer food facili-
ties.'" Food safety regulation has evolved along with our food sys-
tem. The development of a national market for food and the desire
for uniform regulations to combat unsanitary conditions engen-
dered the early twentieth century movement away from a predomi-
nant reliance on state and local regulation of food safety and toward
16. A negative net effect on public health may result from the harmfulness of
saturated fat on heart health in conjunction with the potential detriments of remov-
ing natural trans fat sources. See DIETARY REFERENCE INTAKES, supra note 4, at 14;
Banni et al., supra note 4, at 392-96; Blankson et al., supra note 4, at 2,943-48;
Miller, supra note 4; Mozzafarian et al., supra note 4, at 1,601-13.
17. Given the new scientific evidence and public and industry awareness of the
dangers of trans fats, food producers and restaurants may be overreacting in ways
similar to Starbucks out of recognition that reliance on rulings similar to those that
insulated them from previous tort suits may be misplaced if the producers and
restaurants continue to use trans fats in their foods. See Ctr. for Sci. in the Pub.
Interest (CSPI), Petition for Rulemaking to Revoke the Authority for Industry to use Par-
tially Hydrogenated Vegetable Oil in Food at 30-31 (filed May 18, 2004), available at
http://cspinet.org/new/pdf/trans-fat.petition-final-may-18.pdf (arguing that in
the future, private parties may sue restaurants or food companies for continuing to
use partially hydrogenated vegetable oils when healthier alternatives exist; citing for
comparison Pelman v. McDonald's, 237 F. Supp. 2d 521, 532 (S.D.N.Y. 2003) (hold-
ing that complaint would state a tort claim "if McDonald's products are so extraor-
dinarily unhealthy that they are outside the reasonable contemplation of the con-
suming public or that the products are so extraordinarily unhealthy as to be dan-
gerous in their intended use), and BanTransFats.com v. Kraft Foods N. Am., Inc., CV
032041 (Martin County Super. Ct. Cal. May 2003)).
18. COMM. TO ENSURE SAFE FOOD FROM PROD. TO CONSUMPTION, IOM, ENSURING
SAFE FOOD FROM PRODUCTION TO CONSUMPTION 17-18 (Nat'l Acad. Press 1998).
19. Id. at 19.
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the gradual creation of the large federal regulatory bureaucracy of
today."° As much as the public relies on that bureaucracy to ensure
the safety of the food supply, the increasingly oligarchical food in-
dustry has come to rely on federal regulations as well because of the
uniformity and relative predictability that they provide to the huge
operations that supply food to the national market.
The resulting system is a fragile one; a single major incident can
easily have national effects.' The widespread public recognition
that trans fats are deleterious to health, which followed implementa-
tion of the Food and Drug Administration (FDA) regulation requir-
ing the listing of trans fat content on food labels, is an example of
just such an incident: a nearly omni-present ingredient in our food,
partially hydrogenated vegetable oil, was making us sick. Labels and
ingredient lists on food packages in grocery stores across the nation
seemed to change overnight. Growing public concern over the
presence of trans fats and the absence of a federal regulation requir-
ing producers to limit or eliminate trans fats from our food supply
led state and local governments to pass regulations to fill the regula-
tory gap.'
As a result of such efforts, food producers from the largest cor-
porations to the smallest street vendors in some localities were effec-
tively forced to change one of the bedrock principles of their food
preparation procedures: the fat they cook with. Today, the busi-
nesses that supply our national food system, including the bakeries
that supply Starbucks, face both a federal regulation defining trans
fats in a potentially overbroad way and a patchwork of local regula-
tions limiting the presence of trans fats in the food supply, rather
than a single preemptive federal standard limiting the presence of
trans fat in our food in a uniform manner. To comply efficiently
with the numerous local regulations, to respond effectively to public
hysteria, and potentially out of concern for the tort consequences of
continued trans fat use," many food producers are making rapid
changes based on the FDA's definition of trans fats, changes that
might result in an overall negative effect on public health.'"
20. Id. at 21-22.
21. Id. at 19.
22. See Janet Frankston Lorin, Associated Press, Legislating food becoming issue du
jour in state, city government, Feb. 18, 2007, available at http://
www.boston.com/news/local/connecticut/articles/2007/02/17/legislating__food-b
ecoming-issueduour instatecitygovernment/.
23. See CSPI, supra note 17.
24. See DIETARY REFERENCE INTAKES, supra note 4; see also WHO, supra note 7.
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This article explores the history, current regulations, ongoing
debate, and potential future regulations concerning trans fat in
foods, ultimately recommending that the FDA remove the "gener-
ally recognized as safe" (GRAS) status of artificial trans fat sources,
limit or eliminate their presence in our national food supply
through appropriate preemptive regulations, amend its definition of
trans fatty acid pending the completion of further research to de-
termine whether natural trans fats pose risks similar to artificial va-
rieties, and sponsor industry and consumer education on this sub-
ject, among other things. These steps would protect public health
and insure the uniformity and predictability that the food industry
needs to provide safe and wholesome foods on a national level. Ad-
ditionally, this article analyzes the legal and policy issues that such
action, or continued inaction, would raise.
. This article begins with a brief description of the science and
history behind the use of trans fatty acids: the types of trans fats
and their sources, the movement that led to the nearly universal
adoption of artificial trans fat-containing substances for use in cook-
ing, the subsequent backlash against their use, and the scientific evi-
dence supporting the idea that artificial trans fats are dangerous.25 I
then turn to a discussion of the history, pros and cons, and current
state of the federal government's regulation of trans fats, followed
by an analysis of the current grassroots movement to regulate trans
fats at the state and local government levels in the face of the federal
government's inactivity. 6
Next, this article analyzes the FDA citizen action "Petition for
Rulemaking to Revoke the Authority for Industry to use Partially
Hydrogenated Vegetable Oils in Foods" filed by the Center for Sci-
ence in the Public Interest (CSPI) in depth, supplemented by CSPI
Executive Director Michael Jacobson's thoughts on the current state
of trans fat regulation and the FDA's involvement therein.' Finally,
I discuss whether the FDA must, or at least should, grant the CSPI
petition or a similar alternative, additional steps that the FDA
should take, the issues of federalism that such a regulation would
implicate, whether any resulting regulation should be preemptive,
and the potential consequences of passage on the area of tort litiga-
tion."
25. See infra notes 29-72 and accompanying text.
26. See infra notes 73-139 and accompanying text.
27. See infra notes 140-178 and accompanying text.
28. See infra notes 179-207 and accompanying text.
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III. BACKGROUND
To understand the regulations regarding trans fats, it is first
necessary to have some basic understanding of what trans fats are.
The following section provides a brief overview of the different
types of trans fats; their origins, characteristics, and effects on hu-
man health; and also explains their relation to the current regula-
tions.
A. Natural Sources of Trans Fat:
Partially Covered by the FDA Regulations
Humans have consumed trans fats for as long as they have
eaten ruminants. Indeed, many people do so at birth, as trans fats
are found in the breast milk of mothers in amounts proportional to
their dietary intake.' The 2-5% of total fat in ruminants that is
technically trans fat3° can be subdivided into two categories: conju-
gated linoleic acid (CLA)3' and non-conjugated linoleic acid in the
form of vaccenic acid.
This is an important distinction, because the Food and Drug
Administration (FDA) regulatory definition of trans fats covers only
non-conjugated trans fats." Thus, while the content per serving of
non-conjugated trans fats derived from ruminant sources must be
given on a product's nutrition label if the product contains 0.5
grams or more per serving, the amount of conjugated trans fat (CLA)
in the same food product is not regulated and need not be reported
on the nutrition label, regardless of the product's CLA content per
serving.' Because these two types of fat occur together in products
derived from ruminant fats, businesses like Starbucks that eliminate
trans fats altogether in an effort to attain broad compliance with
potential local ordinances limiting the use of trans fats end up
eliminating CLA de facto, even though it is not included in the trans
29. Sheila M. Innis & D. Janette King, Trans Fatty Acids in Human Milk are In-
versely Associated with Concentrations of Essential All-cis n-6 and n-3 Fatty Acids and
Determine Trans, but not n-6 and n-3, Fatty Acids in Plasma Lipids of Breastfed Infants,
70(3) AM.J. CLINICAL NUTRITION 383 (1999).
30. TRANs FAT TASK FORCE OF HEALTH CANADA, TRANSFORMING THE FOOD
SUPPLY (June 2006), at 4, available at http://www.hc-sc.gc.ca/fn-an/nutrition/gras-
trans-fats/tf-ge/tf-gtjrep-rape.html.
31. T.R. Dhiman et al., Linoleic Acid (CLA) Content of Milk from Cows Offered Diets
Rich in Linoleic and Linolenic Acid, 83(5)J. DAIRY SCI. 1,016 (2000).
32. 68 Fed. Reg. at 41461.
33. Id.
34. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
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fatty acid content listed on nutrition labels and may actually be
beneficial to human health.'
B. The Risks and Benefits of Natural Tram Fats
Scientific evidence suggests that natural trans fats may not have
the same negative health effects that are associated with artificial
trans fats.' Indeed, CLA in particular may be beneficial to human
health.37 Studies have shown that CLA may reduce body fat in both
healthy and overweight humans" and may also prevent breast 9 and
colorectal cancer."° Additionally, vaccenic acid (the non-conjugated
trans fat contained in ruminant meat and covered by the FDA regu-
lations) is actually converted to CIA when it reacts with chemicals in
the body during digestion,4 and some research suggests that vacce-
nic acid intake may reduce the risk of breast cancer."
Some scientific evidence, however, suggests that trans fats from
ruminant sources might also have negative effects. One study sug-
gests that CIA may have negative effects on cardiovascular health
and insulin resistance in obese men,3 and a 2006 review of the lit-
erature on natural trans fat sources in the New England Journal of
35. See Banni et al., supra note 4; Thorn et al., supra note 4; Blankson et al., supra
note 4; Miller, supra note 4; Mozzafarian et al., supra note 4.
36. See Miller, supra note 4; see also Mozzafarian et al., supra note 4.
37. See Thorn et al., supra note 4; see also Blankson et al., supra note 4.
38. See id.
39. See M.M. Ip et al., Prevention of Mammary Cancer with Linoleic Acid: Role of the
Stroma and the Epithelium, 8(1) J. MAMMARY GLAND BIOLOGY & NEOPLASIA 103, 103-
18 (2003) (stating that, taken together, the current data suggest that CIA may be an
excellent candidate for the prevention of breast cancer); but see L.E. Voorrips et al.,
Intake of Linoleic Acid, Fat, and other Fatty Acids in Relation to Postmenopausal Breast
Cancer: the Netherlands Cohort Study on Diet and Cancer, 76(4) AM. J. CLINICAL NUrRI-
TION 873, 873-82 (2002) (stating that the suggested anticarcinogenic property of
CLA in animal and tissue studies was not confirmed in humans through review of
data from a cohort study conducted in the Netherlands).
40. Susanna C. Larsson et al., High-fat Dairy Food and Linoleic Acid Intakes in
Relation to Colorectal Cancer Incidence in the Swedish Mammography Cohort, 82(4) AMER.
J. CLINICAL NUTRITION 894, 894-900 (2005) (concluding that prospective data sug-
gests that high intakes of high-fat dairy foods and CLA might reduce the risk of
colorectal cancer).
41. 68 Fed. Reg. at 41461; see also Banni et al., supra note 4.
42. See Banni et al., supra note 4.
43. See Ulf Risrus et al., Supplementation With Linoleic Acid Causes Isomer-
Dependent Oxidative Stress and Elevated C-Reactive Protein, 106 CIRCULATION 1,925
(2002).
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Medicine noted that their limited negative effect on public health
might be due to their low occurrence in the diet."
Despite the evidence on both sides regarding the benefits and
risks of natural trans fat consumption, these fats may provide impor-
tant indirect benefits to public health as well: the Institute of Medi-
cine (1OM) has acknowledged that any potential benefits of remov-
ing natural trans fat from the diet, including that from ruminant
sources, might introduce undesirable effects, such as inadequate
intake of protein and micronutrients.' Consequently, even though
natural trans fat sources may have some negative public health ef-
fects, their elimination from the food supply might result in a nega-
tive net effect on public health by removing the indirect benefits
that they provide. While the FDA includes natural trans fat sources
in its labeling regulation regardless of this information, some local
U.S. governments have chosen to exclude natural trans fat sources
from their regulations while awaiting further study.'
C. Artificial Trans Fats: Sources and Creation Through Hydrogenation
Hydrogenation is the process whereby hydrogen atoms are
added to a molecule through a chemical process involving a catalyst
and pressure.47 A fat molecule can only carry a certain number of
hydrogen atoms, and once it carries the maximum number it is re-
ferred to as a saturated fat because it is saturated with hydrogen. 8
Thus, partially hydrogenated oils contain unsaturated fats and are
very low in saturated fats.
Partially hydrogenated vegetable oils (PHVO) are the main
source of artificial trans fats and dietary trans fats generally. 9 Until
recently, PHVO was a basic building block of many food products,
either as oil for frying, as shortening for baked goods, or as marga-
rine for spreads." Whereas natural trans fats occur in animal fat at a
level of 2-5% of total fat, artificial trans fats occur in PHVO products
as up to 45% of total fat content.5
44. Mozzafarian et al., supra note 4, at 1,609.
45. DIETARY REFERENCE INTAKES, supra note 4, at 14.
46. See New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2.
47. RAYMOND CHANG, ESSENTIAL CHEMISTRY 375 (McGraw Hill 1996).
48. MARY K. CAMPBELL, BIOCHEMISTRY 198-99 (3d ed. Saunders C. Publishing
1999).
49. New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2.
50. Id.
51. TRANS FAT TASK FORCE OF HEALTH CANADA, supra note 30.
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D. Introduction of Artificial Trans Fats into the Food Supply
The process for hydrogenating liquid oils was brought to Amer-
ica when Proctor and Gamble acquired the U.S. patent and began
marketing the first Crisco in 1911." By the 1960s, PHVO had re-
placed animal fat as the most commonly used fat in the U.S., and
health advocates began to argue that the unsaturated fats that they
contained were healthier than saturated fats. Food producers like
PHVO because it can be used as a malleable fat, is solid at room
temperature, melts when baked or consumed, is very low in satu-
rated fat, is cheap, and increases shelf life. 3
Despite PHVO's widespread popularity among food producers,
fast food restaurants continued to use beef fats and tropical oils
high in saturated fats.' But in 1984, the Center for Science in the
Public Interest (CSPI) and other consumer groups began a six-year
campaign to end the use of those oils in fast food." By 1990, most
of the fast food industry had switched from oils high in saturated
fats to PHVO.6
E. Widespread Use, Warning Signs, and Enactment
of the Current Regulation
By 1987, comments in CSPI's Nutrition Action newsletter
showed just how integral PHVO had become in our food supply.
7
In the newsletter, CSPI acknowledged that PHVO played a vital role
in the nation's food supply, but reassured its readers that PHVO is
not harmful to human health, is relatively benign, and is not a cause
of heart disease. 8 In fact, CSPI claimed that food producers were
actually "(i)mproving on (n)ature" through hydrogenation and ulti-
mately averred that the safety of PHVO was "cause for thanks, be-
cause these fats are everywhere."" In 1988, the first scientific evi-
dence that the trans fats contained in PHVO could have harmful
52. Crisco, History/Timeline, http://www.crisco.com/about/history/1911.asp
(last visited Dec. 28, 2007).
53. See TRANS FAT TASK FORCE OF HEALTH CANADA, supra note 30, at 12.
54. Mary G. Enig, The Tragic Legacy of Center for Science in the Public Interest (CSPI)






59. See Enig, supra note 54.
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effects began to emerge, but the advocates who had pushed for the
switch away from saturated fats and toward PHVO defended the
healthfulness of trans fats up until 1994, when scientists estimated
that approximately 30,000 American deaths from heart disease an-
nually were attributable to trans fat consumption.' Shortly thereaf-
ter, CSPI called a news conference to condemn the use of PHVO
and filed its first FDA citizen action petition regarding trans fats on
February 14, 1994, requesting that the FDA require mandatory la-
beling of trans fatty acid content in foods." The petition resulted in
action in 2003 that culminated in the labeling rule implemented in
2006, nearly twelve years after the initial petition was filed.
F. Artificial Trans Fat's Negative Health Effects
While some critics continue to doubt even the most convincing
evidence that artificial trans fats have a negative effect on health,
these fats are now generally recognized as harmful to cardiovascular
health in particular.' Moreover, a mounting body of evidence sug-
gests that they may have a deleterious effect on health in other ways
as well.
A 2006 article published in the New England Journal of Medicine
reviewed the scientific evidence and concluded that there is strong
proof that a connection exists between trans fat consumption and
an increased risk of coronary heart disease (CHD)6 Specifically, the
scientific evidence shows that trans fat is markedly more harmful to
cardiovascular health than saturated fats when the two substances
are consumed in similar amounts, and that replacement of trans fats
60. W.C. Willett & A. Ascherio, Commentary: Trans fatty acids: are the effects only
marginal?, 84 AM.J. PUB. HEALTH 722 (1994).
61. Letter fromJohn M. Taylor, III, Assoc. Commr. for Reg. Affairs, FDA, to Dr.
Michael F. Jacobson, Exec. Dir., Ctr. Sci. Pub. Interest, Re: Docket No. 94P-0036
(Dec. 19, 2003).
62. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
63. See Steven Milloy, Trans Fat Hysteria could be Lawsuit Bonanza (Nov. 9, 2006),
http://www.foxnews.com/story/0,2933,228537,00.html (last visited Dec. 28, 2007);
see also Gary Becker, The Becker-Posner Blog, Comment on the New York Ban on
Trans Fat-Becker (Dec. 21, 2006), http://www.becker-posner-blog.com/
archives/2006/12/comment on the_4.html (last visited Dec. 28, 2007).
64. See Mozaffarian et al., supra note 4, at 1,613; see also TRANS FAT TASK FORCE
OF HEALTH CANADA, TRANSFORMING THE FOOD SUPPLY: APPENDIX 9iii,
CONSULTATION ON THE HEALTH IMPLICATIONS OF ALTERNATIVES TO TRANS FATTY
ACIDS, SUMMARY OF RESPONSES FROM EXPERTS (2006), available at http://www.hc-
sc.gc.ca/fn-an/nutrition/gras-trans-fats/tf-ge/tf-gt-app9iii-e.html.
65. See Mozaffarian et al., supra note 4, at 1,613.
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with non-trans unsaturated fats could cut a person's risk of CHD by
as much as 53%.' Additionally, trans fats have been shown to have a
sinister effect on cholesterol levels, a key indicator of heart health:
while trans fat consumption increases the level of LDL (bad) choles-
terol, it also decreases the level of HDL (good cholesterol), resulting
in a negative effect on cholesterol levels that is significantly larger
than that caused by saturated fat consumption.67
In addition, trans fats may be harmful to more than just heart
health. Though there is no scientific consensus, some studies have
suggested that trans fat consumption may also result in higher risks
of obesity,' type II diabetes, 9 infertility,"0 and even cancer.' Given
these and other findings, the IOM's recommendation that dietary
trans fats be as low as possible" seems warranted. The next section
discusses the current state of regulations concerning these sub-
stances.
IV. CURRENT REGULATION OF TRANS FATS
There are two basic sources of the current statutes concerning
trans fats: the federal government (via the Food and Drug Admini-
stration's (FDA) authority over food labeling), and state and local
governments. Rather than focusing on the effect that different
types of trans fats have in the human body, the FDA has chosen to
regulate a chemical structure, with the result that the amount of cer-
tain types of natural trans fats must be factored into a product's to-
66. See F.B. Hu et al., Dietary Fat Intake and the Risk of Coronary Heart Disease in
Women, 337(21) NEW ENG.J. MED. 1491 (1997).
67. See A. Ascherio et al., Trans Fatty Acids and Coronary Heart Disease, 340(25)
NEW ENG.J. MED. 1994 (1999).
68. See Anna Gosline, Why Fast Foods are Bad, even in Moderation (June 12, 2006),
http://www.newscientist.com/channel/health/dn9318-why-fast-foods-are-bad-even-
in-moderation.html (last visited Dec. 28, 2007); see also Six Years of Fastfood Supersizes
Monkeys, 2556 NEW SCIENTIST 21 (June 17, 2006), available at http://
www.newscientist.com/channel/health/mg19025565.000-six-years-of-fastfood-fats-
supersizes-monkeys.html.
69. See TRANS FAT TASK FORCE OF HEALTH CANADA, supra note 64; but see R.M.
van Dam et al., Dietary Fat and Meat Intake in Relation to Risk of Type 2 Diabetes in
Men, 25(3) DIABETES CARE 417, 422 (2002) (suggesting no such correlation when
confounding factors were factored into the analysis).
70. See Jorge Chavarro et al., Dietary Fatty Acid Intakes and the Risk of Ovulatory
Infertility, 85(1) AM.J. CLINICAL NUTRITION 231-37 (2007).
71. See Jorge Chavarro et al., A Prospective Study of Blood Trans Fatty Acid Levels
and Risk of Prostate Cancer, 47 PROC. AMER. ASSOC. CANCER RES. (2006); but see TRANS
FAT TASK FORCE OF HEALTH CANADA, supra note 64.
72. See DIETARY REFERENCE INTAKES, supra note 4, at 14.
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tal trans fat content, leading big companies like Starbucks to remove
them even though those fats may actually be beneficial to human
health.73 As the Starbucks story attests, these natural fats are often
hastily replaced with processed fats high in saturated fat but lacking
in the beneficial fats that the natural ingredients contain. Conse-
quently, the current regulatory situation may result in a negative net
effect on public health.74
Aside from the effect that the federal regulations have on large
producers, there is a second force effecting large food producers
and retailers in a similar way: the necessity of complying with mul-
tiple local ordinances, some of which might require the removal of
the natural trans fats covered by the FDA, may prompt national
businesses such as Starbucks to play it safe by going to the extreme
of eliminating all of the trans fats that the FDA labeling requirement
covers in hopes of achieving broad compliance. The sweeping
changes resulting from these two forces may have a negative effect
on the safety and wholesomeness of the food supply because they
are resulting in natural trans fats being eliminated (even though sci-
entific evidence suggests that such fats may be beneficial to con-
sumer health) by large producers and retailers such as Starbucks in
exchange for added saturated fats from the substituted palm oils,
margarines, and interesterified fats that are either known to be det-
rimental to heart health75 or are potentially deleterious." This sec-
tion will analyze each of these regulatory sources in turn-their his-
tory and coverage-to expose their individual shortcomings and the
problems created by their simultaneous operation.
73. See 68 Fed. Reg. at 41461.
74. See supra § III.B.
75. See WHO, supra note 7, at 88.
76. See Ben Harder, A Trans Fat Substitute Might Have Health Risks Too (Feb. 10,
2007), 171(6) SCIENCE NEWS ONLINE, http://www.sciencenews.org/articles/
20070210/food.asp (last visited Dec. 28, 2007) (citing K. Sundram et al., Stearic Acid
Rich Interesterified Fat and Trans-Rich Fat Raise the LDL/HDL ratio and Plasma Glucose
Relative to Palm Olein in Humans, 4 NuTRmON & METABOLISM 3 (2007), available at
http://www.nutritionandmetabolism.com/content/4/1/3). Michael Jacobson
points out that the study cited "had a 'bizarrely high' proportion of saturated fatty
acids," and states that "(i)t looks to me like the palm oil industry was looking for a
way to put a potential competitor in a bad light [by using] unrealistic conditions."
Id.
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A. The Current Federal Regulations: Overbroad
in Scope but Under-Regulatory
While the current FDA regulation requiring the listing of trans
fat content on the nutrition facts label of food products has indi-
rectly led producers to limit the amount of trans fat contained in
their products to an amount lower than 0.5 grams per serving (the
amount below which trans fat content can be claimed as "zero"),' it
is flawed for several reasons: the 0.5 grams per serving allowance is
too high; the definition of trans fats is too broad; and the regulation
merely requires the labeling of a food's trans fat content rather than
directly limiting the amount of trans fat that a given food product
may contain, leading local governments to pass a multitude of dif-
ferent regulations to fill in the regulatory gaps left by the FDA. This
section looks at the history and current state of the federal regula-
tion regarding trans fat and discusses its benefits and shortcomings.
1. History
The road that led to the current regulation of trans fat was a
long one. Following the revelation that approximately 30,000
deaths result from coronary heart disease (CHD) due to trans fat
consumption annually,78 the Center for Science in the Public Interest
(CSPI) changed its position on PHVO and filed a citizen action peti-
tion on February 14, 1994, urging the FDA to require that a prod-
uct's trans fat content be reported on its nutrition facts label. 9 A
proposed rule appeared in the Federal Register on November 17,
1999, suggesting that the nutrition labeling regulations be amended
to require that the amount of trans fats in a food be included in the
amount and percentage daily value declared for saturated fat with a
footnote indicating trans fat content per serving when it exceeded
0.5 grams.'
Three comment periods were successively opened for the pro-
posed rule.8' On September 18, 2001 (over seven years after the
initial citizen action petition was filed), the Office of Information
77. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
78. See Willett & Ascherio, supra note 60.
79. Taylor, supra note 61.
80. Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content
Claims, and Health Claims, 64 Fed. Reg. 67246, at 62755-56 (Nov. 17, 1999) (codi-
fied as amended in 21 C.F.R. pt. 101). This proposed rule was dramatically
amended. See infta § IV.A.2.
81. 68 Fed. Reg. at 41436.
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and Regulatory Affairs of the Office of Management and Budget
sent a letter to the Secretary of Health and Human Services request-
ing that the FDA give greater priority to the November 1999 pro-
posed rule "in light of the growing body of scientific evidence sug-
gesting that consumption of trans fatty acids in foods increases the
consumer's risk of developing CHD." ' The letter went on to state
that such evidence strongly supported "the interests of the Govern-
ment to lower the incidence of and economic burden of CHD in the
United States" by limiting the presence of trans fats in the food sup-
ply.,
Following this letter, the FDA requested a report from the Insti-
tute of Medicine (IOM) on trans fats. In response to the FDA's re-
quest, the IOM issued a report in July of 2002.' In its report, the
IOM concluded that there is no known requirement for trans fatty
acids to facilitate specific body functions," and that because of the
increased risk of CHD that accompanies consumption of trans fats,
their Upper Tolerable Intake Level (UL) should be "zero."' How-
ever, the IOM also acknowledged the following:
Because trans fatty acids are unavoidable in ordinary diets, achieving [a
UL of zero] would require extraordinary changes in patterns of dietary
intakes. Such extraordinary adjustments may introduce other undesir-
able effects (e.g. elimination of foods, such as dairy products and meats,
that contain tram fatty acids may result in inadequate intakes of protein
and certain micronutrients) and unknown and unquantifiable health
risks may be introduced by any extreme adjustments in dietary pattern.
For these reasons, no UL is proposed. Nevertheless, it is recommended
that trans fatty acid consumption be as low as possible while consuming
a nutritionally adequate diet.87
Thus, while the IOM recommended, on the basis of evidence that
trans fatty acids (and particularly artificial trans fatty acids) are dele-
terious to health, that all trans fatty acid intake be zero, it acknowl-
edged that there may be indirect negative health effects resulting
from removing natural sources of trans fats from the diet that would
make complete elimination of all trans fatty acids from the diet ill-
82. Id.
83. Id.
84. DIETARY REFERENCE INTAKES, supra note 4.
85. Id. at 2.
86. Id. at 14.
87. Id.
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advised.' Following the first IOM report from July 2002, the FDA
published a final rule in the Federal Register onJuly 11, 2003.'
In a second report issued in December 2003 (shortly after the
FDA passed its current labeling regulation) at the request of Health
and Human Services, the Department of Agriculture, and Health
Canada, the IOM provided guiding principles for nutrition labeling
and fortification and stated "diets can be planned that provide less
than [one] percent of calories from [trans fatty acids] provided that
the only sources of [trans fatty acids] are naturally occurring (i.e., in
meats, poultry, and dairy products)."' Consequently, this second
report both reiterated the IOM's earlier observation that the elimi-
nation of natural trans fat sources from the diet would be ill-advised
and implied that the elimination of all artificial trans fat sources
would be feasible." In other words, the report implied that the op-
timum diet in terms of balancing trans fat content with overall
wholesomeness would be one that eliminated all artificial trans fat
sources while retaining natural trans fat sources for their overriding
nutritional benefits.'
"To minimize the need for multiple label changes and to pro-
vide additional time for compliance by small businesses," the FDA
set the effective date for the regulation as January 1, 2006-nearly
twelve years after CSPI filed its initial petition." By comparison, it
only took the FDA three years from the passage of the Nutrition
Labeling and Education Act of 1990 to issue and implement a final
rule setting standards for the listing of all of the other nutrients that
are provided on food labeling." If the 1994 estimates"5 were accu-
rate, approximately 360,000 Americans died from CHD attributable
to trans fat consumption in the time between the filing of CSPI's
initial petition and publication of the final rule. At the time that the
final rule was published, the FDA estimated the economic benefit to
88. See id.
89. 68 Fed. Reg. 41434.
90. FOOD & NUTRITION BD., IOM, DIETARY REFERENCE INTAKES: GUIDING





93. 68 Fed. Reg. at 41466.
94. Id at 41434.
95. See Willett & Ascherio, supra note 60.
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cost ratio of the labeling requirement would be sixty-five to one.'
While it is not clear exactly how much was spent on CHD attribut-
able to trans fat consumption in the time that it took the FDA to
approve the CSPI petition, the estimated mortality total and benefit
to cost ratio suggests that the economic cost of bureaucratic red
tape may have been daunting.
2. The Coverage of the Current Regulation
The current regulation97 was passed pursuant to the Nutrition
Labeling and Education Act of 1990's provisions allowing the Secre-
tary of Health and Human Services to add or delete nutrients in-
cluded in the food label through the regulatory power of the FDA,
provided that the Secretary or the FDA finds such action necessary
to assist consumers in maintaining healthy diet practices.98 It defines
trans fat as "all unsaturated fatty acids that contain one or more iso-
lated (i.e., nonconjugated) double bonds in a trans configuration,"
thereby including both artificial and (to a partial extent) natural
sources of trans fat." The regulation goes on to provide that where
a product contains less than 0.5 grams of trans fat per serving, no
trans fat content need be listed if the product makes no claims
about fat, fatty acid, or cholesterol content, and that if such claims
are made the product must include a value for trans fat content on
the nutrition label and must list that value as zero." Finally, if a
statement of a product's trans fat content is not required and not
listed, a footnote must be placed at the bottom of the label stating
"not a significant source of trans fat."' Consequently, the current
regulation requires labeling only within the parameters described
above: any elimination of trans fat is an indirect result and is volun-
tary as far as the FDA is concerned.
3. Analysis of the Current Regulation
As the Starbucks article attests, the current regulation has re-
sulted in several positive steps: many producers have reformulated
96. E-mail from Dr. Michael F. Jacobson, Exec. Dir., CSPI, to Ross Williams
(Mar. 11, 2007, 15:50:12 CST) (on file with author).
97. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
98. 68 Fed. Reg. at 41434.
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their recipes to exclude artificial trans fats, and the level of general
public awareness of the dangers posed by trans fats has grown ap-
preciably since passage of the regulation. At first glance, this is per-
haps the best-case scenario for a regulation that seeks to limit the
inclusion of a harmful substance in food indirectly by requiring
producers to disclose the amount of the substance present in their
products. However, the regulation also has significant shortcomings
that may offset the benefits and that deserve comment and, ulti-
mately, amendment.
a. The FDA's definition of "trans fatty acid" is too broad
Perhaps the most important flaw in the current regulation, the
FDA's definition of trans fatty acid appears overbroad in that it cov-
ers natural sources of trans fats, leading to their elimination from
the recipes of many food producers and potentially to negative net
effects on health."2 Indeed, the soundness of both the FDA's regula-
tion of natural trans fat in general, and their regulation of non-
conjugated linoleic acid (but not conjugated linoleic acid (CLA)) in
particular, deserve closer scrutiny.
On one hand, while the FDA definition of trans fatty acids cov-
ers non-conjugated trans fats generally, it excludes the ruminant fat
CLA-a substance shown to have numerous health benefits.1 3 On
the other hand, the regulation covers the non-conjugated vaccenic
acid found simultaneously in the same animal fat deposits, even
though the FDA acknowledges that vaccenic acid is converted into
CLA in the body."M But because both vaccenic acid and CIA occur
together in animal fat, CLA is regulated de facto, even though it is
technically not covered under the FDA regulations. Consequently,
it would seem imprudent to include natural trans fats in the defini-
tion of trans fats that must be reported on nutrition labels, since
such labeling might mislead consumers into avoiding products con-
taining only natural trans fats (both CLA and vaccenic acid) that
might actually be beneficial to them in several different ways. °"
While some evidence suggests that natural trans fat consumption
might also have its risks, both the July 2002 IOM report published
prior to the issuance of the current FDA labeling regulation and the
December 2003 IOM report published shortly after issuance of the
102. See supra § III.B.
103. 68 Fed. Reg. at 41461.
104. Id,
105. Mozaffarian et al., supra note 4.
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regulation suggest that the elimination of natural trans fats from the
diet might not be advisable because of the indirect health benefits
that attend natural trans fat consumption.'" Indeed, some local U.S.
regulations seem to have followed the IOM's observations in those
reports by excluding natural trans fat sources from their trans fat
definitions.07
Moreover, the FDA's justification for this overbroad definition
seems to conflict with the purpose for passing the regulation in the
first place. The FDA's explanation for only requiring food produc-
ers to list some parts of a cow's fat on the nutrition label is that it is
regulating a chemical structure, rather than the functional or meta-
bolic aspects of the different types of trans fats.' 8 However, this
explanation seems to betray a short sighted approach by the FDA:
these regulations are, after all, being passed in response to recogni-
tion of the negative health effects of trans fat consumption, i.e. their
negative functional or metabolic effect in the human body. Given
that impetus, it may be unwise to define trans fats in a way that
might confuse the public as to the wholesomeness and safety of a
food product containing only natural trans fats. Consequently, it
seems that the way in which trans fatty acids are defined clashes with
the intent of the current regulation-"to provide information to as-
sist consumers in maintaining healthy dietary practices"' .- because it
might actually lead them to adopt less healthy practices by eliminat-
ing natural trans fats from their diets and substituting harmful proc-
essed oils high in saturated fats in their place.
In light of this apparent disconnect between the stated purpose
of the rule and the definition that drives it, an appropriate remedy
may involve changing the definition of "trans fats" to cover only arti-
ficial trans fat sources. This action would also help to divert the
wholesale removal of natural trans fat sources from the food supply,
though it is not clear that such action would be entirely effective
because, as the Starbucks article attests, the food industry has al-
ready begun the removal process in response to public concern.
Unfortunately, it appears that this problem could have been
prevented proactively had the FDA considered the potential nega-
tive effect of the broad scope of its trans fat definition in light of the
IOM's recommendations and amended the definition accordingly
106. See DIETARY REFERENCE INTAKES, supra note 4, at 14; see also GUIDING
PRINCIPLES, supra note 90.
107. See New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2.
108. 68 Fed. Reg. at 41461.
109. Id at 41434.
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prior to approving the final rule. After the IOM suggested that any
consumption of trans fats increases the risk of CHD," ° the FDA
warned that it would "exercise its enforcement discretion" to pre-
vent manufacturers from either labeling their products with a trans
fat content prior to the passage of the final rule, or including the
proposed footnote stating that "intake of trans fats should be as low
as possible."' In other words, the FDA was threatening to punish
manufacturers if they attempted to inform consumers about their
product's content of a substance acknowledged by the IOM to be
harmful at any level of consumption on the rationale that such
forewarning might encourage consumers to eliminate all intake of
trans fatty acids, which the IOM had stated was not desirable."'
However, the FDA's inclusion of natural trans fats in its trans fat
definition has led manufacturers to eliminate natural trans fats in
response to public concern de facto. Thus, the FDA's threat of en-
forcement action exposed the fallacy of the definition of trans fatty
acids in the regulation-it includes natural sources of trans fats, lead-
ing the public and businesses such as Starbucks to call for their
elimination, even though the IOM has stated, and the FDA acknowl-
edges, that such elimination is undesirable. Because this elimination
is effectively happening now, it seems that the FDA should have
been more concerned with the over-breadth of its definition in light
of the IOM report, rather than with the possibility that food pro-
ducers would give consumers advance notice of harmful substances
in their food. By threatening to punish producers who sought to
eliminate all trans fats from their products, the FDA only delayed
the inevitable (and left the consumer uninformed longer), whereas a
change in the definition could have prevented the current problem
by addressing its root cause.
b. The "less than 0.5 grams" labeling standard
Another apparent shortcoming of the current regulation is its
allowance of a zero gram trans fat content listing on nutrition labels
when as much as 0.49 grams of trans fat is present in a food."' This
shortcoming raises several issues.
110. Hence its observation that the ideal UL for trans fats would be "zero."
DIETARY REFERENCE INTAKES, supra note 4, at 14.
111. 68 Fed. Reg. at 41434.
112. Id. at 41459.
113. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
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i. The standard allows continued use of PHVO at relatively high
levels
One major problem with this standard is that it is high enough
to allow for significant continued use of PHVO. The trans fat to
total fat ratio of PHVO depends upon the method of hydrogenation
used.'4 Hydrogenation at twenty p.s.i., the former industry stan-
dard, results in PHVO that contains 40% of its total fat as trans fat."5
This is very high in comparison to natural sources, for instance,
wherein 2-5% of the total fat is composed of trans fat."6 Conse-
quently, PHVO produced through low pressure hydrogenation can-
not meet the requirement that a serving contain less than 0.5 grams
of trans fat to be labeled zero grams trans fat. However, hydrogena-
tion at higher pressures (200 p.s.i.) yields PHVO that contains as low
as 17% of its total fat as trans fat."17 At this low level, PHVO can be
blended with liquid soybean oil to create oil containing less than 0.5
grams per serving."8 Indeed, inspection of ingredient lists at most
local supermarkets will reveal oils and spreads containing this type
of blend. As a result, artificial trans fats contained in PHVO are
allowed to remain in the food supply even though the IOM has
stated that they are harmful to heart health at any level of consump-
tion."9
However, if the FDA had followed the lead of other govern-
ments that have passed regulations limiting the presence of trans
fats in food, this loophole could have been largely avoided. At the
very least, the blended oils would be allowed to contain even less
PHVO. The Canadian standard, for instance, requires less than 0.2
grams of trans fat per serving in order to state that it contains zero
grams of trans fat on the label,'"6 an amount high enough to be met
by most natural trans fat sources but low enough that the current
blended oils may not pass. CSPI Executive Director Michael Jacob-
son believes that while the current less than 0.5 grams standard has
114. F.J. Eller, Preparation of Spread Oils meeting USFDA Labeling Requirements for
Trans Fatty Acids via Pressure-Controlled Hydrogenation, 53(15)J. AGRIc. & FOOD CHEM-





119. DIETARY REFERENCE INTAKES, supra note 4, at 14.
120. CANADIAN FOOD INSPECTION AGENCY, Information Letter: Labelling of Trans
Fatty Acids, http://www.inspection.gc.ca/english/fssa/labeti/inform/20050914e.
shtml (last visited Feb. 6, 2008).
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brought about positive changes, a less than 0.2 grams standard
would have been preferable. The practical effect of the current
regulation is that, while American consumers can be sold food con-
taining as much as 0.49 grams of artificial trans fat per serving under
the guise of zero grams trans fat, if the Canadian standard were fol-
lowed producers could only include 0.19 grams of trans fat per serv-
ing to make similar claims. Considering the IOM's recommendation
to limit trans fat intake as much as possible, it is almost a truism that
a change in the standard to less than 0.2 grams per serving would be
beneficial. This would accomplish the dual benefits of even lower
PHVO content in foods and lower overall trans fat consumption by
the American public. Given the large expense of health care, par-
ticularly heart surgery and rehabilitation therapy, such a change
would almost certainly result in a positive net economic benefit."
ii. The standard is mandatory, leaving consumers in the dark
Another issue raised by the regulations is that they actually
mandate that the nutrition label for any food containing less than
0.5 grams trans fat per serving report the product's trans fat content
as zero grams.12 This means that a food literally containing zero
grams trans fat is indistinguishable to the average consumer from a
food containing 0.49 grams trans fat per serving. This requirement
puts health-conscious consumers at a considerable disadvantage,
because it prevents them from effectively monitoring the trans fat
content of their food or eliminating it altogether without going to
considerable trouble. Granted, the producer must still list PHVO
on the ingredients list, but that puts the onus on the consumer to
doubt the veracity of the nutrition facts label and then be informed
enough to know that a food product contains artificial trans fat
when its ingredient list includes "partially hydrogenated vegetable
oil." Consequently, the potential confusion engendered by a re-
quirement such as this one, effectively forcing producers to keep
consumers in the dark regarding the actual trans fat content of their
foods and placing the burden on consumers to decipher a mislead-
121. E-mail from MichaelJacobson, supra note 96.
122. See Richard Posner, The Becker-Posner Blog, Comment on the New York Ban on
Trans Fats - Posner (Dec. 17, 2006), http://www.becker-posner-blog.com/
archives/2006/12/the-new-york-ci.hunl (last visited Dec. 28, 2007) (discussing an
analogous economic benefit resulting from the New York ordinance limiting the
presence of trans fat in foods).
123. 21 C.F.R. § 101.9(c)(2)(ii) (2006).
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ing nutrition label, conflicts with the stated purpose behind the gov-
ernment's grant of authority to the FDA to amend its rules "to assist
consumers in maintaining healthy diet practices.""' On the con-
trary, the current situation seems to thwart such consumer attempts
rather than assist them by misleading consumers as to the trans fat
content of their food.
Again, given that the IOM has stated that any amount of trans
fat consumption is harmful to health, 15 and that trans fat has been
shown to be considerably more detrimental to health than saturated
fat in comparable amounts," the FDA's mandate that levels of trans
fat in food up to 0.49 grams per serving be reported as zero grams
may result in considerable negative effects on consumer health rela-
tive to other countries. The average health conscious American
consumer eating three meals with three servings each per day, be-
lieving all along that they have consumed zero grams trans fat, could
actually consume as much as 150% more trans fat daily than a Ca-
nadian consumer eating foods making the same claims but regulated
under the Canadian standard. Consequently, the current rule would
go further toward meeting the goal of the statutory grant of author-
ity if it was amended to require producers to list the actual amount
of trans fat contained in their products to the nearest 0.1 grams if
the content per serving is 0.2 grams or above. Increased consumer
awareness, in turn, might lead to a further reduction in CHD attrib-
utable to trans fat consumption, and a concomitant economic bene-
fit.
iii. The current standard distorts the wholesomeness of high satu-
rated fat foods
Additionally, the current regulations are inherently deceptive to
consumers for another reason-they can make high saturated fat
foods seem more wholesome than they really are. As MichaelJacob-
son has pointed out, the current regulations allow food producers to
claim "zero grams trans fat" on the front of food packaging, even
though the food may contain any amount of saturated fat, which is
generally known to be very detrimental to heart health." The prac-
tical effect of this change is well-illustrated by the Starbucks exam-
ple. Because Starbucks removed all trans fat from its baked goods,
124. 68 Fed. Reg. at 41434.
125. DIETARY REFERENCE INTAKES, supra note 4, at 14.
126. See Hu et al., supra note 66.
127. E-mail from Michael Jacobson, supra note 96.
[VOL. 3:39
TROUBLING STATE OF TRANS FAT REGULATION
it can claim zero grams trans fat even though it switched to high
saturated fat oils that may (because the amount of saturated fat in
them is greater than the amount of trans fat formerly in their reci-
pes) have similar or even more deleterious negative health effects.
The result is that consumers buy a product thinking that it is more
beneficial to their health, when in reality it is potentially just as
harmful or even more harmful than the same product made with
the discarded trans fat-containing recipe. As Jacobson points out,
because the FDA never finalized a rule to end this deception by pre-
venting zero grams trans fat claims on food packaging, such market-
ing continues to the potential detriment of consumers.'
c. The current regulations do not address restaurants
and other food vendors
One of the biggest gaps in the current regulation is its failure to
address retail food service, including street vendors, fast food, deliv-
ery, and fine dining establishments. Many Americans dine out or
have their food delivered to them pre-prepared: the food industry
will make $1.5 billion in sales on the average day in 2007, and four
out of five consumers agree that going out to a restaurant is a better
way to use their leisure time than cooking and cleaning up.' In
fact, restaurants contribute more than one-third of the trans fats in
the American diet. ° The current federal labeling regulations do
nothing to directly address the large percentage of the average
American's daily caloric intake that comes from these sources. As a
result, consumers would have to do a considerable amount of inde-
pendent research to find out how much trans fat they are getting
from foods prepared at the lunch counter. To combat this oversight
in the current federal regulations, state and local governments have
stepped into the regulatory gap left by the FDA and have started
limiting the amount and types of trans fats that retail establishments
may use in preparing their foods.
B. Local Efforts to Limit the Amount of Trans Fat in the Food Supply
In addition to the FDA's failure to address trans fat in the con-
text of food service establishments, state and local regulations have
128. Id.
129. Nat'l Rest. Ass'n, Restaurant Industry Facts, http://www.restaurant.org/
research/ind-glance.cfm (last visited Dec. 28, 2007).
130. New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2, at 2.
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also attempted to fill the gap left by the federal regulation's more
general shortcoming-its failure to directly limit the presence of
trans fats in the food supply. To fill these gaps, many state and city
governments have begun legislating food issues in general, and trans
fats in particular.' 3' These efforts range from initiatives by small
towns urging their local food service establishments to voluntarily
switch from artificial trans fats,'32 to regulations by huge cities such
as New York universally preventing all local food service establish-
ments from using any ingredients containing 0.5 grams or more of
artificial trans fat per serving.
While New York's regulation has been lauded by consumer ac-
tivists such as CSPI's Michael Jacobson,' other locales have either
soft-pedaled regulatory efforts (for instance, Chicago's regulation of
food service establishments at different levels depending on their
yearly income)'35 or used extreme rhetoric broadly comparing trans
fats to food contaminants such as E. coli. Even though such state-
ments may be made to support bans limited to artificial trans fat
use, when they are made without qualification they could potentially
lead to uninformed consumers discontinuing use of products that
list trans fat content that is composed only of natural trans fats that
must be reported under the federal regulation. And nothing is
stopping state or local governments from seizing on such rhetoric
and the inclusion of natural trans fat sources in the federal regula-
tion's definition to fashion a ban on the use of all trans fats by local
food service establishments.
Because so many restaurants are part of national chains that use
pre-prepared components shipped in from large manufacturers,
these local regulations can affect large restaurant and commercial
food supply businesses that operate at the national level by forcing
them to comply broadly so that their franchises may comply locally.
And because of the lack of education on the part of the government,
smaller local businesses faced with impending compliance deadlines
are forced to hastily switch to processed fats that may be only
131. See Lorin, supra note 22.
132. Ban Trans Fats, Project Tiburon: America's First Trans Fat-Free City!!!,
http://www.bantransfats.com/projecttiburon.html (last visited Dec. 28, 2007).
133. New York, N.Y., Dep't of Health & Mental Hygiene, supra note 2.
134. E-mail from MichaelJacobson, supra note 96.
135. See Greg Brown, Proposed Trans Fat Ban Irks Chicago Restaurants, Health Care
News (Oct. 2006), available at http://www.heartland.org/Article.cfm?artId=19744.
136. See Lorin, supra note 22 (noting that Connecticut State Senator Andrew
Roraback has said that trans fats are "as much a contaminant as E. coli.").
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slightly healthier than the trans fats they are meant to replace.'
3 7
Consequently, the local regulations can have regional or national
implications.
Ultimately, the current regulatory situation is one of profound
uncertainty for the businesses that supply our national food system.
Faced with myriad local regulations and the potential for more and
varied regulations daily, food suppliers look to the federal govern-
ment for uniformity and certainty. Finding that the federal gov-
ernment has included natural trans fats in their definition, and fear-
ing that public hysteria will lead local governments to do the same in
directly banning or limiting the presence of trans fats in their local
food supplies, producers and retailers may seek broad preemptive
compliance by taking steps similar to those taken by Starbucks: they
may eliminate all trans fats from their products, even though the
IOM has suggested that such action could have significant negative
consequences."i These natural trans fat sources might then be re-
placed with processed oils high in saturated fats and lacking in nu-
trients that would otherwise prevent vitamin and nutritional defi-
ciencies. The result is a food supply of increasing safety yet decreas-
ing wholesomeness, and a step backward for public health.' 9 The
next section discusses current efforts urging the FDA to take further
action on trans fat regulation to address this problem.
V. THE CSPI PETITION
In an effort to address the gaps in the Food and Drug Admini-
stration's (FDA) labeling regulation and in recognition of the poten-
tial for passage of multifarious local regulations (a fear that has
come to fruition), the Center for Science in the Public Interest
(CSPI) filed a citizen action "Petition for Rulemaking to Revoke the
Authority for Industry to Use Partially Hydrogenated Vegetable Oils
137. See E. Charles Hunt, Executive Vice Pres. of N.Y. State Rest. Ass'n, Testimony
at Public Hearing by City Council Committee on Health (Oct. 30, 2006), available at
http://www.restaurant.org/pressroom/pressrelease.cfm?ID=1332 (quoting the
Chair of the American Heart Association's Nutrition Committee's conclusion that
"consumers should avoid increasing their intake of saturated fat in an effort to
minimize trans fat," and asserting that the New York regulation, phased in over
eighteen months, would force food service establishments to take that step); but see
E-mail from Michael Jacobson, supra note 96 (asserting that restaurants will not
have to take such drastic steps because initial enforcement following the effective
date of the ban will take more than a year).
138. See DIETARY REFERENCE INTAKES, supra note 4, at 14.
139. See Hunt, supra note 137.
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in Foods" on May 18, 2004." While the petition requests rulemak-
ing to bring about several important changes that should be granted
by the FDA, it also explicitly endorses the FDA's current definition
of trans fats.14 1 Consequently, even if the petition is granted (which
is unlikely) it may not go far enough to address the problems with
the current regulatory situation. Moreover, CSPI's desire for
prompt action exposes the time sensitive nature of its requests: be-
cause the FDA has failed to act, CSPI's requests, if granted, may no
longer be fully effective in addressing the problems raised by the
current state of trans fat regulation, as many of the dangers that its
requests were designed to avoid (such as state and local regulation)
have already come to pass.
A. CSPI's Requests
Although CSPI's petition explicitly approves of the FDA's cur-
rent definition of trans fatty acid,'42 it does request that the FDA take
three major actions to limit the use of artificial (but not natural)
trans fats in the food supply:
1. Initiate a rulemaking to:
a. revoke the "generally recognized as safe" (GRAS) status"
of partially hydrogenated oils in foods, "so that they would
be legally classified as food additives" and so that their con-
tinued use would be made illegal absent a regulation "pre-
scribing the conditions under which such additives may be
safely used"; "
140. CSPI, supra note 17, at 9.
141. Id. at 2 n.7.
142. Presumably, this approval is to avoid coming across as unreasonable in their
requests. See id.
143. "Section 201(s) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
§ 321(s), excludes from the legal definition of a food additive an ingredient that 'is
generally recognized, among experts qualified by scientific training and experience
to evaluate its safety, as having been adequately shown . . .to be safe under the
conditions of its intended use.' An ingredient can be classified as 'generally recog-
nized a safe' by a public formal determination by the FDA, a letter from the FDA,
or a self-determination by a food company." Id. at 3 n. 15.
144. Id. at 3-4. "Absent a regulation establishing the conditions whereby a food
additive can be safely used, a food that contains a food additive is adulterated and,
accordingly, cannot legally be introduced into interstate commerce." Id. at 4 n.20
(explaining FFDCA § 409(a)(2), 21 U.S.C. § 348(a)(2)).
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b. "revoke the current 'safe conditions' for those partially hy-
drogenated vegetable oils that the FDA has approved as
food additives"; ' and
c. "prohibit the use of any partially hydrogenated vegetable
oil which is not classified as a food additive because the
FDA sanctioned or approved its use prior to September 6,
1958."'4
2.Announce that the rulemaking will be completed by 2008
given the strong scientific evidence establishing the public health
risks of partially hydrogenated vegetable oil (PHVO), thus allowing
two years to observe the impact of the labeling regulation.'47 Indus-
try should be given two years to adapt before the new regulation
becomes effective.
4 8
3. Immediately (prior to deciding on the merits of the regula-
tory actions requested) develop a program to encourage the food
industry to replace partially hydrogenated vegetable oils with the
most healthful ingredients possible.'
49
4. In the alternative, institute rulemaking or request comments
on setting tolerance levels for trans fats."
B. Analysis of CSPI's Requests
1. A Narrowed Scope Allows CSPI's Tolerance Proposal to Swallow
its Requests for GRAS Removal, "Safe Condition" Revocation,
and Prior Use Prohibition
CSPI's request to remove the GRAS status, "safe conditions" of
use, and prior use exemptions for the various types of artificial trans
fats contained in PHVO seems appropriate because strong scientific
evidence suggests that the FDA should exercise its authority to take
such action.'5' However, CSPI inexplicably qualifies its request for
GRAS removal in a way that essentially allows it to be swallowed by





150. CSPI, supra note 17, at 5. CSPI's petition points out that the Danish gov-
ernment limits trans fats to 2% of the total fat in foods. Id. at 10.
151. See id. at 25 (citing 21 C.F.R. § 170.6(c)). Note that the FDA can initiate
rulemaking sua sponte, rather than waiting to rule on a filed petition. See 21 C.F.R.
§ 10.25 (2006).
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the alternative request for the establishment of partially hydrogen-
ated oil (PHO) ' tolerance levels.
On its face, CSPI's request for GRAS removal seems straight-
forward and well-founded. The FDA distinguishes generally be-
tween substances that are food additives and those that are not.
153
Substances classified as food additives cannot be legally used unless
the FDA has issued a regulation "prescribing the conditions under
which such additive may be safely used."'"M A substance will be
deemed a food additive where: (a) its use or intended use results or
can be reasonably expected to result, directly or indirectly, in its
becoming a component or otherwise affecting the characteristics of
any food, and (b) it is not generally recognized among experts quali-
fied by scientific training and experience to evaluate its safety as
having been adequately shown through scientific procedures to be
safe under the conditions of its intended use.
As the CSPI points out in its petition, PHOs clearly satisfy the
first prong because their intended use directly results in their be-
coming a component in food.'56 Additionally, PHOs satisfy the sec-
ond prong because they are not generally recognized by scientists to
be safe under the conditions of their intended use: the IOM con-
cluded that any amount of trans fat intake increases the risk of
coronary heart disease (CHD), and a federal court of appeals has
held that the absence of a safe level of a substance in food justifies
the FDA's determination that the product is unsafe.5 ' Conse-
quently, the CSPI makes a strong case that artificial trans fats are
food additives. Moreover, it makes an equally strong argument that,
as a food additive, PHO should not be GRAS because the current
scientific evidence should prevent it from meeting the "reasonable
certainty of no harm" standard for approval."'
However, the CSPI limits the scope of its request in a way that
may render it a request for tolerances rather than for an effective
ban. Specifically, the CSPI points out that it intends to exclude from
the proposed rulemaking saturated fats (because of their ubiqui-
tousness and natural origin), natural trans fats (presumably because
of their potential direct and indirect nutritional benefits), and PHO
152. PHO includes PHVO, but also encompasses Menhaden (fish) oil.
153. 21 U.S.C. § 321(s) (2006) (defining "food additive").
154. Id. at § 348(a)(2) (2006).
155. CSPI, supra note 17, at 25-26 (citing 21 U.S.C. § 321(s)).
156. Id. at 26.
157. See id. at 5-27.
158. Id. at 18.
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produced by new methods containing insignificant amounts of artificially
produced trans fat.59 While the first two categories make sense, the
third category essentially requests that the FDA establish an artificial
trans fat tolerance rather than an outright ban. But it seems inter-
nally inconsistent for the CSPI to suggest that some PHOs should be
exempted merely because they contain less trans fat per serving,
given the contention of the Institute of Medicine (1OM) (cited in the
CSPI petition) that the Upper Tolerable Intake Level (UL) of trans
fats be zero. 6° Indeed, this qualification essentially allows CSPI's
alternative request-that the FDA establish tolerance levels for artifi-
cial trans fats-to swallow its main request for a ban on PHO use
through GRAS removal. Consequently, CSPI's main request and its
alternative request essentially reach the same result of tolerance
proposals, though they do so through different means (the former
by virtue of its definition of PHO, the latter explicitly). The main
difference between the two requests, then, is that if the FDA was to
grant the explicit tolerance request, it could forego the formality of
removing the GRAS status for PHO.
It is important to note that the CSPI petition does not address
naturally occurring trans fat (presumably because of the IOM's ob-
servations), nor does it address the de minimis amount of trans fat
occurring in conventionally processed (non-PHO) vegetable oils."'
The exclusion of the trans fats in conventional vegetable oils from
the proposed rulemaking may stem from two rationales: a realiza-
tion that any food produced with such oils will still contain some
amount of trans fats,' 2 and a desire to focus on trans fats from
sources shown to be deleterious to health-the partially hydrogen-
ated variety. Indeed, both rationales would make sense; while the
former makes practical sense, the latter seems to comport with the
impetus for trans fat regulation-the protection of public health.
However, these rationales do not explain CSPI's exclusion of trans
fat from PHVO produced through new processing methods, as
those oils contain the same trans fats from the same source (albeit in
slightly lower amounts) as the trans fat widely recognized as being
harmful to health.
The IOM reports clearly say that the desirable UL for trans fats
is zero, and that it is feasible to plan a diet containing no artificial
159. See id. at 27 n.115.
160. DIETARY REFERENCE INTAKES, supra note 4, at 14.
161. CSPI,supra note 17, at27 n.115.
162. Id.
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trans fats from PHO. The CSPI is not requesting a total ban on all
trans fats, and it seems to acknowledge that such a request would be
impractical.'" Rather, the CSPI requests a tolerance level on the use
of PHO because of the deleterious trans fats that it contains." But
as the IOM reports attest, trans fats from these sources can be
eliminated from foods as a practical and as a scientific matter.'
Consequently, the CSPI petition may not go far enough toward pro-
tecting public health by merely requesting tolerances on the use of
artificial trans fats contained in PHOs.
Regardless of this apparent problem with CSPI's petition, it
goes on to request (on the basis of current scientific evidence and
the FDA's "safe ingredient reexamination" commitment)"67 that the
FDA remove the "safe conditions" of use established for all PHOs
qualified as food additives because the new scientific evidence dem-
onstrates that PHO can no longer be considered safe for use as a
food additive, "unless conditions are established to ensure that the
amount of trans fat is minimal," again suggesting that a tolerance
level would be acceptable." Additionally, the CSPI requests that all
PHOs considered safe because they were in use prior to Septem-
ber 6, 1958, now be considered "unsafe" food adulterants.'6" This
request seems prudent, because while the CSPI acknowledges that
no prior sanction or approval exists for any PHO product, it seeks
to prospectively prevent a company that had a prior use from escap-
ing the requested new rule by seeking retroactive prior use approval
under 21 C.F.R. section 181.1(a).'7 °
Ultimately, while CSPI's request for GRAS removal, "safe con-
dition" revocation, and prior use prohibition seems to be a request
for a ban on its face, closer examination reveals that it is actually a
request for tolerances. In light of the scientific evidence cited by the
CSPI, including its assertion that sufficient substitutes containing no
trans fat exist or will be developed by the time the requested rules
163. DIETARY REFERENCE INTAKES, supra note 4, at 14 (stating that the ideal upper
UL for trans fats is zero); GUIDING PRINCIPLES, supra note 90 (stating that it is feasi-
ble to plan a diet wherein the only trans fats are from non-PHO sources).
164. See CSPI, supra note 17, at 27 n. 115.
165. See id. at 5-27.
166. GUIDING PRINCIPLES, supra note 90.
167. CSPI, supra note 17, at 28 (citing 21 C.F.R. § 170.6(c)).
168. Id. at 28.
169. Id. at 28-29 (citing 21 U.S.C. § 342(a)(2)(A); 21 C.F.R. § 181.1(b)).
170. Id. at 29.
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take effect,'7' CSPI's narrowing of the scope of the PHO to be cov-
ered by its requested regulation seems misguided.
2. The Effective Denial of CSPI's Requests for Announcement and
Education
FDA inaction since the filing of CSPI's petition has shown that
its requests for announcement that rulemaking will be completed by
2008 and for immediate implementation of a far-reaching industry
and consumer education program on trans fats and trans fat substi-
tutes have been effectively denied.
First, the FDA's announcement that it will complete rulemaking
by 2008, as per CSPI's request, has not been forthcoming. On the
contrary, Michael Landa, Deputy Director for Regulatory Affairs for
the Center for Food Safety and Applied Nutrition (CFSAN), has
stated that he can acknowledge only that the petition was filed and
that the FDA is reviewing it.n This would suggest that any rulemak-
ing might take place on the same extended time frame that the cur-
rent labeling regulation endured.
Second, any consumer and industry education by the FDA pur-
suant to CSPI's request for immediate implementation of a far-
reaching, comprehensive program has been minimal. Although some
efforts have been made to passively advise these groups via the inter-
net,"3 the proof is in the pudding: stories such as those involving
Starbucks abound," suggesting that industry, the public, and even
academics remain largely uninformed. Therefore, CSPI's requests on
these fronts seem to have been effectively denied, which does not
bode well for the disposition of the remainder of their petition.
3. CSPI's Prediction of State, Local, and Private Action
As an incentive for the FDA to take prompt action on its peti-
tion, the CSPI warned that should the FDA fail to fill the regulatory
171. CSPI, supra note 17, at 23-25.
172. E-mail from Michael Landa, Dep. Dir. Reg. Affairs, Ctr. for Food Safety &
Applied Nutrition, to Ross Williams, (Mar. 1, 2007, 15:07:19) (on file with author).
173. FDA, Revealing Trans Fats, http://www.pueblo.gsa.gov/cic-text/food/reveal-
fats/reveal-fats.htm (last visited Dec. 28, 2007).
174. See, e.g., Hunt, supra note 137 (quoting the Chair of the American Heart
Association's Nutrition Committee's conclusion that "consumers should avoid in-
creasing their intake of saturated fat in an effort to minimize trans fat," and assert-
ing that the New York regulation, phased in over eighteen months, would force
food service establishments to take that step).
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gaps left by its labeling rule-particularly the allowance for continued
use of trans fats by restaurants and food companies-state and local
governments might legislate to protect consumers further and pri-
vate parties might institute suits.'7" This prediction has proven pro-
phetic: since the CSPI filed its petition, numerous state and local
governments have passed ordinances prohibiting or limiting the use
of trans fats.'7 Moreover, as the CSPI points out, suits that are simi-
lar to those dismissed in the past might be successful in the future
given the increased state of public and industry awareness of the
dangers of trans fats.7 Because state and local governments have
already begun to regulate, engendering reflexive industry actions
such as those discussed herein that could lead to negative effects on
public health and dampen or substantially offset any potential gains
from removing trans fats from the food supply, an effective solution
may need to be more drastic than what the CSPI requests in its peti-
tion.
Ultimately, CSPI's petition was apt for the time and place in
which it was filed. But, as its requests for prompt action reveal, its
petition was time sensitive. Because of the FDA's inactivity while it
considered the merits of CSPI's petition, the problems created by
the current state of federal, state, and local trans fat regulation have
been exacerbated to the point that the FDA may need to exercise its
authority178 to go beyond what the CSPI has recommended if it
hopes to provide an effective remedy for the current problem.
175. "State and local governments are legally free to set standards that are more
protective of public health than the FDA has established in those areas - such as the
safety of food ingredients - for which Congress has not explicitly pre-empted such
action." CSPI, supra note 17, at 30 (citing Hillsborough County, Fla. v. Automated
Med. Laboratories, Inc., 471 U.S. 707 (1985) (holding that a local government can
establish its own regulations beyond those of the FDA absent an explicit statutory
pre-emption clause)).
176. See Nat'l Rest. Ass'n, supra note 15.
177. See CSPI, supra note 17, at 31. (arguing that private parties may in the future
sue restaurants or food companies for continuing to use partially hydrogenated
vegetable oils when healthier alternatives exist, citing for comparison Pelman v.
McDonald, 237 F. Supp. 2d 511, 532 (holding that complaint would state a tort
claim "if McDonald's products are so extraordinarily unhealthy that they are out-
side the reasonable contemplation of the consuming public or that the products are
so extraordinarily unhealthy as to be dangerous in their intended use); BanTrans-
Fats.com v. Kraft Foods N. Am., Inc., CV 032041 (Marin County Super. Ct. Cal. May
2003)).
178. See 21 C.F.R. § 10.25 (2006).
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VI. RECOMMENDATIONS FOR FUTURE ACTION BY THE FDA
The outlook seems bleak for passage of the CSPI petition.
1 7
1
But at this point CSPI's petition may actually not request action
drastic enough to correct the current problems: federal regulatory
inactivity has allowed the window of effectiveness to pass for limited
actions such as those requested by the CSPI-state and local govern-
ments have started regulating trans fats, and various standards and
uncertainty abound among consumers and industry, leading to hasty
preventive measures (such as the elimination of all types of trans fats
and replacement with processed oils) that may be ill-advised. As a
result, more drastic measures may be required if the FDA is to pro-
vide uniformity and certainty to the businesses that supply our na-
tional food system, and thereby prevent the potential negative
health effects that could arise from producers and restaurants over-
reacting to the current lack of uniformity and fears over the poten-
tial tort consequences of continued artificial trans fat use.
While a more libertarian view would advocate allowing the
market to work out the problem on its own, the current state of af-
fairs developed from an unregulated state and demonstrates that
regulatory inaction is inefficient legally, medically, and economi-
cally.' The goal of food regulation should be to ensure that the
food supply is both safe and wholesome. While the current regula-
tory conditions ensure the safety of the food supply by eliminating
179. E-mail from Michael Jacobson, supra note 96 (stating that the current FDA
will not pass CSPI's petition and will have to be taken to court).
180. Legally, while under the current deregulated state some businesses (such as
Kentucky Fried Chicken) will eliminate the use of PHVO and thereby eliminate tort
liability, other businesses that have already been involved in tort litigation may na-
ively seek to avoid or delay eliminating trans fat to avoid the appearance of culpabil-
ity, a move which could potentially lead to further suits with increasing prospects of
success. Additionally, challenges to multiple local ordinances could prove costly
should a national company choose to resist elimination of PHVO. A preemptive
federal regulation limiting or eliminating the use of PHVO could prevent these
problems. Medically, a laissez faire attitude to regulation could result in two ex-
tremes--continued use of PHVO by businesses in some unregulated areas, resulting
in continued elevated CHD levels, or complete elimination (as in the Starbucks
example) resulting in the vitamin and nutrient deficiencies warned of by the IOM,
as well as the loss of the potential benefits of natural trans fat consumption. Eco-
nomically, the savings realized from decreased CHD costs through elimination of
PHVO would be limited by the uneven regulation of those substances from one
locale to another, whereas a uniform preemptive federal ban would maximize those
benefits. See, e.g., Posner, supra note 122 (discussing an analogous economic bene-
fit resulting from the New York ordinance limiting the presence of trans fat in
foods); contra Milloy, supra note 63; Becker, supra note 63.
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harmful artificial trans fats, they may simultaneously reduce the
wholesomeness of the food supply by replacing natural trans fat
sources (and their attendant nutritional benefits) with processed oils
high in saturated fat (and lacking in those attendant nutritional
benefits). Therefore, for the FDA to effectively address the current
situation and ensure a food supply that is both safe and wholesome,
it should exercise its authority to act sua sponte"8 and go beyond
CSPI's requests by:
1. amending the current regulatory definition of trans fatty ac-
ids to exclude natural sources of trans fat (both non-conjugated vac-
cenic acid and conjugated linoleic acid (CLA)) from regulation, re-
quiring labeling of only artificial trans fat content;
2. removing the GRAS status, "safe conditions" for use, and/or
prior approval of all PHVO products containing detectable amounts
of artificial trans fatty acids, effectively banning the use of artificial
trans fats while allowing the continued use of natural trans fats (both
vaccenic acid and CLA);
3. immediately sponsoring a far reaching education program as
per the CSPI petition;
4. following Canada's lead in sponsoring continued research
into the effect of natural trans fat sources on the human body;'"
5. sponsoring further research into the safety of interesterified
fats;' and
6. giving the regulation preemptive effect."M
While the FDA is not required to pass a preemptive regulation
in this area, considerations of public policy'" and federalism strongly
support such action.
181. See 21 C.F.R. § 10.25 (2006).
182. See TRANs FAT TASK FORCE OF HEALTH CANADA, supra note 30, at 41.
183. See Harder, supra note 76 (citing Sundram et al., supra note 76; but quoting
Michael Jacobson, who points out that the study cited "had a 'bizarrely high' pro-
portion of saturated fatty acids," and states that "(i)t looks to me like the palm oil
industry was looking for a way to put a potential competitor in a bad light [by us-
ing] unrealistic conditions.").
184. A full analysis of whether such a regulation would be fully preemptive of
state and local laws is beyond the scope of this paper. However, problems may
arise in that state and local governments are legally free to set standards that are
more protective of public health than the FDA has established in those areas for
which Congress has not explicitly pre-empted such action, and the FFDCA does not
lend preemptive effect to food additive regulations. CSPI, supra note 17, at 30.
This means that a new law that includes an express preemption provision for food
additives may have to be passed to prevent state and local governments from pass-
ing laws to regulate trans fats above and beyond the federal regulations-which is
the key concern arising in this context.
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Our federal system was formed largely in response to the rec-
ognition that a decentralized system impeded interstate commerce.
Similar concerns support passing a preemptive regulation banning
the use of artificial trans fat, as required compliance with multiple
local regulations impedes the business of national food producers
and restaurants and threatens the nutrition of the average Ameri-
can. Consequently, a single preemptive regulation is needed to pro-
vide the uniform standard that the businesses that supply our na-
tional food system require to operate efficiently.
By amending the definition of trans fatty acid, the FDA can end
Starbucks-type problems;" because producers will only have to list
the content of artificial trans fats on their labels, they will be less
likely to eliminate natural sources of trans fat and replace them with
unhealthy processed oils. While this action would result in some
hassle for industry as it readjusts yet again to a new standard, the
total economic benefit of such action could be substantial: rather
than replacing natural trans fat sources that are potentially benefi-
cial to consumer health'87 with processed oils high in harmful satu-
rated fats, the consumers would keep the beneficial substances, re-
sulting in a further reduction in CHD levels. Indeed, the CSPI has
estimated that a 47-fold increase in economic benefits over those
realized under the current FDA labeling regulation could be realized
through a ban on artificial trans fat use."M That estimate translates
into a net economic benefit to the economy of $616 billion to $1.26
trillion over a twenty-year period.'89 Given the high cost of treating
such problems, even a slight reduction could result in a net eco-
nomic benefit. Moreover, the amended definition would better
comport with the purpose of the rule and the authority under which
it was granted, as discussed above. Consequently, the amendment
of the current trans fatty acid definition is crucial to providing for a
safer food supply that continues to be wholesome.
Legally, the FDA's commitment that ingredients previously con-
sidered GRAS must have their GRAS status re-examined in light of
new scientific evidence does not bind the FDA to act." ° However,
185. See id.
186. See id.
187. See supra § III.B.
188. CSPI, supra note 17, at 12.
189. Id.
190. See Lars Noah & Richard A. Merrill, Starting from Scratch?: Reinventing the
Food Additive Approval Process, 78 B.U.L. Rev. 329, 359 (1998) ("To revise or repeal
an existing GRAS regulation, the FDA would need to follow only notice-and-
comment rulemaking procedures.").
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given the strong scientific evidence that artificial trans fats are dan-
gerous, the FDA's refusal to remove the GRAS status of these sub-
stances would seem disingenuous and effectively render the FDA's
re-examination commitment meaningless. Such refusal would also
represent bad public policy by allowing industry to continue to use a
substance known to be harmful to consumer health."' In that event,
suits against the FDA and individual companies to force such action
are likely and would be appropriate."
A private party has individual rights to compel the FDA to insti-
tute a rulemaking where a significant factual predicate of a prior
decision on the subject (either to promulgate or not to promulgate
specific rules) has been removed.'93 Such a right has been found
where new evidence came out eliminating any question as to
whether raw milk consumption is dangerous following regulation of
raw milk sales in interstate commerce that was partially stayed so
that the Secretary could determine, through a public hearing,
whether the consumption of raw milk is safe.' Here, shortly after
the final rule was passed in July of 2003, the IOM responded to the
FDA's request for information by issuing the December 2003 re-
port ' implying that it would be feasible to exclude PHVO from the
diet, recognizing that natural trans fats should be left in the diet,
and referring back to its conclusion from the July 2003 report that
trans fats are more deleterious than saturated fats.'" In the situation
presented here, the labeling requirement could be viewed as a stay
pending IOM results that might warrant a more decisive action. Just
as evidence came forward in the raw milk case warranting further
rulemaking to ban the sale of raw milk,"97 evidence came to light
here following the implementation of the labeling rule that warrants
many of the recommendations herein. A suit to compel rulemaking
may prove fruitful here on the rationale that this new evidence con-
stitutes the removal of a factual predicate of the original labeling
rule.
Were GRAS removal, "safe use" revocation, and prior use pro-
hibition granted, they would effectively constitute a ban on artificial
191. See supra § III.B.
192. See E-mail from Michael Jacobson, supra note 96 (wherein Dr. Jacobson states
that the CSPI will probably have to take the FDA to court to have their requests
met).
193. Pub. Citizen v. Heckler, 653 F. Supp. 1,229, 1,241 (D.D.C. 1986).
194. See id.
195. See GUIDING PRINCIPLES, supra note 90, at 100.
196. See DIETARY REFERENCE INTAKES, supra note 4, at 14.
197. See Heckler, 653 F. Supp. at 1,232.
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trans fat use. Upon such action, artificial trans fats would be con-
sidered new food additives, and as such would have to be shown to
pose a "reasonable certainty of no harm" before being approved for
use.' The burden for showing "a reasonable certainty of no harm"
rests on the applicant'": in this case, a company seeking approval of
a PHO would have to show that it did not pose an increased risk of
heart disease. There is virtually no likelihood that a company could
do this in the face of the current scientific evidence to the contrary,
and as a result any GRAS removal would essentially function as a
ban on artificial trans fat use. Additionally, if the current evidence
linking artificial trans fat consumption to cancer is strengthened,
approval following GRAS removal might be prevented by the De-
laney Clause.'
The key to making trans fat regulation effective in the long
term will be education and continued research."°1 Even if artificial
trans fats are banned, optimum benefits to public health and the
economy will not be realized unless producers and consumers un-
derstand the difference between harmful and beneficial trans fats,
and are aware of the healthiest substitutes available. In this vein,
continued research should be conducted to confirm or refute the
preliminary evidence that natural trans fats are beneficial to health,
and further research should be conducted on the healthfulness of
interesterified fats so that their use may be appropriately curtailed
should the preliminary studies prove reliable.
The most important aspect of these recommendations to insure
the amelioration of the short-term issues raised in this article is the
suggestion that the regulations be made preemptive. Only through
lending these changes preemptive effect can the FDA hope to cure
the uncertainty and misguided action that industry's attempts to
achieve broad compliance with multiple local regulations have en-
gendered. While enforcement of these standards could be left up to
local authorities, the definition and limitations upon the use of trans
fats should be controlled by one uniform, preemptive federal stan-
dard. Aside from the economic and regulatory benefits that a pre-
emptive standard would provide, regulation would also confer a
crucial benefit on the public in that it would obviate, to some extent,
198. See CSPI, supra note 17, at 22.
199. Id.
200. 21 U.S.C. § 348(c)(3)(A) (2006).
201. Both research and education are addressed by the Canadian Trans Fat Task
Force in their recommendations. TRANS FAT TASK FORCE OF HEALTH CANADA, supra
note 30, at 41.
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the need for consumers to be minutely informed to follow the best
dietary practices. As Richard Posner has observed, we live in a
world of nearly unlimited information, and the individual's ability to
absorb and apply all of that information is finite."2 The bottom line
is that a single standard will remove the guesswork from producing
and consuming foods that are both safe and wholesome, at least as
far as trans fat content is concerned, by consolidating the informa-
tion assimilation process.
Another issue regarding current trans fat regulation involves its
effect on tort litigation. While some commentators have voiced
concern that a trans fat ban would start a "lawsuit bonanza, " " in
reality the FDA's adoption of these or similar recommendations may
actually head off such litigation to a large extent."° Under the cur-
rent regulatory system, some producers and restaurants (including
McDonald's) have either put off their promises to switch from trans
fats or have neglected to do so altogether."5 Given the early rulings
in tort claims for obesity caused by fast food products, the prefer-
ence of some companies to ignore the "pink elephant" of scientific
evidence that trans fats are harmful may actually lead to more law-
suits down the road.0 6 On the other hand, a preemptive federal ban
on the use of artificial trans fats that explicitly acknowledges their
harmfulness would prompt the holdouts to make the switch away
from artificial trans fats promptly, as their continued use would no
longer be suspect. The faster that this change takes place, the less
likelihood that a "lawsuit bonanza" may occur. Think of it as a taxi
meter: the more artificial trans fat containing foods that consumers
eat during the period that some fast food companies continue to
include PHOs in their food despite scientific evidence and public
awareness that they are harmful, the more money in terms of poten-
tial damages and settlement amounts that accrues against those
companies on behalf of consumers that fall ill or die as a result of
CHD attributable to trans fat consumption. Considering the Danish
Nutrition Council's finding that, gram for gram, consumption of
trans fatty acids instead of saturated fats results in a ten fold higher
202. See Posner, supra note 122.
203. Milloy, supra note 63.
204. See CSPI, supra note 17, at 31.
205. Associated Press, McDonald's Revisits Fat in Fries: New Test Shows Fries Contain
a Third More Tram Fat Than Thought (Feb. 8, 2006), available at
http://www.cbsnews.com/stories/2006/02/08/health/man1299086.shtml.
206. See CSPI, supra note 17, at 30-31 (arguing that private parties may in the
future sue restaurants or food companies for continuing to use partially hydrogen-
ated vegetable oils when healthier alternatives exist).
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risk increment for the development of heart disease,27 such accrual
could be considerable and the likelihood for claim success signifi-
cant. The FDA and industry can stop the meter on these claims now
by banning artificial trans fats preemptively and doing so as soon as
possible. Or they can let the meter continue to run into the hun-
dreds of millions or even billions of dollars.
VII. CONCLUSION
On balance, only time will tell if industry and consumer prac-
tice regarding trans fats has changed to the extent that amending
the regulatory system will not yield positive changes. The ball can-
not be advanced when an agency buries its head in the sand, as the
current state of affairs attests. On the contrary, where an agency
abdicates its obligation to provide uniform federal regulations to a
national industry, chaos can ensue as state and local governments
attempt to regulate the industry via multiple local ordinances. Con-
sumers may have already decided that all trans fats are harmful, and
producers may have determined that it is better to simply remove all
trans fats from their recipes, even though those actions may not only
be misguided, but harmful to public health. Nevertheless, the ex-
perience to date with trans fat regulation suggests that a laissez-faire
approach does not achieve optimum outcomes. Should the current
situation continue unchanged, ten years from now the Institute of
Medicine's concern regarding nutritional deficiencies from the
elimination of natural trans fat sources' may come to fruition, a
new round of increasing coronary heart disease may develop from
increased use of interesterified fats and processed oils to replace
trans fats, and settlement and damages from trans fat tort suits may
rival those previously realized in tobacco litigation. The better
course-legally, medically, and economically-may be to make the
appropriate changes now, cross our fingers, and hope that it is not
too late to ensure that, in terms of trans fat content, our food supply
will be both safe and wholesome.
207. STEEN STENDER & JoRN DYERBERG, DANISH NUTRITION COUNCIL, THE
INFLUENCE OF TRANS FATrY ACIDS ON HEALTH, 4th ed., at 9 (2003), available at
http://www.meraadet.dk/gfx/uploads/Rapporter-pdf/Trans%20fatty%20acids-4.t
h%20ed._UK www.pdf.
208. See DIETARY REFERENCE INTAKES, supra note 4, at 14.
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I. INTRODUCTION
The market for organic products has increased dramatically in
the United States and across the world in recent years.' Since 1997,
sales of organic foods have grown from 15% to 21% per year, and
while organic foods accounted for only 2.5% of total food sales in
the United States in 2005, those sales amounted to $13.8 billion.
* Jennifer Fiser is a May 2008 J.D. candidate at the University of Arkansas
School of Law, Fayetteville, Arkansas. The author would like to thank Professor
Harrison Pittman for his guidance in the preparation of this comment. The author
would also like to thank Jennifer Akre Hill, 2006-2007 Note and Comment Editor,
for her help and encouragement.
1. CAROLYN DIMrIu & CATHERINE GREENE, USDA ECON. RES. SERV. (ERS),
RECENT GROWTH PATTERNS IN THE U.S. ORGANIC FOODS MARKET, AGRIC. INFO. BULL.
No. AIB777, at iii, available at http://www.ers.usda.gov/publications/aib777/.
2. ORGANIC TRADE ASS'N (OTA), 2006 MANUFACTURER SURVEY, at 1, available at
http://www.ota.com/pics/documents/short%20overview%20MMS.pdf.
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Organic food currently represents one of the fastest-growing seg-
ments of U.S. agriculture.3 In response to increasing consumer de-
mand, more large companies and producers are entering the or-
ganic foods market. As organic foods have become more popular, a
shift from small companies and farms to large farms and giant cor-
porations has begun as new players have entered the industry with
others likely to follow.4 Previously, organic foods were typically
found in smaller specialty stores; however, today even giant retailers
like Wal-Mart and Target have entered the market.'
Consumers are choosing to buy organic foods for a variety of
reasons. They may believe that organic foods are healthier and
safer, more nutritious, and less damaging to the environment;' how-
ever, these benefits are not proven and remain controversial The
United States Department of Agriculture (USDA) has described the
organic label as simply a marketing program that indicates only the
method of production, but not food safety or nutrition levels.8 Nev-
ertheless, consumers continue to pay higher prices for organically-
grown foods in increasing numbers.9
As the market for organic foods has changed, so have the laws
that regulate them. Congress passed the Organic Foods Production
Act (OFPA) in 1990 in order to develop consistent standards for
foods sold as "organic" and to facilitate interstate commerce.'0 As
proscribed by the OFPA, the USDA, through the Agricultural Mar-
keting Service, developed regulations setting forth the requirements
3. USDA ERS, Briefing Room-Organic Farming and Marketing: Overview,
http://www.ers.usda.gov/briefing/organic/ (last visited Feb. 12, 2007).
4. DIMITRI & GREEN, supra note 1, at 1; Pallavi Gogoi, Wal-Mart's Organic Offen-
sive, Bus. WK. ONLINE, Mar. 29, 2006, http://www.businessweek.com/
bwdaily/dnflash/mar2006/nf20060329-6971.htm (last visited Jan. 14, 2008).
5. See Target Offers Organic Foods, Los ANGELES TIMEs, Sept. 29, 2006, at C3; see
also Whole Foods' Shares Drop On Signal of Slower Sales; Competition Heavy in Organic
Foods, WASH. POST, Nov. 4, 2006, at D1.
6. David Conner, Beyond Organic: Information Provision for Sustainable Agriculture
in a Changing Market, 35(1)J. Food Distribution Res. 34, 34-35 (2004).
7. Carl K. Winter & Sarah F. Davis, Organic Foods, 71 J. FOOD SCI. 117 (2006)
(finding that it is premature, based on scientific comparisons between conventional
and organic foods, to conclude that either method is superior or provides clear
benefits). But see OTA, Natural Considerations, http://www.ota.com/organic/
benefits/nutrition.html (last visited Jan. 28, 2008) (citing numerous studies which
have found higher nutrient levels in organic produce than in conventional pro-
duce).
8. Thin line between organic, ordinary, CHICAGO TRIBUNE, Dec. 4, 2006, at 41.
9. See DIMrrRI & GREEN, supra note 1, at iii.
10. Organic Foods Production Act of 1990, 7 U.S.C. § 6501 (2006).
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for foods to be labeled as "organic."" The purpose of the National
Organic Program (NOP) regulations is to ensure uniform growing
and production methods across the country, allowing consumers to
have a clear understanding of exactly what they are purchasing.'"
The traditional definition of "organic" as understood by con-
sumers is not necessarily the same definition that is used by the
USDA.'" For many consumers, "organic" implies that the produc-
tion is local and sustainable; however, the USDA provisions do not
encompass all of these consumer expectations." One criticism of
some of the new producers entering the organic market is that they
may be more interested in earning a profit than upholding the ide-
als that the organic movement has traditionally embraced.'" While
the NOP does address issues such as soil fertility" and pest control,'
7
it does not guarantee local control or participation in the produc-
tion of food, or even a general attitude of environmental steward-
ship from the producers.'8 The result is that many consumers may
not know exactly what "organic" really means."
The rules concerning the production and labeling of organic
products expressly prohibit the use of sewage sludge, ° genetically
modified organisms,' growth-promoting hormones,' and ionizing
radiation in organic food production. Consumers may be unaware,
however, that the USDA does allow some synthetic ingredients to be
used in foods labeled as "organic."' "Synthetic" is defined by the
OFPA and the NOP as a "substance that is formulated or manufac-
11. National Organic Program, 7 C.F.R. § 205 (2007).
12. See OTA, National Organic Rules Backgrounder, http://www.ota.com/
standards/nop/norb.html (last visited Feb. 12, 2007).
13. See David Conner & Ralph Christy, The Organic Label: How to Reconcile its
Meaning with Consumer Preferences, 35(1)J. FOOD DISTRIBUTION REs. 40, 40-43 (2004).
14. Id. at 42.
15. See Conner, supra note 6, at 34.
16. 7 C.F.R. § 205.203 (2007).
17. Id. § 205.206(b).
18. See Conner & Christy, supra note 13, at 42.
19. Id. at 4243.
20. 7 C.F.R. § 205.105(g) (2007).
21. Id. § 205.105(e) (stating that products labeled "organic" must be produced
and handled without the use of excluded methods); id. § 205.2 (defining "excluded
methods" as "[a] variety of methods used to genetically modify organisms or influ-
ence their growth and development by means that are not possible under natural
conditions or processes and are not considered compatible with organic produc-
tion.").
22. Id, § 205.238(c)(3).
23. Id. § 205.105(f).
24. Id § 205.605(b).
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tured by a chemical process or by a process that chemically changes
a substance extracted from naturally occurring plant, animal, or
mineral sources, except that such term shall not apply to substances
created by naturally occurring biological processes."' A food prod-
uct may contain up to 5% non-organic ingredients and still bear the
USDA "organic" label.' While 5% seems like a small amount, the
use of synthetic substances in organic products recently became
highly controversial and split the organic community into two fac-
tions, pitting consumer groups against producers, and creating fric-
tion among producers." The case of Harvey v. Veneman " brought
attention to this issue and ignited a debate that questioned what
"organic" should be.
The use of synthetic substances is especially important among
producers of processed organic foods, one of the fastest-growing
segments of the industry, who may rely heavily on the approved syn-
thetic substances in their production methods.' The interest in
processed organic foods is not surprising considering the increase in
25. 7 U.S.C. § 6502(21) (2006); 7 C.F.R. § 205.2 (2007).
26. Id. § 205.301. The NOP establishes four different classes for labeling pur-
poses: 1) "100% organic"; 2) "organic," which may contain up to 5% non-organic
ingredients if those ingredients are not available in organic form or are included on
the National List; 3) products "made with organic ingredients," which contain at
least 70% organic ingredients; and 4) products containing less than 70% organic
ingredients. Id.
27. See JEAN M. RAWSON, CONGRESSIONAL RESEARCH SERVICE, CRS REPORT FOR
CONGRESS, ORGANIC AGRICULTURE IN THE UNITED STATES: PROGRAM AND POLICY
ISSUES 10 (2006), available at http://fpc.state.gov/documents/
organization/57848.pdf. The Harvey lawsuit brought a renewed focus on organic
standards, but it was not the first time that Congress and the USDA have been ac-
cused of relaxing standards to favor large producers. See generally Claire S. Carroll,
Comment, What Does Organic Mean Now? Chickens and Wild Fish are Undermining the
Organic Foods Production Ad of 1990, 14 San Joaquin L.R. 117 (2004).
28. No. Civ. 02-216-P-H, 2003 WL 22327171 (D. Me. Oct. 10, 2003) (recommen-
dation of Magistrate Judge); adopted in par rejected in part, 297 F. Supp. 2d 334 (D.
Me. 2004); affd in part rev'd in part and remanded, 396 F.3d 28 (1st Cir. 2005); super-
seded by statute, Agriculture, Rural Development, Food and Drug Administration
and Related Agencies Appropriations Act of 2006, Pub. L. No. 109-97, 119 Stat.
2120; as recognized in Harvey v. Johanns, 462 F. Supp. 2d 69 (D. Me. 2006); Harvey
v. Johanns, No. Civ. 02-216-P-H, 2006 WL 3392617 (D. Me. Nov. 21, 2006) (issuing
judgment for the Secretary of Agriculture with respect to count three regarding the
use of synthetic substances); Harvey v. Johanns, 494 F.3d 237 (1st Cir. 2007) (af-
firming judgment for Secretary with respect to count three).
29. See THE NATIONAL ORGANIC PROGRAM: IMPACT OF HARVEY V. JOHANNS AND
RESTORING THE NOP TO PRE-LAwSurr STATUS, A REPORT TO CONGRESS 8-9 (Mar.
2006), available at http://www.ams.usda.gov/NOP/NOPCongressStudyl-
06_06.pdf [hereinafter REPORT TO CONGRESS].
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demand for conventionally-produced processed convenience foods,
including ready-to-eat and frozen meals which require no prepara-
tion." This segment of the organic food industry had become de-
pendent on certain synthetic substances and was especially threat-
ened by the court's decision.'
In Harvey v. Veneman, which attacked the provisions of the
NOP, the First Circuit Court of Appeals interpreted the OFPA and
held that, contrary to prior opinion, the OFPA did not allow the use
of synthetic substances in the processing of organic foods." In re-
sponse, Congress quickly amended the OFPA, nullifying the court's
interpretation and allowing the use of synthetics to continue as it
had prior to the court's decision." Consumer groups criticized the
amendment on the grounds that it made the rules more lenient and,
therefore, was a move away from the original purpose of the OFPA
and the NOP. 4 Consumer groups further alleged that the changes
would cause consumer confidence in organic products to be eroded
and the benefits of organic production to be lost.' Many producers
supported the amendment, arguing that the organic industry would
30. See Jeanie Lerche Davis, America's Food Trends: More People Eating Healthy,
Eating at Home, WebMD Medical News (Aug. 26, 2003),
http://www.webmd.com/content/Article/72/81891.htm (last visited Jan. 14,
2008).
31. See Jack Kittredge, Sligh: "Stay the Course," THE NATURAL FARMER 38 (Spring
2006), available at http://www.nofa.org/tnf/2006spring/Sligh%20-%2Stay%
20the%2OCourse.pdf (quoting Michael Sligh, founding chair of the National Or-
ganic Standards Board, discussing the initial allowance of synthetics: "The farmers
put a few categories of exemptions for synthetics used in growing in the legislat-
ion .... Processors used that argument to get their own list, too. If the farmers
were given a short list of synthetics, people felt it was only fair to give the proces-
sors one, too. It was sold as somehow not a permanent thing. But in fact the proc-
essors began to build their industry around those synthetics. I think we underap-
preciated how slippery a slope it was!").
32. 396 F.3d 28, 38-40 (1st Cir. 2005).
33. Agriculture, Rural Development, Food and Drug Administration and Re-
lated Agencies Appropriations Act of 2006, Pub. L. No. 109-97, 119 Stat. 2165.
(codified at 7 U.S.C. § 6517(c)(1)) [hereinafter Appropriations Act].
34. See Steve Gilman, Holding on to Organic: A Grassroots Perspective Concerning Big
Food's Threat to Organic Standards, THE NATURAL FARMER 25-28, Spring 2006, avail-
able at http://www.nofa.org/tnf/2006spring/Holding%20On%2OTo%200r-
ganic!.pdf; see also ConsumerReports.org, Fighting for a Strong "organic" label,
http://www.consumerreports.org/cro/aboutus/mission/viewpoint/fightingforastr
ongorganiclabel0602/index.htm (last visitedJan. 14, 2008).
35. See Organic Consumers Association (OCA), Open Letter to the OTA & the
Organic Community on the Recent Sneak Attack on Organic Standards (Nov. 18, 2005),
http://www.organicconsumers.org/sos/openletterl12105.cfm (last visited Jan. 28,
2008).
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suffer a huge loss if the use of certain synthetic substances was disal-
lowed.'
The Harvey decision and ensuing amendment and attention il-
lustrate the difficulties faced by the organic industry as it continues
to expand and adapt to economic realities, and the compromises
that must be made to meet increasing consumer demand for or-
ganic products. This article will focus on the decision in Harvey and
the subsequent amendments to the OFPA by Congress," and their
effects on producers and consumers of organic foods. 8 Further, this
article will discuss how the argument over the use of synthetic sub-
stances in organic food processing highlights a greater divide within
the organic community, how the compromises made by Congress in
this instance were necessary to ensure the vitality of this growing
industry, and how the need for consumer education regarding or-
ganic products is greater than ever before. 9
II. HISTORY
The history of the organic foods movement in the U.S. can be
traced back as early as the 1940s."° While the organic food commu-
nity was a minor player in the food industry for most of its exis-
tence, it has recently attracted increased attention from consumers,
and this demand has enticed more producers to enter the market
and is transforming the industry." As more producers enter the
organic food industry and more consumers purchase organic foods,
the need for consistency and clarity in the regulations concerning
the production and labeling of these products has become increas-
ingly important.
36. See REPORT TO CONGRESS, supra note 29, at 8; see also Grace Gurshuny, Harvey
and the Soul of Organic (2003), http://www.ota.com/wisewords3.htnl (last visited
Feb. 12, 2007) (stating that, by some estimates, the court's ruling would have re-
moved the "organic" label from up to 90% of processed products carrying the or-
ganic label at that time; Gurshuny was a founding member of the OTA).
37. See infra notes 40-105 and accompanying text.
38. See infta notes 106-139 and accompanying text.
39. See infra notes 106-143 and accompanying text.
40. USDA, National Organic Program: History and Background, http://
www.ams.usda.gov/nop/Consumers/background.html (last visitedJan. 14, 2008).
41. See DIMrirI & GREEN, supra note 1, at iii.
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A. Early Regulation of Organic Foods and the
Organic Foods Production Act of 1990
Prior to the passage of the Organic Foods Production Act
(OFPA), certification of organic products was carried out by inde-
pendent certifying entities." These entities did not use consistent
criteria when certifying products, and these inconsistencies created
complications for interstate business and confusion on the part of
buyers.'3
These problems led to a demand for national standards to regu-
late organic food products, and Congress responded by passing the
OFPA in 1990." The responsibility of developing the national or-
ganic standards required by the OFPA was placed on the United
States Department of Agriculture (USDA) through the Agricultural
Marketing Service.
One issue addressed by the OFPA is the use of synthetic sub-
stances, used by many producers during production and handling,
in organic food products.' Generally, synthetic substances are not
allowed to be used in the processing of organic foods; however, the
act does provide for establishment of the National List, a list setting
forth each synthetic substance that has been granted an exemption
and allowed for use in the production of organic foods under speci-
fied uses and applications.' The OFPA provides that an exemption
may be granted for prohibited substances used in organic produc-
tion and handling if the substance is used in production and con-
tains an active synthetic ingredient falling into one of the specified
categories, or is used in production and contains synthetic inert in-
gredients not classified by the Environmental Protection Agency as
being of toxicological concern." The substance must also not be
42. See generally T. ROBERT FETTER &JULIE A. CASWELL, FOOD MKTG. POL'Y CTR.,
VARIATION IN ORGANIC STANDARDS PRIOR TO THE NATIONAL ORGANIC PROGRAM, RES.
REP. No. 72 (2002), at 1-2, available at http://www.fmpc.uconn.edu/
publications/rr/rr72.pdf. In 2000 and 2001, there were thirty-nine private and
fourteen state organic certification agencies. CATHERINE GREENE & AMY KREMEN,
USDA ERS, U.S. ORGANIC FARMING IN 2000-2001: ADOPTION OF CERTIFIED SYSTEMS,
AGRIC. INFOR. BULL. No. 780, at 5 (2003), available at http://
www.ers.usda.gov/Publications/aib780/.
43. See FETTER & CASWELL, supra note 42, at 1.
44. 7 U.S.C. §§ 6501-6522 (2006); see also USDA, supra note 40.
45. 7 U.S.C. § 6517 (2006).
46. Id. § 6517(a)-(b).
47. Id. § 6517(c)(1)(B). The language of section 6517(c)(1) was changed from
"production" to "production and handling" in 2006. Appropriations Act, Pub. L.
No. 109-97, 119 Stat. 2165.
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harmful to humans or the environment, be necessary to the produc-
tion or handling of the agricultural product because of unavailability
of a natural substitute, and be consistent with organic farming and
handling." The OFPA further establishes that exceptions for syn-
thetic substances may not be made other than those for substances
contained in the Proposed National List or Proposed Amendments
to the National List, which are published in the Federal Register and
open to public comment before taking effect." Finally, the OFPA
provides a sunset provision that requires exempted substances to be
reviewed every five years.
The OFPA also created the National Organic Standards Board
(NOSB) to assist in the development of standards and to offer ad-
vice on other aspects of implementation of the program. One re-
sponsibility of the NOSB was to develop the National List." The
NOSB was also given the responsibility to convene technical advi-
sory panels to evaluate materials to be included on the National List
based on guidelines provided in the OFPAY In addition, the NOSB
was required to develop procedures by which people could petition
the board for evaluation of additional substances for inclusion on
the National List.'
B. The National Organic Program
As required by the OFPA, the USDA fulfilled its obligation by
creating a set of standards for the production and labeling of or-
48. 7 U.S.C. § 6517(c)(1)(A) (2006).
49. Id. § 6517(d)(2), (4).
50. Id. § 6517(e).
51. Id. § 6518(a). The National Organic Standards Board is comprised of fifteen
members: four who own or operate an organic farming operation; two who own or
operate an organic handling operation; one who owns or operates a retail estab-
lishment selling organic products; three who have expertise in environmental pro-
tection and resource conservation; three who represent public interest or consumer
groups; one who has toxicology, ecology, or biochemistry expertise; and one who is
an organic certifying agent. Id. § 6518(b).
52. Id. § 6518(k)(2).
53. 7 U.S.C. § 6518(k)(3) (2006). The OFPA provides seven factors for consid-
eration when deciding whether to place a substance on the National List: 1) the
potential for detrimental chemical interactions with other materials, 2) the toxicity
and mode of action of the substance and its breakdown products, 3) the probability
of environmental contamination, 4) the effect on human health, 5) the effect on
biological and chemical interactions in the agroecosystem, 6) alternative practices
or materials that could be used, and 7) compatibility with sustainable agriculture
systems. Id. § 6518(m).
54. 7 U.S.C. § 6518(n).
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ganic foods, resulting in the National Organic Program (NOP).'
After a comment period, the Final Rule creating the NOP was pub-
lished on December 21, 2000,' and enforcement began on October
21, 2002." When the final version of the NOP was announced, the
Organic Trade Association (OTA) stated that the NOP would "pro-
tect the integrity of the organic guarantee .... ."" The NOP estab-
lishes national standards governing the marketing, production, and
handling of organic products, 9 and it also establishes the National
List pursuant to the OFPA.Y
The NOP provisions regarding the National List include addi-
tional considerations to be used in the evaluation of synthetic proc-
essing aids or adjuvants." The rules specify certain synthetic sub-
stances that are allowed to be used as ingredients in or on processed
foods labeled as "organic" or "made with organic products" as long
as used pursuant to any restrictions that are specified." Some ex-
55. 7 C.F.R. § 205 (2007); see also HARRISON M. PrrTMAN, NAT'LAGRIC. L. CTR., A
LEGAL GUIDE TO THE NATIONAL ORGANIC PROGRAM (Mar. 2004),
http://www.nationalaglawcenter.org/assets/articles/pittman-organicprogran.pdf
(last visited Feb. 12, 2007); see generally Nat'l Agric. L. Ctr., National Organic Program
Reading Room, http://www.nationalaglawcenter.org/readingrooms/organic-
program/ (last visited Feb. 12, 2007).
56. National Organic Program, 65 Fed. Reg. 80548 (Dec. 21, 2000) (codified as
amended at 7 C.F.R. pt. 205).
57. National Organic Program, 71 Fed. Reg. 32803 (June 7, 2006).
58. Press Release, OTA, National organic standards will open markets domesti-
cally, globally (Dec. 20, 2000), http://www.ota.com/news/press/65.html (last vis-
ited Feb. 12, 2007).
59. See generally National Organic Program, 7 C.F.R. § 205 (2007).
60. Id. §§ 205.600-.607.
61. Id. § 205.600(b). Factors to be considered include: whether the substance
cannot be produced from a natural source and no organic substitutes exist; whether
the substance's manufacture, use and disposal have adverse effects on the environ-
ment; whether the nutritional quality of the food is maintained; that the primary
use is not as a preservative or to recreate or improve flavors, colors, textures or
nutritive value lost during processing (except where use is required by law); that the
substance is generally recognized as safe by the Food and Drug Administration and
contains no heavy metal residues; and that the substance is essential for the han-
dling of organic agricultural products. Id.
62. Id. § 205.605. "Processing" is defined as "cooking, baking, curing, heating,
drying, mixing, grinding, churning, separating, extracting, slaughtering, cutting,
fermenting, distilling, eviscerating, preserving, dehydrating, freezing, chilling, or
otherwise manufacturing" and includes "packaging, canning, jarring, or otherwise
enclosing food in a container." Id. at § 205.2.
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amples of substances included on the list are cellulose, ethylene gas,
hydrogen peroxide, and ozone.'
C. The Harvey v. Veneman Lawsuit
The NOP's allowance of the use of specified synthetic ingredi-
ents was met with disagreement from some producers and consum-
ers. One member of the organic community, Arthur Harvey, filed a
lawsuit pro se on October 23, 2002, two days after the NOP regula-
tions became effective.' Harvey was a certified organic blueberry
farmer, an organic inspector, and a consumer of organic products.'
Harvey's lawsuit alleged that the NOP did not comply with the
OFPA.' He argued that the discrepancies between the NOP and the
OFPA would harm consumers because foods would be allowed to be
sold with the "organic" label that did not meet the standards set
forth in the OFPAY He also asserted that organic producers and
marketers would be harmed because of the resulting loss of con-
sumer confidence, as well as by having to face competition from
producers whose products do not meet the requirements of the
OFPA but qualify for the same labeling under the NOP&
Harvey's lawsuit consisted of nine counts, one of which directly
challenged the NOP's allowance of synthetic substances used in
processing of organic foods.' Count three of Harvey's complaint
alleged that the NOP's regulations that permitted the use of synthet-
ics in organically-labeled processed foods violated the OFPA, which
had a general prohibition on synthetic ingredients during process-
ing except for when otherwise required by health and safety laws."
Harvey argued that, although the OFPA does allow for the crea-
tion of the National List covering both handling and production, the
63. See id. § 205.605. Cellulose is allowed for use in regenerative casings and as
an anti-caking agent and filtering aid. Id. Ethylene gas is allowed for use in post-
harvest ripening of tropical fruit. Id.
64. James Gormley, The New Organics Ruling - What Now? (2005),
http://www.npicenter.com/anm/anmviewer.asp?a=11721&z=86 (last visited Feb.
12, 2007).
65. Brief of Plaintiff-Appellant Arthur Harvey at 3, Harvey v. Veneman, 396 F.3d
28 (D. Me. 2004) (No. 04-1379), 2005 U.S. 1st Cir. Briefs LEXIS 16 [hereinafter
Harvey Brief].
66. Id.
67. Id. at 4.
68. Id.
69. Harvey Brief, supra note 65, at 15.
70. Id. at 35.
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OFPA places very precise limitations on those general provisions.7'
Harvey's argument relied on the OFPA's statement that a substance
may be included on the National List only if it met one of three cri-
teria: 1) it is used in production and contains an active synthetic
ingredient in one of the specified categories, 2) it is used in produc-
tion and contains synthetic inert ingredients not classified by the
Environmental Protection Agency (EPA) as being of toxicological
concern, or 3) it is used in handling and is non-synthetic and not
organically produced.' According to Harvey, the OFPA only al-
lowed strictly limited use of synthetic ingredients during "produc-
tion," which he interpreted as including only farming, and not dur-
ing "handling."" The OFPA provides that handling operations shall
not "add any synthetic ingredient not appearing on the National List
during the processing or any post harvest handling of the product.""
Thus, Harvey's interpretation was that the provision for the National
List did not allow for synthetics to be used in processing, because
handling (which includes processing) could not use synthetics.'
On January 7, 2004, summary judgment was entered in favor of
the Secretary of Agriculture on all nine counts in District Court. 6
The decision regarding count three was based on a recommenda-
tion by the Magistrate Judge that the NOP provisions addressing
synthetics did not "violate the spirit of the OFPA" and seemed in
accord with the OFPA, considering that the OFPA anticipated some
exceptions for synthetics and that the Secretary of the USDA was
given appropriate discretion regarding which substances would be
allowed." Harvey filed a notice of appeal on March 8, 2004.8
Two amicus curiae briefs were filed in support of Harvey's posi-
tion. One was filed by the Organic Consumers Association (OCA);
71. Id. at 31-36.
72. Id. at 32 (summarizing 7 U.S.C. § 6517(c)(1)(B)). Section 6517(c)(1)(B)(iii),
regarding the use of substances used in handling that are non-synthetic and not
organically produced, was stricken in the subsequent amendment of the OFPA.
Appropriations Act, Pub. L. No. 109-97, 119 Stat. 2165.
73. Harvey Brief, supra note 65, at 31. The OFPA defines "handle" as "to sell,
process or package agricultural products." 7 U.S.C. § 6502(8) (2006). "Production"
is not defined by the OFPA, but "producer" is defined as "a person who engages in
the growing or producing of food or feed." Id. § 6502(18).
74. 7 U.S.C. § 6510(a)(1) (2006).
75. Harvey Brief, supra note 65, at 31-36.
76. Harvey v. Veneman, 297 F. Supp. 2d 334 (D. Me. 2004).
77. Harvey v. Veneman, No. Civ. 02-216-P-H, 2003 WL 22327171, at *8 (D. Me.
Oct. 10, 2003).
78. OTA, Lawsuit Chronology, http://www.ota.com/LawsuitChronology.html
(last visited on Jan. 24, 2007).
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the Sierra Club; Public Citizen, Inc.; Northeast Organic Fanning
Association/Massachusetts Chapter, Inc.; John Clark; Merrill Clark;
Anne Mendenhall; Greenpeace, U.S.A.; and Waterkeeper Alliance
[hereinafter OCA Briefi."' The other brief was filed by Rural Ad-
vancement Foundation International-USA, the Center for Food
Safety, and Beyond Pesticides [hereinafter Rural Brief].'
The OCA Brief emphasized that one of the goals of Congress in
creating the OFPA was to recognize and build upon the consumer
expectations of organic foods that already existed prior to the en-
actment of the OFPA, and that consumers expect that food bearing
the organic label does not contain synthetics." They urged the court
to vacate the regulations allowing synthetics, except for the two ex-
ceptions in the OFPA, in order to be consistent with the statutory
intent and reasonable consumer expectations.'
The Rural Brief also focused on the importance of meeting
consumer expectations, and alleged that "consumers and farmers
will not accept 'exceptions' to the law, and that their reaction to ex-
ceptions could deliver a 'fatal blow' to the organic market."' They
acknowledged that policy arguments could be made both for and
against strict limitations on synthetic substances in organic prod-
ucts.' Limitations could play a "technology forcing role" because
producers and food handlers may have to search for natural sub-
stances or different processes to use for organic products.' They
also acknowledged that advocates of more lenient rules could argue
that some synthetic substances have been used for a long time and
have no history of adverse effects.' Despite the possible arguments
for a more lenient interpretation, they felt that the wisdom of the
policy was irrelevant because Congress addressed this issue and, be-
yond the narrow exceptions contained in the OFPA, no synthetics
79. Brief of Amicus Curiae Organic Consumers Ass'n et al. in Support of Plaintiff-
Appellant, Harvey v. Veneman, 396 F.3d 28 (1st Cir. 2004) (No. 04-1379), 2004 U.S.
1st Cir. Briefs LEXIS 96 [hereinafter OCA Brief].
80. See Brief of Amici Curiae Rural Advancement Found. Int'l-USA et al. in Sup-
port of Plaintiff/Appellant, Harvey v. Veneman, 396 F.3d 28 (1st Cir. 2004) (No. 04-
1379), available at http://www.centerforfoodsafety.org/pubs/HarveyAmicusBrief
6.15.2004.pdf [hereinafter Rural Brief].
81. OCA Brief, supra note 79, at *2.
82. Id. at *20.
83. See Rural Brief, supra note 80, at 2.
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were allowed to be used in the handling of organic foods based on
the statutory language.87
The USDA argued that the NOP Final Rule was a permissible
construction of the OFPA.' With respect to count three, the USDA
argued that the allowance of the thirty-six synthetic substances
(listed in section 205.606 of the NOP) to be permitted as ingredients
in or on processed foods was authorized by the OFPA." It stated
that the OFPA clearly contemplated an exception allowing the use
of synthetics in handling and production, citing that the OFPA
states, "the Secretary shall establish a National List of approved and
prohibited substances that shall be included in the standards for
organic production and handling ... ."' The USDA also alleged
that its interpretation was supported by the OFPA's language stating
that "the National list may provide for the use of [prohibited] sub-
stances in an organic farming or handling operation" if they are
"necessary to production or handling," and "consistent with organic
farming and handling.""' The USDA asserted that it was not sensible
for these substances to be prohibited in handling if they are allowed
to be used upstream in production.'
The First Circuit Court of Appeals ruled in favor of Harvey on
count three concerning the use of synthetic substances and count
seven regarding organic dairy operation. 3 The court agreed that the
NOP's provisions allowing synthetic substances to be used as proc-
essing aids or adjuvants if they meet the specified criteria contra-
vened the plain language of the OFPA, and were therefore outside
the authority granted by Congress.' The court expressly rejected
Secretary Veneman's argument that Section 6517, which governs the
87. Id.
88. Brief of Appellee Ann Veneman, Sec'y of the USDA, at *6, Harvey v. Vene-
man, 396 F.3d 28 (1st Cir. 2004) (No 04-1379), 2004 U.S. 1st Cir. Briefs LEXIS 95.
89. Id. at *20-21.
90. Id. at *21 (quoting 7 U.S.C. § 6517(a)).
91. Id. (quoting 7 U.S.C. § 6517(c)).
92. Id. at *23. Harvey countered that this prohibition did make sense because
production involves different substances and considerations, and that those synthet-
ics used in production generally do not end up as ingredients in the final product.
Reply Brief of Plaintiff-Appellant Arthur Harvey, at *16, Harvey v. Veneman, 396
F.3d 28 (D. Me. 2004), 2004 U.S. 1st Cir. Briefs LEXIS 97.
93. Harvey v. Veneman, 396 F.3d 28, 31 (1st Cir. 2005). The court's ruling re-
garding conversion of dairy herds to organic production was also the subject of
subsequent Congressional amendment and much debate and criticism. See generally
Chad Kruse, Comment, The Not-So-Organic Dairy Regulations of the Organic Food Pro-
duction Act of 1990, 30 S. ILL. U. LJ. 501 (2006).
94. Harvey, 396 F.3d at 38-39.
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creation of exemptions, allowed the listing of synthetic substances
for use in handling despite the "general prohibition" of the OFPA."
The court stated that "handle" meant "to sell, process, or package
agricultural products" and found that the OFPA did not contem-
plate use of synthetic substances during handling.' The court also
rejected the Secretary's claim that the use of the phrase "farming or
handling" in some sections of the OFPA rendered the OFPA am-
biguous, allowing the Secretary to construe this phrase in a reason-
able way.'
D. Congressional Amendment of the OFPA
As part of the Agriculture, Rural Development, Food and Drug
Administration and Related Agencies Appropriations Act of 2006,98
the National List was restored to its pre-lawsuit status by Congress. "
The language of the OFPA was amended by the insertion of the
phrase "in organic production and handling,""° clarifying that syn-
thetics approved for use by inclusion on the National List were al-
lowed for use in both production and handling activities. Congress
made this change because it was persuaded that the loss of many of
the synthetic substances previously allowed on the list would cost the
organic foods industry billions of dollars, and that this cost would
extend to consumers and cause a decline in demand for organic
goods as prices rose. '
After the OFPA was amended by Congress, Harvey petitioned
the District Court to enforce its judgment regarding count three.'2
The District Court refused, holding that its prior ruling was super-
seded by the amendments. ' On appeal, the First Circuit Court of
Appeals affirmed that the ruling was superseded, stating that "(t)he
amended version of the OFPA may not be a perfect syntactical
95. Id. at 39.
96. Id.
97. Id.
98. Appropriations Act, Pub. L. No. 109-97, 119 Stat. 2120.
99. REPORT TO CONGRESS, supra note 29, at 1. As a result of the Congressional
amendment, the USDA announced that it would not revise the NOP in response to
the Harvey decision. 71 Fed. Reg. 32803, 32804 (June 7, 2006).
100. Appropriations Act, Pub. L. No. 109-97, 119 Stat. 2165 (codified at 7 U.S.C.
§ 6517 (2006)).
101. REPORT TO CONGRESS, supra note 29, at 8.
102. Harvey v.Johanns, 462 F. Supp. 2d 69 (D. Me. 2006).
103. Id. at 72.
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model, but any ambiguities are easily resolved once one accounts for
context." '°4
III. ANALYSIS
The action taken by Congress to restore the National Organic
Program (NOP) to its pre-lawsuit status in response to the court's
ruling in Harvey v. Veneman was welcomed by many producers in the
organic foods industry, but was criticized by numerous consumer
groups. °5 The amendment that nullified the court decision was
largely based on recommendations to Congress by the Organic
Trade Association (OTA), which came without much input from
consumers and was described as a "sneak attack" by the Organic
Consumers Association (OCA).l° Some critics claimed that the de-
cision to restore the allowance of synthetics to pre-lawsuit status was
an example of the USDA giving into the lobbying pressure of corpo-
rate giants, without regard for the wishes of consumers and produc-
ers who wanted a stricter standard."°7 The dispute was also described
as a "cultural battle" between those who wanted a strict organic pro-
gram and those who wanted the standards relaxed to allow easier
entrance to the organic market.'
The quick action of Congress in response to the Harvey decision
indicates that Congress favors a more liberal interpretation than the
one suggested by the First Circuit in the Harvey opinion." The
United States Department of Agriculture (USDA) organic label has
been described as a marketing device rather than a program for the
104. Harvey v.Johanns, 494 F.3d 237, 244 (1st Cir. 2007) ("To sum up, the timing
and scope of the 2005 Amendments, together with Congress's specific references to
our decision in Harvey I, make it transparently clear that Congress set out to
achieve the goal of restoring the 'count 3' regulations to their pre-suit status; after
all, Congress amended both sections on which Harvey I relied and, at the same
time, took pains to excise the language that we identified as an obstacle to the Sec-
retary's regulatory scheme.").
105. See Gurshuny, supra note 36; OCA, supra note 35.
106. OCA, supra note 35. Consumer groups disagreed not only with the sub-
stance of the amendment, but also with the process by which it was accomplished.
The OCA alleged that the amendment was the result of "closed-door deliberations"
and did not consider the input of many of the stakeholders in the organic commu-
nity. Id.
107. An Organic Drift, N.Y. TIMEs, Nov. 4, 2005, at A26.
108. Id.
109. The OFPA was amended on Nov. 10, 2005, less than ten months after the
court's decision. Appropriations Act, Pub. L. No. 109-97, 119 Stat. 2120.
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benefit of consumers."' Therefore, it seems predictable that the
OFPA was amended by Congress in response to producers' con-
cerns despite substantial consumer disagreement.
A. Potential Impact of the Court Ruling on the Organic Foods Industry
Companies entering the organic foods market face substantial
financial risks; organic production may cost up to 50% more than
conventional production and, just as is the case with conventional
products, there is no guarantee that a product will be successful."'
If the court's decision, establishing that synthetic substances could
not be used in the handling organic foods, had been allowed to
stand, the impact on the organic foods industry would have been
extreme. "2 The producers of some fresh foods, including organic
produce, would have been affected by the rule, since some synthetic
substances such as carbon dioxide are used in post-harvest activities
including ripening.' In one study, about 50% of growers reported
using at least one synthetic substance."' While the court's ruling
would only have affected ingredients that constitute up to 5% of the
total finished product, it could have required producers to either
reformulate or discontinue the production of hundreds of product
lines or to stop using the USDA organic seal."5 One study estimated
that the adjustment costs, including reformulation and labeling
changes, would be $1.5 billion, and found that approximately 25%
of manufacturers would stop using organic ingredients."6 The esti-
mated total cost, including losses from product elimination, adjust-
ment costs, and price premium reduction cost, was $1.9 billion."7
Ultimately, the NOP is a labeling program; the only visible dif-
ference to a consumer between an organically-grown and a conven-
tionally-grown apple sitting on a store shelf is the label. The USDA
organic label has been shown to have a significant effect on con-
sumers' willingness to pay higher prices for organically-grown prod-
ucts, and if companies were forced to use a lesser distinguishing
label (such as "made with organic ingredients"), they feared that
110. See Thin line between organic, ordinary, supra note 8.
111. Ann Zimmerman, Planting the Seed-Big Food Companies Sell More Organic
Products, But Production Is Risky, WALL ST.J., Aug. 23, 2006, at BI.
112. REPORT TO CONGRESS, supra note 29, at 1.
113. Id. at 9-10.
114. Id. at9.
115. Id. at 10.
116. Id. at 10-11.
117. REPORT TO CONGRESS, supra note 29, at 10.
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consumers would be unwilling to pay more for those items.' 8 A
study investigating consumer willingness to purchase processed
foods with different levels of organic ingredients found that con-
sumers were willing to pay increased prices for foods with less than
100% organic ingredients, but exactly how much consumer willing-
ness to pay changes with decreasing levels of organic ingredients is
unclear."9
Although consumer groups implied that the amendment fa-
vored big companies at the expense of smaller producers, the Harvey
decision could have had even greater detrimental effects on small
producers than large ones." Small producers might have been less
able to handle the disruption of their production and cost of refor-
mulating their products to comply with the new requirements. In
addition, large producers are generally better able to handle the
regulatory compliance issues created by stricter rules.'"' The Harvey
decision could have further placed small producers at a competitive
disadvantage in the rapidly changing marketplace for organic
foods.' At the same time, if larger producers are allowed to adhere
to more lenient standards while some smaller producers use more
costly ingredients and methods that do not involve synthetics, this
could give large producers an advantage in the marketplace. The
final result of the Harvey decision, if it had been allowed to stand,
would have been difficult for organic producers of all sizes. Con-
gressional amendment of the OFPA created benefits for producers,
and those benefits extend to the consumers of organic products as
well.
B. Impact of the Amendment on Consumers
Several consumer groups spoke out about the Congressional
amendment of the OFPA in response to the Harvey decision. As
asserted in the amicus briefs, some opponents alleged that most con-
sumers believe that no synthetic substances are allowed to be used
118. Id. at 8.
119. See Marvin T. Batte et al., Customer Willingness to Pay for Multi-Ingredient Proc-
essed Organic Food Products 15-16, selected paper for presentation at the Amer. Ag-
tic. Econ. Ass'n Annual Meeting, Denver, July 2004, available at
http://agecon.lib.umn.edu/cgi-bin/pdfview.pl?paperid=14338&ftype=.pdf.
120. See Gurshuny, supra note 36.
121. See id.
122. See id.
123. See Gilman, supra note 34, at 25; see also ConsumerReports.org, supra note
34.
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in organic food production." They further asserted that because of
this belief, the NOP's regulations allowing the use of synthetics in
products labeled as organic "defy those expectations which had been
established long before OFPA created a federal role in organic food
production and labeling.'
2 5
In amending the OFPA, Congress reasoned that the opposite
was true-consumers' previous demand for organic products, de-
spite the synthetic substances allowed for use, was evidence that
consumers supported the NOP as it stood before the court's deci-
sion."6 In reality, the acceptance or rejection of synthetic ingredi-
ents by consumers probably does not meet either extreme point of
view.
The position taken by Congress assumes that consumers under-
stand that some of the substances used in the production of the or-
ganic foods they buy are not organic; however, consumer under-
standing of the organic regulations is less clear than Congress and
the USDA believe. One study found that only 13.5% of people sur-
veyed were aware that products containing up to 5% non-organic
ingredients could still carry the "organic" label. 27 Only 9.3% of re-
spondents in the study were even aware that there were different
categories for organic processed foods. 8 Some consumers who re-
sponded to the study expressed confusion regarding the division of
organic foods into multiple categories, believing that foods should
either be organic or not, with no division into different degrees of
"organic-ness.' 2 9  Those responses suggest that some consumers
could object to the use of the "organic" label for products that are
less than 100% organic; however, other consumers may prefer the
solution reached by Congress if the alternative is for those organic
foods that cannot be produced without synthetics to become un-
124. OCA Brief, supra note 79, at *20.
125. Id.
126. See REPORT TO CONGRESS, supra note 29, at 10.
127. See RON STROCHLIC, USDA, REGULATING ORGANIC: IMPACTS OF THE NATIONAL
ORGANIC STANDARDS ON CONSUMER AWARENESS AND ORGANIC CONSUMPTION
PATTERNS 17, Dec. 2005, available at http://www.ams.usda.gov/tmd/
MSB/PDFpubList/RegulatingOrganic.pdf.
128. See id. at 16.
129. See id. at 17. One respondent to the study stated that having multiple catego-
ries of organic products "is like being a little pregnant. Either you're pregnant or
you're not. For me, it's either organic or it's not." Id. Fifty-three percent of re-
spondents said that knowledge of the different categories of organic products
might affect their decision to purchase organic products bearing the USDA seal. Id
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available, or to have less choice because so many producers have
been forced out of business.
Some respondents to the 1995 study expressed a belief that or-
ganic products are better regardless of whether they were 100% or-
ganic." Over half of the respondents felt that their knowledge that
products containing less than 100% organic may display the organic
label would have no effect on their decision to purchase organic
foods."' For those consumers who do prefer foods with completely
organic ingredients, products that are made with 100% organic in-
gredients are allowed to display that information on the package;
however, if consumers are unaware that a difference can exist be-
tween "100% organic" and "organic" products, a producer of a
100% organic product will be unable to distinguish itself among
competitors on this basis.
In light of those studies, the compromise reached by Congress
seems to protect both the economic viability of the organic foods
industry and consumer choice."2 The issue then becomes whether
consumers understand what they are paying for. While some syn-
thetic substances may be needed to make organic food production
economically feasible, one must wonder whether the use of such
substances should be more clearly disclosed to consumers so that
they may make informed choices about which organic foods they
choose to purchase.
The USDA organic label has been shown to be a significant fac-
tor in the marketing of organic products to consumers. 3 If prod-
ucts using the synthetics were forced to use a label that signifies
something less than a completely organic product (such as "made
with organic ingredients"), rather than being able to simply label
their products as "organic," it could further confuse consumers and
decrease demand for products.'" While consumer education could
help to resolve these issues, the expansion of the organic market
into mainstream retail establishments is not necessarily conducive to
that goal:
With this [transition] also comes a dramatic change in who will educate
consumers about organic products, for the Achilles heel of mainstream
retail is that the front lines of customer service are staffed by 15, 16, and
130. See id. at 17.
131. See id.
132. See generally REPORT TO CONGRESS, supra note 29.
133. See id. at 8.
134. See STROCHLIC, supra note 127, at 17 (summarizing survey respondents' con-
fusion regarding different categories of organic products).
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17 year olds who typically have trouble telling oranges from tangerines,
let alone organic practices from conventional practices. By hitching its
wagon to the mainstream grocery star, the organic industry has ceded
the battleground for effective consumer education.""
An additional concern of consumer groups is that, although
many of the synthetic substances currently allowed for use in proc-
essing are known to be harmless, the amendment "will open the
door" to the allowance of an even wider range of synthetics and
chemicals.'" The ability of the Secretary of Agriculture to grant an
exemption based on unavailability of an organic ingredient is also a
cause for concern because of fears that a company would succeed in
getting an exemption if an organic version of an ingredient was sim-
ply too expensive."7 This is becoming an even greater cause for
concern now that major retailers are entering the market and pres-
suring suppliers to reduce costs to be more competitive.'"
IV. CONCLUSION
Sales of organic foods have increased dramatically in recent
years,' 9 and this growth has been supported by the Organic Foods
Production Act (OFPA) and the National Organic Program (NOP).
These regulations created standards to insure that foods labeled
"organic" meet specific criteria, helping consumers to know what
they are purchasing. The Harvey v. Veneman lawsuit brought atten-
tion to the debate about whether the organic standards developed
by the USDA uphold the values that "organic" has traditionally rep-
resented. Harvey's challenge of the use of synthetic substances in
organic foods revealed the existence of extreme differences of opin-
ion between some producers and consumers of organic products.'"
The USDA must balance the needs of industry and the expecta-
tions of consumers in implementing the NOP. The use of synthetics
in organic foods, as allowed by the amendment of the OFPA, per-
mits the continued expansion of the organic market and allows pro-
135. Kevin Edberg, Executive Director, Coop. Dev. Servs., The Growth of the Or-
ganic Market: Producers' Perspectives, Agricultural Outlook Forum 2004 (Feb. 19,
2004), available at http://agecon.lib.umn.edu/cgi-bin/pdf view.pl?paperid=
12736&ftype=.pdf.
136. Melanie Warner, A Struggle Over Standards In a Fast-Growing Food Category,
N.Y. TIMEs, Nov. 1, 2005, at C1.
137. Id.
138. See id.
139. See DiMrrRI & GREENE, supra note 1, at iii.
140. See RAWSON, supra note 27, at 10.
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ducers to continue to offer a wide variety of organic products to
consumers to meet their increasing demand.'4 ' Increasing education
of consumers should also be a goal of the USDA. Consumer confi-
dence in the "organic" label is crucial to the success of the organic
food industry,'4" perhaps as crucial as the synthetic substances that
are allowed for use under the amended language of the OFPA. Ul-
timately, the burden rests upon consumers to determine exacdy
what may be in the products they choose to buy.
141. See generally REPORT TO CONGRESS, supra note 29.
142. See Emily Brown Rosen, The Devil is in the Details: or Why Organic Standards
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I. INTRODUCTION
Michael T. Roberts and Margie Alsbrook noted in the Journal's
inaugural Food Law Update that "[t]he one constancy about food law
in the United States is change, especially in a rapidly-developing
food industry."' This observation holds true today and also augurs a
change in authorship of this section of the Journal. I hope to follow
my colleagues' lead and provide timely and cogent updates of the
federal (and occasionally state) statutes, regulations, and judicial
decisions impacting food law and policy. It is both an honor and a
duty, as food and its legal implications remain in many respects "the
world's most important subject."'
This update summarizes significant changes and developments
in food law throughout the second half of 2006. Out of necessity,
not every change is included; rather, this update is limited to signifi-
cant changes in national law. This series of updates provides a start-
ing point for scholars, practitioners, food scientists, and policymak-
ers determined to understand the shaping of food law in modern
society. Tracing the development of food law through these updates
also builds an important historical context for the overall develop-
ment of the discipline.
* Assistant Professor of Agricultural Law, University of Illinois. This research
is supported by the Cooperative State Research Education & Extension Service,
USDA, Project No. ILLU-470-309. Any opinions, findings, and conclusions or rec-
ommendations expressed in this publication are those of the author and do not
necessarily reflect the view of the funding agency.
1. Michael T. Roberts & Margie Alsbrook, United States Food Law Update, I J.
FOOD L. & POL'Y 187, 187 (2005).
2. Id. (quoting FELIPE FERNANDEZ-ARMESTO, NEAR A THOUSAND TABLES: A
HISTORY OF FOOD ix (2002)).
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II. RECENT FEDERAL ADMINISTRATIVE ACTIONS
A. FDA: Produce Safety Initiatives
With the possible exceptions of the ongoing war in Iraq, the
mid-term elections, and the Cruise-Holmes celebrity wedding, food
law, specifically issues of food safety, captured the nation's attention
in the second half of 2006.'
On September 14, 2006, the Food and Drug Administration
(FDA) and Center for Disease Control and Prevention (CDC) issued
alerts regarding fifty instances of illness nationwide associated with
the deadly E. coli 0157:H7 pathogen.' In an abrupt departure from
the government's repeated urging to eat more produce as part of a
healthy diet,' the two agencies warned consumers to immediately
3. See, e.g., Michael Pollan, The Vegetable-Industrial Complex, N.Y. TIMES
MAGAZINE, Oct. 15, 2006, at 14 (discussing food safety in the context of industrial-
scale production); see also CBS News, E. coli Outbreak Source Located, Sept. 16, 2006,
http://www.cbsnews.com/stories/2006/09/15/health/printable2Ol2579.shtml
(last visited Sept. 20, 2007).
4. Press Release, Centers for Disease Control & Prevention (CDC), CDC Health
Alert: Multiple States Investigating a Large Outbreak of E. coil 0157:H7 Infections
(Sept. 14, 2006), http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?-
AlertNum=00249 (last visited Sept. 20, 2007); Press Release, Food & Drug Adminis-
tration (FDA), FDA Warning on Serious Foodborne E. coli 0157:H7 Outbreak
(Sept. 14, 2006), http://www.fda.gov/bbs/topics/NEWS/2006/NEW01450.html
(last visited Sept. 20, 2007).
Currently, there are four recognized classes of enterovirulent E. coli (col-
lectively referred to as the EEC group) that cause gastroenteritis in hu-
mans. Among these is the enterohemorrhagic (EHEC) strain designated
E. coli 0157:H7. E. coli is a normal inhabitant of the intestines of all ani-
mals, including humans. When aerobic culture methods are used, E. coli is
the dominant species found in feces. Normally E. coli serves a useful func-
tion in the body by suppressing the growth of harmful bacterial species
and by synthesizing appreciable amounts of vitamins. A minority of E. coli
strains are capable of causing human illness by several different mechan-
isms. E. coli serotype 0157:H7 is a rare variety of E. coli that produces
large quantities of one or more related, potent toxins that cause severe
damage to the lining of the intestine. These toxins [verotoxin (VT), shiga-
like toxin] are closely related or identical to the toxin produced by Shigella
dysenteriae.
FDA, CENTER FOR FOOD SAFETY & APPLF. NUTRITION (CFSAN), FOODBORNE
PATHOGENIC MICROORGANISMS AND NATURAL ToxINs HANDBOOK: ESCHERICHIA COLI
0157:H7 (2001), http://www.cfsan.fda.gov/-mow/chapl5.html (last visited Sept.
20, 2007). See also CDC, Escherichia coli 0157:H7, http://www.cdc.gov/
ncidod/dbmd/diseaseinfo/escherichiacolig.htm (last visited Sept. 20, 2007).
5. United States Dep't of Agric. (USDA), Dietary Guidelines,
http://www.mypyramid.gov/guidelines/index.html (last visited Sept. 20, 2007)
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cease consumption of bagged fresh spinach.' By October 6th, the
CDC identified 199 cases of E. coli-induced illness (three of which
resulted in the victim's death) across twenty-six states.7 On October
12th, the FDA and the State of California announced the results of a
joint investigation that traced back the particular outbreak strain of
E. coli 0157:H7 to cattle feces on a ranch in California's Central
Valley.8
Less than two months later, the CDC and the FDA warned the
public about another E. coli 0157:H7 outbreak associated with fresh
produce.9 In this instance, the agencies traced seventy-one illnesses
to lettuce from Taco Bell restaurants in four northeastern states."
During this same November-December time period, yet another
E. coli outbreak linked to iceberg lettuce injured eighty-one patrons
of Taco John's restaurants in Minnesota, Iowa, and Wisconsin." As
of this writing, the source of the tainted lettuce in the Taco Bell in-
cidents has yet to be officially determined, but health officials in
California, Minnesota, Iowa, and Wisconsin have matched the DNA
of the E. coli associated with the Taco John's outbreak with samples
gathered from dairy farms near lettuce fields in the Central Valley."2
Though the public's awareness of the association between
E. coli and fresh lettuce peaked in the second half of 2006, the FDA
(stating that a healthy diet should emphasize fruits and vegetables); FDA,
CFSAN/OFFICE OF PLANT AND DIARY FOODS, PRODUCE SAFETY FROM PRODUCTION TO
CONSUMPTION: 2004 ACTION PLAN TO MINIMIZE FOODBORNE ILLNESS ASSOCIATED
WITH FRESH PRODUCE CONSUMPTION (Oct. 2004), http://www.cfsan.
fda.gov/-dms/prodpla2.html (last visited Sept. 20, 2007) [hereinafter PRODUCE
SAFETY ACTION PLAN].
6. Press Release, FDA, supra note 4; Press Release, CDC, supra note 4.
7. Press Release, FDA, FDA Statement on Foodborne E. coli 0157:H7 Out-
break in Spinach (Oct. 6, 2006), http://www.fda.gov/bbs/topics/NEWS/
2006/NEW01486.html (last visited Sept. 20, 2007).
8. Press Release, FDA, FDA Statement on Foodbourne E. coli 0157:H7 Out-
break in Spinach (Oct. 12, 2006), http://www.fda.gov/bbs/topics/NEWS/
2006/NEW01489.html (last visited Sept. 20, 2007).
9. Press Release, FDA, FDA Investigating E. coli 0157:H7 Infections Associated
with Taco Bell Restaurants in Northeast (Dec. 6, 2006), http://www.
fda.gov/bbs/topics/NEWS/2006/NEW01517.html (last visited Sept. 20, 2007).
10. Press Release, FDA, Update: FDA Narrows Investigation of E. coli 0157:H7
Outbreak at Taco Bell Restaurants (Dec. 13, 2006), http://www.
fda.gov/bbs/topics/NEWS/2006/NEW01525.html (last visited Sept. 20, 2007).
11. Press Release, FDA, FDA and States Closer to Identifying Source of E. coli
Contamination Associated with Illnesses at Taco John's Restaurants (Jan. 12, 2007),
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has long expressed concern about the number of foodborne ill-
nesses associated with fresh produce, including lettuce.'3 In 2004,
the FDA initiated the Produce Safety Action Plan with the goal of
minimizing the incidence of foodborne illness associated with con-
sumption of fresh produce" via contamination prevention, minimiz-
ing the public health impact when contamination occurs, improving
communication about foodborne illness from farm to fork, and
supporting research relevant to fresh produce safety."
Specific Produce Safety Action Plan steps included develop-
ment of commodity-specific and practice-specific guidance for the
production, packing, processing, transportation, distribution, and
preparation of fresh produce. 6 Education efforts focused on the
promotion of Good Agricultural Practices (GAPs) and Good Manu-
facturing Practices (GMPs), as well as raising consumer awareness
via the media and broader use of the internet. 
7
In response to recurring outbreaks of E. coli 0157:H7 asso-
ciated with fresh and fresh-cut lettuce, but before the disruptions
described above, the FDA launched a Lettuce Safety Initiative (LSI)
in August 2006.8 Scheduled to commence during the Fall 2006
harvest, the LSI has four primary objectives: (1) to assess current
industry practices and, if appropriate, encourage improvements in
lettuce safety; (2) to respond rapidly and alert consumers in the
event of an outbreak; (3) to develop or refine guidance to minimize
contamination; and (4) to consider regulatory action in the event of
conditions that could lead to contamination." Initial steps by the
FDA consisted of working with California's Department of Health
Services and Department of Food and Agriculture to visit and in-
spect farms and processing facilities to assess existing GAPs and
13. PRODUCE SAFETY ACTION PLAN, supra note 5 ("Because most produce is
grown in a natural environment, it is vulnerable to contamination with pathogens..
. . The fact that produce is often consumed raw without any type of intervention
that would reduce, control, or eliminate pathogens prior to consumption contri-
butes to its potential as a source of foodborne illness.").
14. See id. ("The plan's scope included fresh fruits and vegetables, both in un-
peeled, natural form and raw products that have received some minimal processing
(such as peeling, chopping, or trimming).") The plan did not include frozen fruits




18. FDA, CFSAN, LETrUCE SAFETY INITIATIVE (Aug. 23, 2006),
http://www.cfsan.fda.gov/ dms/lettsafe.html (last visited Sept. 20, 2007).
19. Id.
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GMPs.2 ' Future FDA actions include continuing outreach along all
points of the supply chain and facilitating lettuce safety research.'
On November 15, 2006, the FDA and the CDC appeared before
the Senate Committee on Health, Education, Labor and Pensions to
discuss the Fall 2006 E. coli outbreak in spinach.' Both agencies
noted the persistent problem of foodborne illness associated with
fresh produce, especially ready-to-eat products. 3
Due to its recent adoption, the effectiveness of the LSI remains
to be seen, and the Fall 2006 outbreaks may not indicate an inherent
weakness with the LSI. Rather, the events amplify the need to direct
increased attention toward produce safety. Although the FDA will
assume the lead in the federal effort to improve produce safety, the
agency acknowledges that obtaining significant results will require
collaboration with the CDC, the United States Department of Agri-
culture (USDA), and counterparts at the local, state, and interna-
tional level, as well as with the private sector and academia.4 Not
surprisingly, Congress reacted to the increased public awareness of
food safety with the introduction of several food-related bills, a topic
for a future update in 2007.25
B. USDA: Meat and Poultry Inspection Programs
Although certainly not of the same public profile as the spi-
nach/lettuce E. coli issues that arose in Fall 2006, the USDA's Office
of Inspector General (OIG) issued an Audit Report criticizing the
20. Id.
21. Id.
22. CDC Food Safety Activities and the Recent E. coli Spinach Outbreak: Hearings
Before the Committee on Health, Education, Labor and Pensions, Nov. 15, 2006 (testi-
mony of Lonnie J. King, Sr. Veterinarian, CDC), available at
http://www.hhs.gov/asl/testify/t061115.html; Ensuring Food Safety: FDA's Role in
Tracking and Resolving the Recent E. coli Spinach Outbreak: Hearing Before the Committee
on Health, Education, Labor and Pensions, Nov. 15, 2006 (testimony of Robert E.
Brackett, Ph.D., CFSAN Director), available at http://help.senate.gov/
Hearings/2006 11_15/Brackett.pdf.
23. Testimony of Lonnie J. King, supra note 22, at 5-6; testimony of Robert E.
Brackett, supra note 22.
24. See PRODUCE SAFETY ACTION PLAN, supra note 5.
25. See generally GEOFFREY S. BECKER, CONGRESSIONAL RESEARCH SERVICE, CRS
REPORT FOR CONGRESS, FOOD SAFETY: SELECTED ISSUES AND BILLS IN THE 110TH
CONGRESS (2007), Order Code RL34152, available at http://
www.nationalaglawcenter.org/assets/crs/RL34152.pdf.
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Food Safety and Inspection Service's (FSIS) state meat and poultry
inspection program.6
The FSIS is responsible for inspecting all meat and poultry
products sold in interstate and foreign commerce." It accomplishes
this goal, in part, by entering into cooperative agreements with
states to enforce standards that are "at least equal to" federal laws
and regulations.28 Twenty-eight states have implemented "at least
equal to" meat and poultry inspection (MPI) programs.' Federal
guidelines apply in the remaining twenty-two states." In response to
concerns regarding the adequacy of state-inspected facilities, the
2002 Farm Bill directed the Secretary of Agriculture to review state
MPI programs and report the findings to Congress.3 Accordingly,
the FSIS instituted a comprehensive review system in October 2003
to recertify state programs under new, more secure guidelines.'
2
The OIG found that the FSIS failed to complete the reviews in a
timely manner (only eight of twenty-eight on-site visits were com-
pleted over a twenty-one-month period) and of the twenty-four re-
views started through April 2006, eleven initial determinations as to
compliance with the "at least equal to" standard were either "de-
ferred" or found to have significant concerns or worse.3 In addi-
tion, the OIG noted that for the four state reviews that the FSIS
completed, the agency failed to fully document or justify its conclu-
sions.' For example, three states were found to be "at least equal
to" federal standards although 100%, 100%, and 77% of the sampled
establishments had deficiencies.' In contrast, the fourth state, of
26. See generally USDA, AUDIT REPORT: FOOD SAFETY AND INSPECTION SERVICE-
STATE MEAT AND POULTRY INSPECTION PROGRAMS, REPORT No. 24005-1-AT (2006),
available at http://www.usda.gov/oig/webdocs/24005-01-AT.pdf [hereinafter FSIS
AUDIT].
27. See Federal Meat Inspection Act, 21 U.S.C. § 661(a)(1)-(2) (2007); see also
Poultry Products Inspection Act, 21 U.S.C. § 455(a)(1) (2006).
28. FSIS AUDIT, supra note 26, at i.
29. Id. at 1.
30. Id.
31. Id. at 2, n.6.
32. Id. at 4. Hazard Analysis and Critical Control Points (HACCP) programs,
Sanitation Standard Operating Procedures (SSOP), and Sanitation Performance
Standards (SPS) provide guidance for state meat and poultry inspection (MPI) pro-
grams. Id. at 1.
33. Id. at 3-4. The Food Safety and Inspection Service (FSIS) deferred determi-
nations for nine states, made one preliminary determination that there were "signif-
icant concerns," and made one preliminary finding that the state's program "did
not support at least equal to." Id. at 3, n.7.
34. Id. at 8-9.
35. Id. at 8, Tbl. 1.
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which the FSIS found 86% of the sampled establishments to be defi-
cient, was deemed to have "significant concerns. "3
In response to these and other criticisms identified by the OIG,
the FSIS updated its Manual for State Meat and Poultry Inspection
Reviews." Under the revised state review procedures, the FSIS re-
vised the two-stage determination of a state's "at least equal to" sta-
tus and placed new emphasis on compliance with the Humane Me-
thods of Slaughter Act (HMSA).3
During the state's examination process under the new review
process, the FSIS will make independent "at least equal to" determi-
nations for each stage of the review-state self-assessment and FSIS
on-site review (including verification of the self-assessment). States
not scheduled for on-site review in a particular year, however, will
receive a single determination based solely on the self-assessment. °
States receiving an on-site review will receive a determination by the
FSIS based on both the self-assessment and the on-site review."
As part of its new emphasis on humane slaughter, the FSIS will
determine compliance with the HMSA as part of the annual state
self-assessment of Statutory Authority and Food Safety Regulations."
Previously, the FSIS assessed compliance with HMSA provisions on-
ly during on-site reviews." States must demonstrate that they have
either adopted the HMSA or promulgated equivalent regulations
along with legal authority to enforce the rules."
C. FDA and Department of Treasury: Food and
Beverage Allergen Labeling
The Federal Food, Drug, and Cosmetic Act (FFDCA) and the
Food Allergen Labeling and Consumer Protection Act of 2004
(FALCPA) address the labeling of foods that contain potential food
36. Id. at 8-9 and Thl. 1.
37. See id. at 11 (noting FSIS's response to OG Recommendation 3); see general-
ly, USDA, FSIS, FSIS MANUAL FOR STATE MEAT AND POULTRY INSPECTION REVIEWS
(2006), available at http://www.fsis.usda.gov/PDF/StatePrograms_Review_
Manual.pdf [hereinafter FSIS MPI MANUAL].
38. FSIS MPI MANUAL, supra note 37, at 5-6.




43. FSIS MPI MANUAL, supra note 37, at 5.
44. Id. at 6.
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allergens."5 In October 2006, the FDA revised, for the third time, its
industry guidance for food allergen labeling. ' In a related action,
the Department of Treasury, Bureau of Alcohol and Tobacco Tax
and Trade (TTB) issued an interim rule for the adoption of volunta-
iy labeling standards for major food allergens used in the produc-
tion of alcoholic beverages. 7 A brief discussion of these two regula-
tory actions follows.
1. FDA Industry Guidance Regarding Food Allergens
In the FALCPA, Congress designated eight foods or food
groups as "major food allergens," which comprise 90% of all known
food allergens. ' Packaged foods containing a designated "major
food allergen," and labeled on or after January 1, 2006, must comply
with the FALCPA's food allergen labeling requirements. 9 The
FDA's October 2006 guidance revision clarified four issues for in-
dustry-the common names for nineteen tree nuts," the identifica-
tion of acceptable market names for imported and domestically
available seafood that comply with the declaration of the "species of
fish or Crustacean shellfish" requirement," that the term "wheat"
includes any species in the genus Triticum (e.g., common wheat,
spelt, semolina, kamut, and triticale), 2 and that even single ingre-
dient foods must comply with allergen declaration requirements.
45. Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C.A. § 343 (w)-(x)
(2007) (addressing labeling, misbranding, and food allergens); Food Allergen Labe-
ling and Consumer Protection Act of 2004 (FALCPA), Pub. L. No. 108-282, § 201-
210 (codified in scattered sections of 21 U.S.C.A.).
46. See FDA, GUIDANCE FOR INDUSTRY: QUESTIONS AND ANSWERS REGARDING FOOD
ALLERGENS, INCLUDING THE FOOD ALLERGEN LABELING AND CONSUMER PROTECTION
ACT OF 2004 (4th ed. 2006), available at http://www.cfsan.fda.gov/
~dms/alrguid4.html [hereinafter FDA FOOD ALLERGEN GUIDANCE].
47. See Major Food Allergen Labeling for Wines, Distilled Spirits, and Malt Beve-
rages, Interim Rule, 71 Fed. Reg. 42260 (July 26, 2006) (to be codified at 27 C.F.R.
pts. 4, 5 and 7).
48. FDA FOOD ALLERGEN GUIDANCE, supra note 46. FALCPA defines a "major
food allergen" as an ingredient that is one of the following five foods or food
groups, or an ingredient containing a protein derived from one of the following:
milk, egg, fish, crustacean shellfish, tree nuts, wheat, peanuts, or soybeans. 21
U.S.C. § 321(qq) (2005).
49. FDA FOOD ALLERGEN GUIDANCE, supra note 46.
50. Id. (listing tree nuts by their common and scientific names).
51. Id. See also FDA, CFSAN, Seafood List Introduction (2002),
http://www.cfsan.fda.gov/- frf/seaintro.html (last visited Oct. 1, 2007).
52. FDA FOOD ALLERGEN GUIDANCE, supra note 46 (listing types of wheat).
53. Id.
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2. TrB Interim Rule for Alcohol Beverage Food Allergen Labeling
The TTB administers the Federal Alcohol Administration Act
(FAA Act),' which, among its other actions, regulates the labeling of
wines with at least 7% alcohol, distilled spirits, and malt (alcohol)
beverages. Section 105 of the FAA Act authorizes the promulgation
of regulations regarding the labeling of alcohol beverages with re-
spect to identity and quality to prevent consumer deception.55
Although the TIB regulations do not require full ingredient
labeling for alcoholic beverages, the agency has a long-standing me-
morandum of understanding with the FDA to coordinate mandatory
labeling of "ingredients in alcohol beverages that pose a recognized
public health problem."' If the FDA determines that the presence
of an ingredient poses a public health problem, the TrB will initiate
rulemaking procedures to require indication of the ingredient on
the label.57 For example, the TrB rules require labels to indicate the
use of aspartame in the production of malt beverages, the addition
of FD&C Yellow No. 5, and the presence of sulfites above 10 parts
per million."
Acknowledging this history of cooperation between the FDA
and the TTB, Congress called on the agencies to promulgate appro-
priate allergen labeling regulations for products under TTBjurisdic-
tion.5 In cooperation with the FDA, the TTB issued regulations that
adopt, in large part, the FALCPA and the FDA guidance, described
above.'M As of this writing, the TTB allergen labeling regulations
remain voluntary. The T'B, however, simultaneously published a
54. See generally 27 U.S.C. § 201 (2006); see also 27 U.S.C. § 202(f) (2006) (allow-
ing the Secretary of the Treasury to utilize other governmental agencies).
55. 27 U.S.C. § 205(e) (2006). For specific Alcohol and Tobacco Tax and Trade
Bureau (TrB) regulations regarding the labeling of alcohol beverages, see 27 C.F.R.
§ 4-5, 7 (2007).
56. Memorandum of Understanding, 52 Fed. Reg. 45502 (Nov. 30, 1987).
57. Major Food Allergen Labeling for Wines, Distilled Spirits, and Malt Beverag-
es, Interim Rule, 71 Fed. Reg. 42260, 42261 (July 26, 2006) (to be codified at 27
C.F.R. pts. 4, 5 and 7) (describing the Memorandum of Understanding with the
FDA).
58. Id. (citing 58 Fed. Reg. 44131 (August 19, 1993) (codified at 27 C.F.R. pt. 7)
(discussing aspartame); 48 Fed. Reg. 45549 (October 6, 1983) (codified at 27 C.F.R.
pts. 4, 5 and 7) (discussing Yellow No. 5); 51 Fed. Reg. 34706 (September 30, 1986)
(codified at 27 C.F.R. pts. 4, 5 and 7) (discussing sulfites)).
59. Id. at 42262 (citing H.R. Rep. No. 108-608, at 3 (2004)). Authority for TrB's
actions, however, rests with the Federal Alcohol Administration Act, rather than the
FALCPA or the FFDCA. Id.
60. Id. at 42264.
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notice of proposed rulemaking and solicited comments on a pro-
posal to make major food allergen labeling mandatory."
The interim regulations provide that if an individual chooses to
label any major food allergen (i.e., opt-in to the program), then the
individual must declare all major food allergens used in production
of the alcohol beverage.' Although compliance with the voluntary
labeling program generally tracks the FALCPA rules for food, the
alcohol beverage labeling rules do not require the identification of
specific fish species due to the inability of vintners and brewers to
ascertain the species when purchasing supplies.6 In addition, an
individual may petition the TFB for a labeling exemption if the use
of a major food allergen in the production of a specific alcohol be-
verage differs from its use in food and does not cause an allergic
reaction or contain an allergic protein.' This early petition process
for exemptions may allow the regulated community time to transi-
tion to the proposed mandatory program.
III. RECENT CASE DECISIONS
A. Food Safety: Criminal Convictions for Improper Food Storage
According to the Court of Appeals for the Seventh Circuit,
"[t]he conditions at LaGrou's cold storage warehouse at 2101 Persh-
ing Road in Chicago were enough to turn even the most enthusiastic
meat-loving carnivore into a vegetarian. "' Approximately two mil-
lion pounds of food passed through the warehouse on a daily basis.'
Unfortunately, the rat population was of similar scale and employee
"rat patrols" tallied as many as fifty trapped rats per day." Product
loss due to extensive rodent damage (e.g., beef brisket chewed by
rats) continued for several years with employees adopting short-
hand codes such as "MM" (short for "Mickey Mouse") on shipping
61. See Major Food Allergen Labeling for Wines, Distilled Spirits, and Malt Beve-
rages, Notice of Proposed Rulemaking, 71 Fed. Reg. 42329-44 (July 18, 2006) (to be
codified at 27 C.F.R. pts. 4, 5 and 7).
62. Major Food Allergen Labeling for Wines, Distilled Spirits, and Malt Beverag-
es, Interim Rule, 71 Fed. Reg. 42260, 42264 (July 26, 2006) (to be codified at 27
C.F.R. pts. 4, 5 and 7).
63. Id.
64. Id. at 42265 (discussing petitions for exemption from TrB regulation).
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documents to differentiate rodent damage from other warehouse-
related product loss.'
In May 2002, a team of United States Department of Agricul-
ture (USDA), Food and Drug Administration (FDA), Illinois De-
partment of Public Health, Chicago Department of Public Health,
and Illinois Department of Agriculture officials inspected the Persh-
ing Road warehouse.69 A USDA microbiologist present at the in-
spection testified that the warehouse was "the 'worst case' she had
seen in her 28 years with the USDA."' The government detained all
22 million pounds of meat, poultry, and food products at the ware-
house."'
The corporate defendant LaGrou Distribution Systems, Inc.
(LaGrou), was convicted of three felony countsn for (1) knowing
improper storage of poultry products," (2) knowing improper sto-
rage of meat products,74 and (3) knowing improper storage of food
products.75 The trial court sentenced LaGrou to five years proba-
tion, a total fine of $2 million, and ordered $8.2 million in restitu-
tion."
Although certainly an egregious example of good manufactur-
ing practices, the case warrants discussion in this Update because
of the Seventh Circuit's analysis of the mens rea requirements for a
68. Id. at 588.
69. Id. at 589.
70. LaGrou, 466 F.3d at 589. Even after the warehouse manager and twenty-
eight employees spent all night cleaning in anticipation of the inspection, officials
found and photographed
rat droppings and rat nesting material throughout the warehouse, includ-
ing next to and on product; rodent-gnawed meat, poultry, and other food
products; live rodent sightings; blood from meat product on the floor
mixed with rodent droppings and rat tail marks; dirt and debris on meat
product; potential rodent access points, including open sewer drains...
holes in ceilings, walls and doors; ice buildup on the ceilings directly above
stored product and water dripping... onto the product; mold and filth on
the walls and ceilings; several inoperable bathrooms, which forced workers
to use broken toilets and "flush" them with buckets of water; and raw se-
wage and standing water on the floors.
Id.
71. Id. at 590.
72. Id. at 586-87.
73. See 21 U.S.C. § 458(a)(3) and § 461(a) (2006).
74. See 21 U.S.C. § 610(d) and § 676(a) (2006).
75. See 21 U.S.C. § 331(b), § 333(a)(2), and § 342(a)(4) (2006).
76. LaGrou, 466 F.3d at 587.
77. See generally Current Good Manufacturing Practice in Manufacturing, Pack-
ing or Holding Human Food, 21 C.F.R. § 110 (2007).
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corporate criminal conviction and reasonable restitution amounts in
light of Apprendi v. New Jersey8 and United States v. Booker!"
1. "Knowingly" stored products under insanitary conditions.
The critical element for the criminal conviction in this case was
a finding that the corporation, through its authorized agents or em-
ployees, knowingly stored products under insanitary conditions.'
The jury instructions noted that a corporation acquires "knowledge"
through its agents and "[w]here a corporate agent obtains know-
ledge while acting in the scope of agency" there is a presumption
that the agent will report that knowledge to the corporate princip-
al.' In this case, LaGrou's president, warehouse manager, and em-
ployees on the "rat patrol" were "well aware of the rodent infesta-
tion problem and other insanitary conditions ... yet persisted in stor-
ing and distributing meat, poultry, and other food products [at the
Pershing Warehouse]."' The Seventh Circuit upheld the jury in-
struction and felony conviction.'
2. Restitution and Fines
On appeal, LaGrou urged the court to review the lower court's
restitution order in light of the newly-issued Apprendi and Booker
decisions.' The court rejected LaGrou's arguments and held that
restitution is a civil penalty "for harm done" and is "administered
for convenience by the courts," and therefore is not within the sole
providence of the jury.' Accordingly, the Sixth Amendment, as in-
terpreted by Booker, and Apprendi, do not apply.'6
The court went on to review the trial court's $8.2 million order
for restitution based on an abuse of discretion standard.' Of the
approximately 22 million pounds seized, health officials salvaged
over 12 million pounds at a decontamination cost of $2.7 million.'
78. 530 U.S. 466 (2000).
79. 543 U.S. 220 (2005).
80. LaGrou, 466 F.3d at 591-92.
81. Id. at 591.
82. Id. at 592.
83. Id. at 592, 594.
84. Id. at 592-93.
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The government, however, could not recondition and therefore de-
stroyed over 8 million pounds of customers' products with a whole-
sale price of $5.5 million.' The court found the expenses incurred
for decontamination to be "reasonable," as well as the use of whole-
sale prices to assess the balance of the restitution amount."
The trial court sentenced LaGrou to a total of $2 million in
fines in accordance with the Sentencing Guidelines for corporate
defendants found guilty of a felony ranging from "not more than
the greater of (a) $500,000; (b) twice the gross gain; or (c) twice the
gross loss.""' The trial court sentenced LaGrou to $500,000 on
count three (poultry), $500,000 on count four (meat), and $1 mil-
lion on count five (food products).' Because the court failed to give
a special interrogatory or verdict form to the jury, the statutory max-
imum for each count was limited to $500,000. Accordingly, the ap-
peals court remanded for resentencing on the $1 million fine for
count five. 3 Absent a jury's determination, the court held that the
trial judge improperly used a preponderance of the evidence stan-
dard to determine the "loss amount" under section (c), rather than a
jury standard of beyond a reasonable doubt.'
B. Genetic Engineering Field Trials: Environmental Assessments
In February 2004, a group of environmental and food safety in-
terest groups filed suit alleging that the USDA's Animal and Plant
Health Inspection Service (APHIS) failed to comply with the Endan-
gered Species Act (ESA) and the National Environmental Policy Act
(NEPA) when it approved permits for the open-air field testing of
genetically engineered, pharmaceutical-producing plant varieties
(GEPPVs) in Hawaii.'5 After protracted litigation, the district court
granted in part and denied in part the parties' competing motions
for summary judgment. 6 Although this case dealt specifically with
89. Id.
90. LaGrou, 466 F.3d at 593-94.
91. Id. at 594 (citing 18 U.S.C. § 3571(c)(3), (d)).
92. Id. at 594.
93. Id. As of this writing, the Supreme Court has further refined Apprendi in
Cunningham v. California, 127 S. Ct. 856 (2007), the implication of which is beyond
the scope of this paper.
94. LaGrou, 466 F.3d at 594.
95. See Center for Food Safety v. Veneman, 364 F. Supp. 2d 1202, 1205 (D. Haw.
2005) (denying motion to dismiss).
96. Center for Food Safety v. Johanns, 451 F. Supp. 2d 1165, 1171 (D. Haw.
2006).
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GEPPVs, the ESA and NEPA requirements could apply to future
APHIS decisions that permit open-air field testing of genetically en-
gineered plant varieties destined for food or feed that do not other-
wise qualify for APHIS's streamlined "notification" provisions for
field testing.'
The plaintiffs argued in their motion for summary judgment,
inter alia, that APHIS failed to evaluate properly the environmental
impact of the genetically engineered crops before issuing permits
for field testing." Moreover, the plaintiffs alleged that the experi-
mental use permits for the Hawaii field trials were part of a broader
GEPPV program and APHIS failed to consider the environmental
consequences of the program as a whole.' In so doing, the plaintiffs
claimed that APHIS violated the ESA and NEPA."' APHIS coun-
tered that it fulfilled its statutory obligations and placed strict condi-
tions on the permits at issue to ensure protection of the environ-
ment. '1
The court concluded that APHIS violated both the ESA and
NEPA in issuing the individual field testing permits and entered
summary judgment for plaintiffs."' However, the court granted
summary judgment for the government defendants with respect to
ESA and NEPA compliance for APHIS's alleged GEPPV program.1'
A brief discussion of the court's decision follows.
1. Endangered Species Act Claims
APHIS did not dispute that the issuance of the individual field
testing permits was "agency action" sufficient to implicate the ESA.
APHIS argued, however, that once it determined that the proposed
field trials would not affect listed species or critical habitat, a formal
consultation with the United States Fish and Wildlife Service (FWS)
97. See Introduction of Organisms and Products Altered or Produced through
Genetic Engineering, 7 C.F.R. § 340.3 (2007). For a description of the streamlined
.notification" procedures and genetically engineered plants eligible for this process,
see USDA, Animal and Plant Health Inspection Service (APHIS), Biotechnology Noti-
fications, http://www.aphis.usda.gov/biotechnology/notifications.shtml (last visited
Sept. 25, 2007); and USDA, APHIS, BIOTECHNOLOGY REGULATORY SERVICES USER'S
GUIDE (DRAFT GUIDANCE), Chapter 6 (2007), available at http://
www.aphis.usda.gov/brs/pdf/brs -userguide_6_Notification.pdf.
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and the National Marine Fisheries Service (NMFS) was not re-
quired.TM The court held that regardless of whether a formal consul-
tation may or may not eventually be required, APHIS failed to take
the initial step of requesting information about listed species and
critical habitats from the FWS and the NMFS. °5 The initial proce-
dural requirement to request information is a necessary first step."M
Accordingly, APHIS must request information from the FWS and
the NMFS regarding listed species and critical habitats before de-
termining whether to engage in formal consultation or issuing fur-
ther field testing permits in Hawaii."n
2. National Environmental Policy Act Claim
Because avoidance of environmental impacts is built into the
agency action when issuing some permits,"M APHIS regulations pro-
vide for a categorical exclusion for the preparation of an environ-
mental assessment (EA) or an environmental impact statement (EIS)
for "confined field releases of genetically engineered organisms."' °
APHIS argued that each of the GEPPV permits in this case involved
confined or controlled field tests."' Accordingly, APHIS asserted
that its approval of the permits did not require a separate EA or
EIS."' The court agreed with APHIS's reasoning, but refused to
defer to the agency's post hoc explanation because the administrative
record for each permit was devoid of any reference to consideration
of environmental consequences as required by NEPA."' Moreover,
APHIS failed to document in the administrative record that it consi-
dered whether an exception to the categorical exclusions applied."'
104. Id. at 1181-82.
105. Id. at 1182 (interpreting 16 U.S.C. § 1536(c)(1) and Interagency Coopera-
don-Endangered Species Act, 50 C.F.R. § 402.12).
106. Id. at 1182 (noting that "[e]ven if APHIS is ultimately correct in its assertion
that no listed species or habitats have been harmed, APHIS's actions are neverthe-
less tainted because APHIS failed to comply with a fundamental procedural re-
quirement").
107. Id. at 1181-82. Hawaii has 329 endangered and threatened species. Id. at
1170. Yet, the mild climate and year-round growing conditions are ideal for expe-
rimental field trials. Id. at 1211 (noting the long history of field trials in Hawaii).
108. Center for Food Safety, 451 F. Supp. 2d at 1184.
109. National Environmental Policy Act Implementing Procedures, 7 C.F.R. §
372.5(c)(3)(ii) (2007).
110. Centerfor Food Safety, 451 F. Supp. 2d at 1184.
111. Id.
112. Id.
113. Id. at 1185-86.
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Despite these deficiencies with the individual permits, the court
found that APHIS's internal procedures and protocols for approv-
ing GEPPV permits as part of a general program did not violate
NEPA or the ESA."' Although the cumulative effect of the permits
may constitute an organized method of issuing GEPPV permits,
there was no "final agency action" that would require a broader
programmatic EIS under NEPA,"' or "agency action" to trigger the
ESA's procedural requirements."' The court, accordingly, entered
summary judgment for APHIS on the programmatic issues."7
With the plaintiffs' consent, the court entered only declaratory
relief on the ESA and NEPA claims related to the individual per-
mits." Because the field tests were complete and injunctive relief
ordering APHIS to comply with the ESA and NEPA would be super-
fluous, the court declined to order further action such as an envi-
ronmental study of the effects of the open-air tests."9 Despite the
limited relief, this case provides important guidance for APHIS in-
ternal operating procedures for future permitting decisions.
IV. CONCLUSION
Food safety issues (e.g., E. coli, state meat and poultry inspec-
tion programs, warehouse sanitation) dominated the news and fed-
eral judicial and administrative actions for the second half of 2006.
Concerns related to the production, storage, and distribution of safe
food in this increasingly globally connected world will remain pree-
minent issues for all involved in the food supply chain. Greater
consumer awareness and agency interaction with the public via the
internet and other distribution channels will ensure the focus of
continued political attention to this important aspect of food law.
In addition, the introduction of enhanced technology (e.g., genetic
engineering, cloning) into the food supply promises to engender
significant passion and present challenges for the food industry.
114. Id. at 1190.
115. Center for Food Safety, 451 F. Supp. 2d at 1189.
116. Id. at 1190.
117. Id. at 1192.
118. Id. at 1195.
119. Id.
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Nicole Coutrelis*
I. PUBLISHED REGULATIONS
A. Labeling of Foodstuffs
On December 23, 2006, the European Commission published
Commission Directive 2006/142/EC "amending Annex IlIa of Di-
rective 2000/13/EC of the European Parliament and of the Council
listing the ingredients which must under all circumstances appear
on the labelling of foodstuffs" in regard to Directive 2000/13/EC of
the European Parliament and of the Council of March 20, 2000, "on
the approximation of the laws of the Member States relating to the
labelling, presentation and advertising of foodstuffs."' "Annex IIla
of Directive 2000/13/EC lists the ingredients which must under all
circumstances appear on the labeling of foodstuffs . .. ," and the
new Directive added two new allergens which must be indicated on
packaging of foodstuffs: Lupin and products thereof and Molluscs
and products thereof.'
B. Food Additives
Directive 2006/52/EC of the European Parliament and of the
Council of July 5, 2006, "amending Directive 95/2/EC on food ad-
ditives other than colours and sweeteners and Directive 94/35/EC
* Nicole Coutrelis is a member of the Paris, France Bar and an attorney for
Coutrelis & Associates in Brussels, Belgium and Paris, France. Her practice focuses
on litigation and lobbying efforts in the area of food law. She also serves as Secre-
tary General of the European Food Law Association and she is a member of the
Paris Bar Association, the International Bar Association, and the Food and Drug
Law Institute. She has taught several courses and published many articles on the
subject of food law in the European Union.
1. Commission Directive 2006/142, 2006 O.J. (L 368) 110 (EC).
2. Directive 2006/142, whereas (1)-(5), at 110.
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on sweeteners for use in foodstuffs" was adopted.! Some new addi-
tives were added to Directive 95/2/EC, while others were deleted,
which means that they can no longer be used as additives.4 A new
additive was added to Directive 94/35/EC to be used as a sweet-
ener-erythritol' Additionally, more stringent requirements were
established for the use of nitrites and nitrates in meat.6 The direc-
tive also extended the permitted uses of some food additives
C. Foods for Particular Nutritional Uses
New Directive 2006/141/EC "on infant formulae and follow-on
formulae and amending Directive 1999/21/EC" was adopted.8 The
main purpose of the new Directive is to recast previous legislation,
Directive 91/321/EEC, in the interest of clarity. The Directive also
includes some modifications. Definitions of infant formula and fol-
low-on formula have been slightly changed. Quantities of sub-
stances which can be added to these products have also been par-
tially modified.
D. Protected Food Names
During March 2006, the European Commission published
Council Regulation No. 510/2006/EC "on the protection of geo-
graphical indications and designations of origin for agricultural
products and foodstuffs."9 This regulation repealed Regulation
2081/92/EEC on the same issue. ° The new regulation was adopted
following the decision of the World Trade Organization (WTO)
Dispute Settlement Body of March 15, 2005." It establishes that
operators in third countries are entitled to submit applications for
the protection of geographic names and statements of objection to
applications directly to the European Commission.12
3. Council Directive 2006/52, 2006 O.J. (L 204) 10 (EC).
4. Directive 2006/52, art. 1, at 12.
5. Directive 2006/52, at 22.
6. Directive 2006/52, at 10.
7. Directive 2006/52, at 11.
8. Commission Directive 2006/141, 2006 O.J. (L 401) 1-33 (EC).
9. Council Regulation 510/2006, 2006 O.J. (L 93) 12 (EC).
10. Regulation 510/2006, at 13.
11. Panel Report, European Communities-Protection of Trademarks & Geographical
Indicators for Agricultural Products & Foodstuff, WT/DS174/R (Mar. 15, 2005).
12. Id. at 165.
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As a result of this new Council Regulation being adopted, a new
Commission Regulation (EC) No. 1898/2006 of December 14, 2006,
"laying down detailed rules of implementation of Council Regula-
tion (EC) No. 510/2006 on the protection of geographical indica-
tions and designations of origin for agricultural products and food-
stuffs" was adopted."
E. Pesticides
Commission Directive 2006/92/EC "amending Annexes to
Council Directives 76/895/EEC, 86/362/EEC and 90/642/EEC as
regards maximum residue levels for captan, dichlorvos, ethion and
folpet"'4 was adopted on November 9, 2006. This directive amends
three other directives concerning maximum residue levels of some
pesticides in some types of vegetables, fruits, and cereals.
F. Food Hygiene
Commission Regulation (EC) No. 1662/2006 of November 6,
2006, "amending Regulation (EC) No. 853/2004 of the European
Parliament and of the Council laying down specific hygiene rules for
food of animal origin" sets up new hygiene provisions." "Fish oil is
included in the definition of fishery products [and specific] re-
quirements for production and placing on the market of fish oil for
human consumption" were therefore established.'" Specific hygiene
rules for colostrum production were also established."
Conditions for the production of collagen were modified be-
cause a new opinion of the European Food Safety Authority (EFSA)
considered a new processing method for the production of collagen
to be safe.'8 New provisions were also established on the complete
skinning of the carcass of domestic ungulates." Commission Regu-
lation (EC) No. 1663/2006 of November 6, 2006 "amending Regula-
tion (EC) No. 854/2004 of the European Parliament and of the
Council laying down specific rules for the organisation of official
controls on products of animal origin intended for human con-
13. Commission Regulation 1898/2006, 2006 O.J. (L 369) 1 (EC).
14. Commission Directive 2006/92, 2006 O.J. (L 311) 31 (EC).
15. Commission Regulation 1662/2006 O.J. (L 320) 1 (EC).
16. Regulation 1662/2006, at 1.
17. Regulation 1662/2006, at 1.
18. Regulation 1662/2006, at 1.
19. Regulation 1662/2006, at 1.
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sumption" established appropriate control measures for the new
requirements established by Regulation 1662/2006/EC." Commis-
sion Regulation (EC) No. 1664/2006 of November 6, 2006, "amend-
ing Regulation (EC) No. 2074/2005 as regards implementing meas-
ures for certain products of animal origin intended for human con-
sumption and repealing certain implementing measures" established
new health certificates for imports of certain products of animal or-
igin intended for human consumption.21 "These certificates [were]
developed to comply with the expert system 'Traces' developed by
the Commission to follow any movement of animals and products
derived therefrom within the EU territory and from third coun-
tries," and set up new requirements for testing and certifying certain
animal products (e.g., fishery products, molluscs, milk).2
G. Genetically Modified Organisms (GMOs)
Following importation of non-authorized genetically modified
rice, LL RICE 601, from the United States, the European Commis-
sion adopted three decisions on emergency measures regarding the
non-authorized genetically modified organism LL RICE 601 in rice
products." These decisions established that Member States shall
allow the first placing on the market of some listed rice products
only where an original analytical report based on suitable and vali-
dated method for detection of genetically modified rice LL RICE
601 and issued by an accredited laboratory accompanying the con-
signment demonstrates that the product does not contain geneti-
cally modified rice LL RICE 601. The Commission insists on con-
trol measures which are done at the Member States level. 4
H. Transmissible Spongiform Encephalopathies (TSE)
On December 18, 2006, a new Regulation (EC) No. 1923/2006
of the European Parliament and of the Council amended Regulation
(EC) No. 999/2001 "laying down rules for the prevention, control
20. Commission Regulation 1663/2006, 2006 O.J. (L 320) 11-12 (EC).
21. Commission Regulation 1664/2006, 2006 O.J. (L 320) 13 (EC).
22. Regulation 1664/2006, at 13.
23. Commission Decision 2006/578, 2006 O.J. (L 230) 8 (EC); Commission De-
cision 2006/601, 2006 O.J. (L 244) 27 (EC); Commission Decision 2006/754, 2006
O.J. (L 306) 17 (EC).
24. Decision 2006/578, art. 2-3, at 10; Decision 2006/601, art. 2-3, at 28-29;
Decision 2006/754, art. 2-3, at 18-19.
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and eradication of certain transmissible spongiform encephalo-
pathies."'
Rules for the disposal of specific risk materials and animals in-
fected by transmissible spongiform encephalopathies were repealed
from the Regulation as all measures are now established in Regula-
tion 1774/2002/EC "laying down health rules concerning animal
by-products not intended for human consumption. " 6 "Based on
evolving scientific knowledge, Regulation (EC) No. 999/2001 should
allow the extension to other species of the scope of rules concerning
the placing on the market and export of bovine, ovine and caprine
animals, their semen, embryos and ova." 7 This new regulation gives
more power to the European Commission to approve rapid tests
established by Member States, to adapt the age of animals under
surveillance, to introduce tolerance level (based on a favorable risk
assessment, a decision may be taken in accordance with the proce-
dure referred to in Article 24(3) to introduce a tolerance level for
insignificant amounts of animal proteins in feedingstuffs caused
through adventitious and technically unavoidable contamination,
taking into account at least the amount and possible source of con-
tamination and the final destination of the consignment), and to
allow feeding of young animals of ruminant species with protein
derived from fish and extending certain provisions for other animal
species. 8 The Commission is also empowered to establish rules pro-
viding for exemptions from the requirement to remove and destroy
specific risk material, to establish criteria to demonstrate improve-
ment of the epidemiological situation, and to establish criteria for
granting exemptions from certain restrictions as well as production
processes.'
L Food Contaminants
During July 2006, Regulation 1041/2006/EC "amending Annex
III to Regulation (EC) No. 999/2001/EC of the European Parlia-
ment and of the Council as regards monitoring of transmissible
spongiform encephalopathies in ovine animals" extended the moni-
25. Commission Regulation 1923/2006, O.J. (L 404) 1 (EC).
26. Regulation 1923/2006, at 4.
27. Regulation 1923/2006, at 4.
28. Regulation 1923/2006, at 3.
29. Regulation 1923/2006, at 3.
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toring of sheep in order to improve Community eradication pro-
grams."
A new Commission Regulation (EC) No. 1881/2006 of Decem-
ber 19, 2006, "setting maximum levels for certain contaminants in
foodstuffs" was adopted." It repealed previous Regulation No.
466/2001 which was amended many times and therefore needed to
be codified.' The new regulation amended maximum levels for
certain contaminants."
Two other Commission Regulations were also adopted at the
same time: Commission Regulation (EC) No. 1882/2006 of De-
cember 19, 2006, "laying down methods of sampling and analysis for
the official control of the levels of nitrates in certain foodstuffs;"
and Commission Regulation (EC) No. 1883/2006 of December 19,
2006, "laying down methods of sampling and analysis for the official
control of levels of dioxins and dioxin-like PCBs in certain food-
stuffs."
A new Recommendation 2006/794/EC "on the monitoring of
background levels of dioxins, dioxin-like PCBs and non-dioxin-like
PCBs in foodstuffs" was adopted.' It repeals the previous Recom-
mendation 2004/705/EC 7 The monitoring program was modified,
taking into account the experiences acquired.
II. PENDING DRAFr REGULATIONS
A. Food Additives and Food Enzymes
The European Commission has issued two draft proposals: a
draft regulation on food additives,'0 and a draft regulation on food
30. Commission Regulation 1041/2006, 2006 O.J. (L 187) 10 (EC).
31. Commission Regulation 1881/2006, 2006 O.J. (L 364) 5 (EC).
32. Regulation 1881/2006, at 5.
33. Regulation 1881/2006, at 5.
34. Commission Regulation 1882/2006, 2006 O.J. (L 364) 25 (EC).
35. Commission Regulation 1883/2006, 2006 O.J. (L 364) 32 (EC).
36. Commission Recommendation 2006/794, 2006 O.J. (L 322) 24 (EC).
37. Recommendation 2006/794, at 24.
38. See Commission Proposal for a Regulation of the European Parliament and of the
Council on Food Additives, COM (2006) 428 final (July 28, 2006), available at
http://ec.europa.eu/food/food/chemicalsafety/additives/com2006_428_en.pdf
[hereinafter Commission Proposal on Food Additives].
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enzymes used in foodstuffs. 9 Both proposals were transmitted to
the Council and European Parliament onJuly 28, 2006.40
The proposed regulation on food additives repeals previous ex-
isting directives to establish a single legislation including sweeteners,
colors, and other additives."1 The second proposal is new, as there
was no previous European legislation on food enzymes authorized
in foodstuffs because different measures were being applied in each
Member State.2
B. Food Flavorings
The European Commission issued a proposal for a Regulation
on flavorings and certain food ingredients with flavoring properties
for use in and on food. This proposal was transmitted to the
European Parliament and to the Council on July 28, 2006." It aims
to establish a list of flavorings allowed in foodstuffs and their condi-
tion for use. It also concerns labeling of flavorings.
A proposal for a Regulation establishing a common authoriza-
tion procedure for food additives, food enzymes, and food flavor-
ings was also transmitted to the Council and the European Parlia-
39. See Commission Proposal for a Regulation of the European Parliament and of the
Council on Food Enzymes and Amending Council Directive 83/417/EEC, Council Regula-
tion (EC) No. 1493/1999, Directive 2000/13/EC, and Council Directive 2001/112/EC,
COM (2006) 425 final (July 28, 2006), available at
http://ec.europa.eu/food/food/chemicalsafety/additives/com2006_425_en.pdf
[hereinafter Commission Proposal on Food Enzymes].
40. See Commission Proposal on Food Additives, COM (2006) 428 final (July 28,
2006); see also Commission Proposal on Food Enzymes, COM (2006) 425 final (July 28,
2006).
41. Commission Proposal on Food Additives, at 1-3 COM (2006) 428 final (July 28,
2006).
42. Commission Proposal on Food Enzymes, at 2 COM (2006) 425 final (July 28,
2006).
43. See Commission Proposal for a Regulation of the European Parliament and of the
Council on Flavorings & Certain Food Ingredients with Flavoring Properties for Use In
and On Foods and Amending Council Regulation (EEC) No. 1576/89, Council Regulation
(EEC) No. 1601/91, Regulation (EC) No. 2232/9666 and Directive 2000/13/EC, COM
(2006) 427 final (July 28, 2006), available at http://ec.europa.eu/food/food/
chemicalsafety/additives/com2006_427_en.pdf [hereinafter Commission Proposal on
Flavoring Properties].
44. See Commission Proposal on Flavoring Properties, COM (2006) 427 final (July 28,
2006).
45. Commission Proposal on Flavoring Properties, at 2-3 COM (2006) 427 final (July
28, 2006).
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ment.'  Its main objectives are to set up a "centrali[z]ed, effective,
expedient and transparent" authorization procedure "based on risk
assessment[s] carried out by the European Food Safety Authority,"
and to replace the various existing procedures. 7
III. CASE LAW-JUDGMENTS ISSUED
A. Responsibility of Distributors
Following the submission of a request for a preliminary ruling
deferred to the European Court of Justice by an Italian jurisdiction,
the Court had to deal with an issue on responsibilities for labeling of
foodstuffs.48
An Italian distributor sold an alcoholic beverage, "Amaro alle
erbe," in an oudet. 9 The distributor bought the product from a
German producer who pre-packaged it in Germany to be sold as
such to the final consumer.' Controls carried out by Italian authori-
ties showed that the alcoholic strength by volume of the product was
lower than that stated on the product label, which did not conform
to provisions of Directive 2000/13/EC on the labeling of food-
stuffs.5 Indeed, Directive 2000/13/EC states that labeling should
not mislead consumers. 2 The labeling was done by the producer in
Germany."
The Municipality of Arcole ordered the distributor to pay an
administrative fee.' The distributor challenged this decision before
the Giudice di pace (Justice of the Peace) who decided to refer to
46. See Commission Proposal for a Regulation of the European Parliament & of the
Council Establishing a Common Authorization Procedure for Food Additives, Food En-
zymes, and Food Flavorings, COM (2006) 423 final (July 28, 2006), available at
http://ec.europa.eu/food/food/chemicalsafety/additives/com2006_423_en.pdf
[hereinafter Commission Proposal for Common Authorization Procedures].
47. Commission Proposal for Common Authorization Procedures, at 2 COM (2006)
423 final (July 28, 2006).
48. Case C-315/05, Lidl Italia Sri v. Comune Di Arcole (VR), 2006 ECJ CELEX








53. See Lidl Italia Srl, supra note 48.
54. Id.
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the European Court of Justice to determine whether Community
provisions establishing responsibilities for labeling of pre-packaged
foodstuffs are imposed only on the producer of the foodstuff or
whether they can also apply to the distributor.'
The Court explained that Directive 2000/13/EC on labeling of
foodstuffs prohibits, inter alia, labeling and methods used for mis-
leading the purchaser as to characteristics of foodstuffs and added
that
an examination of the general scheme of... Directive 2000/13 and of
the context in which it occurs and the objects of that directive gives suf-
ficient convergent indications permitting the conclusion to be drawn
that it does not preclude national legislation, ... which provides that a
distributor may be held liable for infringement of the obligation as re-
gards labelling imposed by those provisions.'
Moreover, the Court stated that Regulation 178/2002/EC, laying
down the general principles and requirements of food law, states
"that operators in the food sector should ensure at every stage of
production, processing and distribution in the undertakings under
their control that the foodstuffs comply with the requirements of
the food legislation applicable to their operations and should check
that those requirements are fulfilled."
57
Therefore, the European Court of Justice decided that Directive
on labeling of foodstuffs did not preclude legislation of a Member
State from stating that a distributor will be held responsible for an
infringement of one of the provisions of the directive resulting from
the producer's inaccurate statement on the product label, even
when it "simply markets the products as delivered to it by the pro-
ducer."'
B. Free Movements of Goods
In another case, the European Court of Justice had to deal with
an issue concerning the free movement of goods and, more specifi-




58. See Lidl Italia Srl, supra note 48.
59. Joined Cases 158 & 159/04, Alfa Vita Vassilopoulos AE & Carrefour Mari-
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quick thawing followed by re-heating or baking, at the sales oudets,
of fully or partially pre-baked and frozen products."'
Greek legislation stated that to establish a bakery or a bread
shop, a license should be obtained first from the competent local
authority.6 Two food shops sold bread and used ovens for the bak-
ing of frozen bread without any license. Greek authorities ordered
cessation of operation of the bread ovens.62 The two shops chal-
lenged this decision before the National Court.'
The National Court referred to the European Court of Justice
for preliminary ruling. The main question was whether a require-
ment for prior license in order to make "bake-off' products consti-
tuted a "measure equivalent to a quantitative restriction within the
meaning of Article 28" of the Treaty.' Article 28 prohibits measures
having equivalent effects to quantitative restrictions of import be-
tween Member States.'
The Court has, however, clarified that measures having equivalent effect
to quantitative restrictions and therefore prohibited by Article 28 EC do
not include national provisions restricting or prohibiting certain selling
arrangements, so long as those provisions apply to all relevant traders
operating, within the national territory and so long as they affect in the
same manner, in law and in fact, the marketing of domestic products of
those from other Member States.6
In the case at stake, the Court stated that the Greek measure dealt
with the process of production of the product, and not with "certain
selling arrangements."67 Therefore, there was no doubt that Article
28 of the Treaty could apply to the measure.' Nevertheless, "a na-
tional rule which hinders the free movement of goods is not neces-
sarily contrary to Community law if it may be justified "by a public
interest reason such as health protection."'
The Court recognized that "the national legislation aimed at
ensuring that bakery products are prepared and marketed in proper










69. SeeJoined Cases 158 & 159/04, supra note 59.
70. Id.
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requirements relating to the manufacturing method of traditional
bakery products [were] inappropriate and [went] beyond what [was]
necessary for 'bake-off products."7  The measure was dispropor-
tionate regarding health protection.' The Court decided that the
legislation, as far as "bake off" products were concerned, was con-
trary to Community law and established a measure having equiva-
lent effect to quantitative restrictions to trade. 3
C. Bovine Spongiform Encephalopathy (BSE)
In another case, the Court of First Instance (CFI) had to deal
with an action for damages allegedly suffered by the applicants
(people living in France) as a consequence of the infection and sub-
sequent death of members of their families who suffered from the
new variant of Creutzfeld-Jakob disease after consuming infected
meat some time ago. '4 The applicants considered that the Commis-
sion and the Council failed to adopt adequate measures in order to
prevent contamination of consumers by the new variant of
Creutzfeld-Jakob disease at the end of the 1980s."
The applicants based their action on the extra-contractual re-
sponsibility of the European Institutions (Commission and Council),
provided for in two articles of the Treaty establishing the European
Community:
Article 288, § 2: "In the case of non-contractual liability, the Commu-
nity shall, in accordance with the general principles common to the laws
of the Member States, make good any damage caused by its institutions
or by its servants in the performance of their duties."76
Article 235: "The Court of Justice shall have jurisdiction in disputes re-
lating to compensation for damage provided for in the second para-
graph of Article 288.
"77
The Court indicated that, regarding the Community's non-
contractual liability, a right to reparation is conferred where three
conditions are met: (1) the rule of law infringed must be intended




74. Case T-138/03, E.R. & Others v. Council & Commission (July 5, 2003).
75. Id.
76. Id.; see also Treaty Establishing the European Community, Dec. 24, 2002,
2002 O.J. (C 325) 147 [hereinafter EC Treaty].
77. See Case T-138/03, supra note 74; see also EC Treaty supra note 76, at 128.
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serious; (2) the existence of a damage must be established; and (3)
there must be a direct causal link between the breach of the obliga-
tion resting on the Community and the damage suffered by the in-
jured parties.78
The applicants claimed that the defendants made a manifest error of as-
sessment in their management of the risks associated with the BSE epi-
demic by not recommending a forward scientific evaluation of the risk
of BSE developing[] in various geographical areas of the Union at the
time of identification of the causes of the epidemic and of adoption of
the first protective measures in the United Kingdom.79
"In support of their claims, the applicants submitted that the defen-
dants' conduct in this case constitute[d] a misuse of powers inas-
much as it was aimed only at protecting in an ill-considered manner
the interests of the market and of the beef sector." 8°
"The applicants further maintain[ed] that the defendants' in-
ternal disorgani[z]ation led their staff to underestimate the risks of
BSE developing and by that very fact constitute[d] a serious breach
of the legitimate expectations of European consumers."" The CFI
did not deny the fact that people had died from the new variant of
Creutzfeld-Jakob disease because of consuming meat infected by
BSE.' Nonetheless, the Court considered that, even if legislation
had forbidden at that time the consumption of specified risk mate-
rials (SRM) (specific part of beef considered to be very contagious)
in all Member States, it was not sure that the applicant would not
have been infected by Creutzfeld-Jakob disease.' Therefore, the
Court refused to establish responsibilities of European Institutions
as there was no direct causal link between the breach of the obliga-
tion resting on the Community and the damage suffered by the in-
78. See Case T-138/03, supra note 74.
79. Action Against the Council of the European Union and Commission of the Euro-




Action Against the Council & Commission]; see also Case T-138/03, supra note 74.
80. See Action Against the Council & Commission, supra note 79; see also Case T-
138/03, supra note 74.
81. See Action Against the Council & Commission, supra note 79; see also Case T-
138/03, supra note 74.
82. See Case T-138/03, supra note 74.
83. Id.
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jured parties.' The applicants have decided to appeal against this
judgment in the European Court ofJustice.'
IV. OTHER RELEVANT NEWS
A. Regulations Entered Into Application
1. Labeling: Health Claims
On December 20, 2006, Regulation (EC) No. 1924/2006 of the
European Parliament and of the Council "on nutrition and health
claims made on foods" was finally adopted.' It will become effective
onJuly 1, 2007.
The proposed Health and Nutrition Claims Regulation lays
down strict conditions "for the use of nutrition claims such as 'low
fat,' 'high fiber,' or 'reduced sugar.'" Set thresholds will have to be
met before such claims can be made.
[C]laim[s] can only be used if the product bearing the claim fits a certain
nutritional profile (i.e. below a certain salt, fat and/or sugar level).
These nutritional profiles will be set by Commission and Member States
through Comitology procedure, based on the opinion of the European
Food Safety Authority (EFSA), within twenty-four months of the Regula-
tion entering into force. 89
With regard to health claims, the Commission will draw up,
within three years of the Regulation entering into force, a positive
list of established claims on the basis of lists submitted by Member
States.' "Any claims submitted for the European Union list after
this period will have to be examined by EFSA and approved by the





86. Corrigendum to Council Regulation 1924/2006, 2007 OJ. (L 12) 3 (EC).
87. Regulation 1924/2006, art. 29, at 15.
88. Press Release, Europa, Commission Kyprianou Welcomes European Parlia-
ment Vote on Heath & Nutrition Claims (May 16, 2006), available at
http://europa.eu/rapid/pressReleasesAction.do?reference=IP/06/626&format=H
TML&aged=0&language=EN [hereinafter Vote on Health & Nutrition]; see also
Regulation 1924/2006, Annex, at 16-18.
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"The use of new health claims or disease reduction claims ...
will require specific authori[z]ation by the Commission through the
Comitology procedure, following scientific assessment and verifica-
tion of the claim by EFSA."2 Transitional provisions are also set up
for products legally labeled before the entry into force of the regula-
tion.
2. Food Fortification with Vitamins and Minerals
Regulation (EC) No 1925/2006 of the European Parliament
and of the Council of December 20, 2006, "on the addition of vita-
mins and minerals and of certain other substances to foods"' was
adopted at the same time as the "nutrition and health claims" Regu-
lation. This Regulation aims at creating harmonized EU rules on
the addition of vitamins, minerals, and other substances to food.95
Strict labeling criteria for fortified foods are also set out in the Regu-
lation.'
An EU list of approved vitamins and minerals is set out in the
Regulation, and vitamins and minerals not included on this list will
no longer be allowed to be added to food." Minimum and maxi-
mum levels for the addition of different nutrients to food will also
be established through the Comitology procedure based on scien-
tific advice from the EFSA.9 The regulation also deals with sub-
stances, other than vitamins or minerals, that have a nutritional or
physiological effect." Lists of prohibited or restricted-in-use sub-
stances will be established.'" Scientific evaluation will be done by
the EFSA.' ' In the meantime, national rules still apply regarding
these substances.
92. See id ; see also Corrigendum to Regulation 1924/2006, whereas (12), at 4,
whereas (23), at 6.
93. Regulation 1924/2006, art. 2, at 14-15.
94. Council Regulation 1925/2006, 2006 O.J. (L 404) 26 (EC).
95. Regulation 1925/2006, whereas (2), at 26.
96. Regulation 1925/2006, art. 7, at 31.
97. Regulation 1925/2006, art. 3, at 29.
98. Regulation 1925/2006, art. 6, at 30.
99. Regulation 1925/2006, art. 2, at 29.
100. Regulation 1925/2006, art. 8, at 31.
101. Regulation 1925/2006, art. 8, at 31.
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B. Unofficial documents and announcements
1. Food Colors
On December 7, 2006, the European Food Safety Authority
(EFSA) launched a call for data on food colors as part of a system-
atic re-evaluation of all authorized food additives in the EU.I° The
European Commission asked the EFSA to proceed as such in order
to take an account of new information since the original assessments
were done. 3 The EFSA planned to provide scientific advice on col-
ors in early 2007."'° Interested stakeholders were to submit informa-
tion by March 31, 2007.I°
2. Genetically Modified Organisms (GMOs)
On December 15, 2006, the "EFSA launched a public consulta-
tion on the use of animal feeding trials to assess the safety a nutri-
tional value of [genetically modified] food or feed."l" The EFSA has
already discussed the different types of scientific tests available and
seeks views of all interested parties before final recommendations
are made.' 7
3. Acrylamide
Acrylamide is "a chemical which has been shown to be present
in food as a result of cooking practices, some of which have been
used for many years, even centuries.""° The Commission has been
coordinating several initiatives on that topic in the EU. For the
moment, there is still a need to clarify the risk incurred by the con-
102. Press Release, European Food Safety Auth., Food Colours: Call for Data to




105. European Food Safety Auth., Food Colours: Call for Data to Support Re-
Evaluation, http://www.efsa-europa.eu/EFSA/efsalocale- 1178620753812_117862
0771267.htm (last visited Oct. 18, 2007).
106. Press Release, European Food Safety Auth., EFSA Launches Public Consulta-
tion on GMO Feeding Trials (Dec. 15, 2006), available at
http://www.efsa.europa.eu/EFSA/NewsPR/pr-gmo-feeding-en.pdf.
107. Id.
108. EUROPA, Food Safety: From the Farm to the Fork,
http://ec.europa.eu/food/food/chemicalsafety/contaminants/acrylamide_en.htm
(last visited Oct. 18, 2007).
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sumption of acrylamide because acrylamide could raise toxicological
problems." The European Food Industry (CIAA) issued a toolbox
to highlight ways to lower levels of acrylamide in food."'
109. Id.
110. CONFEDERATION OF THE FOOD & DRINK INDUSTRIES OF THE EU (CIAA), THE
CIAA ACRYLAMIDE "TOOLBOX," available at http://www.ciaa.eu/documents/bro-
chures/CIAAAcrylamideToolboxOct2006.pdf.
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